1	Thrombosis	NNP	O	Thrombosis	nn	2	SENT_1	[p1l806t81r947b103],
2	Research	NNP	O	Research	_	0	SENT_1	[p1l958t81r1065b103],
3	125	CD	NUMBER	125	number	4	SENT_1	[p1l1077t82r1118b103],
4	(	CD	NUMBER	(	dep	2	SENT_1	[p1l1132t81r1211b108],
5	2010	CD	DATE	2010	num	7	SENT_1	[p1l1132t81r1211b108],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l1132t81r1211b108],
7	e265	NN	O	e265	dep	4	SENT_1	[p1l1223t82r1355b103],
8	—	CD	NUMBER	—	num	9	SENT_1	[p1l1223t82r1355b103],
9	e268	NN	O	e268	dep	2	SENT_1	[p1l1223t82r1355b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l783t191r917b215],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l931t191r988b215],
3	available	JJ	O	available	amod	2	SENT_2	[p1l1002t191r1130b215],
4	at	IN	O	at	_	0	SENT_2	[p1l1143t194r1171b215],
5	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1184t191r1389b215],

1	TI	NNP	O	TI	nn	3	SENT_3	[p1l1947t234r1969b251],
2	l	NN	O	l	nn	3	SENT_3	[p1l1978t234r1981b251],
3	ROIVII	NN	O	roivius	_	0	SENT_3	[p1l1989t234r2124b251],
4	‘	SYM	O	‘	dep	3	SENT_3	[p1l1989t234r2124b251],
5	-	:	O	-	_	0	SENT_3	[p1l1989t234r2124b251],
6	(	CD	NUMBER	(	dep	3	SENT_3	[p1l1989t234r2124b251],
7	ISIS	NNP	ORGANIZATION	ISIS	nn	8	SENT_3	[p1l1989t234r2124b251],
8	RI	NN	O	rus	rcmod	6	SENT_3	[p1l1971t260r1991b278],
9	SI	NNP	O	SI	dep	8	SENT_3	[p1l2002t260r2102b278],
10	]	SYM	O	]	dep	8	SENT_3	[p1l2002t260r2102b278],
11	-	:	O	-	_	0	SENT_3	[p1l2002t260r2102b278],
12	\	NN	O	\	nn	13	SENT_3	[p1l2002t260r2102b278],
13	l	NN	O	l	dep	6	SENT_3	[p1l2002t260r2102b278],
14	{	CD	NUMBER	{	num	16	SENT_3	[p1l2002t260r2102b278],
15	L’	NN	O	l’	nn	16	SENT_3	[p1l2002t260r2102b278],
16	|	NN	O	|	dep	13	SENT_3	[p1l2002t260r2102b278],
17	l	NN	O	l	tmod	13	SENT_3	[p1l2002t260r2102b278],

1	Thrombosis	NNP	O	Thrombosis	nn	2	SENT_4	[p1l804t287r1110b334],
2	Research	NNP	O	Research	_	0	SENT_4	[p1l1134t287r1365b334],

1	—	NN	O	—	_	0	SENT_5	[p1l15t420r52b438],
2	;	:	O	;	_	0	SENT_5	[p1l15t420r52b438],
3	,	,	O	,	_	0	SENT_5	[p1l78t420r243b442],
4	;	:	O	;	_	0	SENT_5	[p1l78t420r243b442],
5	~	NN	O	~	dep	3	SENT_5	[p1l78t420r243b442],
6	.	.	O	.	_	0	SENT_5	[p1l78t420r243b442],

1	—	NN	O	—	_	0	SENT_6	[p1l78t420r243b442],
2	.	.	O	.	_	0	SENT_6	[p1l78t420r243b442],

1	.	.	O	.	_	0	SENT_7	[p1l78t420r243b442],

1	—	NN	O	—	_	0	SENT_8	[p1l78t420r243b442],
2	.	.	O	.	_	0	SENT_8	[p1l78t420r243b442],

1	,	,	O	,	_	0	SENT_9	[p1l78t420r243b442],
2	,	,	O	,	_	0	SENT_9	[p1l78t420r243b442],
3	‘	NN	O	‘	nsubj	5	SENT_9	[p1l78t420r243b442],
4	,	,	O	,	_	0	SENT_9	[p1l78t420r243b442],
5	~	NN	O	~	_	0	SENT_9	[p1l78t420r243b442],
6	~	NN	O	~	dobj	5	SENT_9	[p1l78t420r243b442],
7	.	.	O	.	_	0	SENT_9	[p1l78t420r243b442],

1	—	NN	O	—	_	0	SENT_10	[p1l78t420r243b442],
2	.	.	O	.	_	0	SENT_10	[p1l78t420r243b442],

1	~	NN	O	~	_	0	SENT_11	[p1l78t420r243b442],
2	_	NN	O	_	dep	1	SENT_11	[p1l78t420r243b442],
3	,	,	O	,	_	0	SENT_11	[p1l78t420r243b442],
4	.	.	O	.	_	0	SENT_11	[p1l78t420r243b442],

1	—	NN	O	—	_	0	SENT_12	[p1l78t420r243b442],
2	.	.	O	.	_	0	SENT_12	[p1l78t420r243b442],

1	_	NN	O	_	_	0	SENT_13	[p1l78t420r243b442],
2	.	.	O	.	_	0	SENT_13	[p1l78t420r243b442],

1	—	NN	O	—	_	0	SENT_14	[p1l78t420r243b442],
2	.	.	O	.	_	0	SENT_14	[p1l78t420r243b442],

1	;	:	O	;	_	0	SENT_15	[p1l78t420r243b442],
2	journal	NN	O	journal	nn	3	SENT_15	[p1l580t407r704b437],
3	homepage	NN	O	homepage	_	0	SENT_15	[p1l724t407r918b437],
4	:	:	O	:	_	0	SENT_15	[p1l724t407r918b437],
5	www.elsevier.com/locate/thromres	NNS	O	www.elsevier.com/locate/thromres	dep	3	SENT_15	[p1l938t407r1588b432],

1	Regular	JJ	O	regular	dep	128	SENT_16	[p1l6t541r143b581],
2	Article	NN	O	article	dep	128	SENT_16	[p1l156t541r274b573],
3	The	DT	O	the	dep	128	SENT_16	[p1l6t619r98b664],
4	GPIIIa	NN	O	gpiium	dep	128	SENT_16	[p1l116t621r263b664],
5	PIA	NN	O	pium	dep	128	SENT_16	[p1l281t619r364b663],
6	polymorphism	NN	O	polymorphism	dep	128	SENT_16	[p1l380t619r753b675],
7	and	CC	O	and	dep	128	SENT_16	[p1l770t619r862b664],
8	the	DT	O	the	dep	128	SENT_16	[p1l880t619r960b664],
9	platelet	NN	O	platelet	dep	128	SENT_16	[p1l978t619r1169b675],
10	hyperactivity	NN	O	hyperactivity	dep	128	SENT_16	[p1l1187t619r1523b675],
11	in	IN	O	in	dep	128	SENT_16	[p1l1540t620r1586b663],
12	Tunisian	JJ	MISC	tunisian	dep	128	SENT_16	[p1l1602t620r1818b664],
13	patients	NNS	O	patient	dep	128	SENT_16	[p1l1836t620r2038b675],
14	with	IN	O	with	dep	128	SENT_16	[p1l6t690r122b736],
15	stable	JJ	O	stable	dep	128	SENT_16	[p1l141t690r287b736],
16	coronary	JJ	O	coronary	dep	128	SENT_16	[p1l310t703r535b747],
17	artery	NN	O	artery	dep	128	SENT_16	[p1l556t697r708b747],
18	disease	NN	O	disease	dep	128	SENT_16	[p1l729t690r910b736],
19	treated	VBN	O	treat	dep	128	SENT_16	[p1l933t690r1113b736],
20	with	IN	O	with	dep	128	SENT_16	[p1l1134t690r1251b735],
21	aspirin	NN	O	aspirin	dep	128	SENT_16	[p1l1273t691r1445b747],
22	Fatma	NNP	PERSON	Fatma	dep	128	SENT_16	[p1l6t795r126b828],
23	Abderrazek	NNP	PERSON	Abderrazek	dep	128	SENT_16	[p1l139t793r369b828],
24	3	CD	NUMBER	3	dep	128	SENT_16	[p1l379t792r403b834],
25	,	,	O	,	_	0	SENT_16	[p1l379t792r403b834],
26	Tahar	NNP	PERSON	Tahar	dep	128	SENT_16	[p1l416t793r530b828],
27	Chakroun	NNP	PERSON	Chakroun	dep	128	SENT_16	[p1l543t793r735b828],
28	"	``	O	"	dep	128	SENT_16	[p1l747t785r806b834],
29	'	''	O	'	_	0	SENT_16	[p1l747t785r806b834],
30	*	CD	NUMBER	*	dep	128	SENT_16	[p1l747t785r806b834],
31	,	,	O	,	_	0	SENT_16	[p1l747t785r806b834],
32	Faouzi	NNP	PERSON	Faouzi	dep	128	SENT_16	[p1l821t793r947b828],
33	Addad	NNP	PERSON	Addad	dep	128	SENT_16	[p1l960t793r1088b828],
34	C	NNP	O	C	dep	128	SENT_16	[p1l1100t792r1123b834],
35	,	,	O	,	_	0	SENT_16	[p1l1100t792r1123b834],
36	Zohra	NNP	PERSON	Zohra	dep	128	SENT_16	[p1l1137t793r1251b828],
37	Dridi	NNP	PERSON	Dridi	dep	128	SENT_16	[p1l1265t793r1363b828],
38	°	NN	O	°	dep	128	SENT_16	[p1l1375t792r1397b834],
39	,	,	O	,	_	0	SENT_16	[p1l1375t792r1397b834],
40	Grigoris	NNP	PERSON	Grigoris	dep	128	SENT_16	[p1l1412t794r1569b837],
41	Gerotziafas	NNP	PERSON	Gerotziafas	dep	128	SENT_16	[p1l1584t793r1805b828],
42	d	NN	O	d	dep	128	SENT_16	[p1l1817t785r1844b834],
43	,	,	O	,	_	0	SENT_16	[p1l1817t785r1844b834],
44	Habib	NNP	PERSON	Habib	dep	128	SENT_16	[p1l1859t793r1974b828],
45	Gamra	NNP	PERSON	Gamra	dep	128	SENT_16	[p1l1989t795r2120b828],
46	C	NNP	O	C	dep	128	SENT_16	[p1l2131t792r2154b834],
47	,	,	O	,	_	0	SENT_16	[p1l2131t792r2154b834],
48	Mohsen	NNP	PERSON	Mohsen	dep	128	SENT_16	[p1l6t846r164b881],
49	Hassine	NNP	PERSON	Hassine	dep	128	SENT_16	[p1l182t847r334b881],
50	3	CD	NUMBER	3	dep	128	SENT_16	[p1l346t845r370b887],
51	,	,	O	,	_	0	SENT_16	[p1l346t845r370b887],
52	Ismail	NNP	PERSON	Ismail	dep	128	SENT_16	[p1l389t846r506b881],
53	Elalamy	NNP	PERSON	Elalamy	dep	128	SENT_16	[p1l524t846r682b890],
54	d	NN	O	d	dep	128	SENT_16	[p1l692t838r709b862],
55	3	CD	NUMBER	3	dep	128	SENT_16	[p1l6t921r15b931],
56	Haematology	NN	O	haematology	dep	128	SENT_16	[p1l26t922r196b949],
57	/	:	O	/	dep	128	SENT_16	[p1l26t922r196b949],
58	's	POS	O	's	dep	128	SENT_16	[p1l26t922r196b949],
59	Laboratory	NN	O	laboratory	dep	128	SENT_16	[p1l206t922r340b949],
60	;	:	O	;	_	0	SENT_16	[p1l206t922r340b949],
61	Fattouma	NNP	ORGANIZATION	Fattouma	dep	128	SENT_16	[p1l351t923r460b944],
62	Bourguiba	NNP	ORGANIZATION	Bourguiba	dep	128	SENT_16	[p1l471t922r589b949],
63	University	NNP	ORGANIZATION	University	dep	128	SENT_16	[p1l601t922r717b949],
64	Hospital	NNP	ORGANIZATION	Hospital	dep	128	SENT_16	[p1l727t922r827b949],
65	,	,	O	,	_	0	SENT_16	[p1l727t922r827b949],
66	Monastir	NNP	LOCATION	Monastir	dep	128	SENT_16	[p1l838t922r947b947],
67	,	,	O	,	_	0	SENT_16	[p1l838t922r947b947],
68	Tunisia	NNP	LOCATION	Tunisia	dep	128	SENT_16	[p1l958t922r1040b944],
69	‘’	CD	NUMBER	‘’	dep	128	SENT_16	[p1l6t952r16b967],
70	Regional	NNP	ORGANIZATION	Regional	dep	128	SENT_16	[p1l27t957r127b984],
71	Center	NNP	ORGANIZATION	Center	dep	128	SENT_16	[p1l137t958r212b979],
72	of	IN	ORGANIZATION	of	dep	128	SENT_16	[p1l221t957r246b984],
73	Blood	NNP	ORGANIZATION	Blood	dep	128	SENT_16	[p1l251t957r316b979],
74	Transfusion	NNP	ORGANIZATION	Transfusion	dep	128	SENT_16	[p1l326t957r464b984],
75	,	,	O	,	_	0	SENT_16	[p1l326t957r464b984],
76	Research	NNP	O	Research	dep	128	SENT_16	[p1l475t957r577b979],
77	Unit	NNP	O	Unit	dep	128	SENT_16	[p1l589t957r638b979],
78	"	``	O	"	dep	128	SENT_16	[p1l648t957r744b979],
79	Platelet	NN	O	platelet	dep	128	SENT_16	[p1l648t957r744b979],
80	function	NN	O	function	dep	128	SENT_16	[p1l748t957r846b984],
81	Study	NN	O	study	dep	128	SENT_16	[p1l856t957r922b984],
82	»	CD	NUMBER	»	dep	128	SENT_16	[p1l932t965r942b977],
83	UR	NN	O	ur	dep	128	SENT_16	[p1l953t958r1080b982],
84	.06	CD	NUMBER	.06	dep	128	SENT_16	[p1l953t958r1080b982],
85	SP05	NN	O	sp05	dep	128	SENT_16	[p1l953t958r1080b982],
86	,	,	O	,	_	0	SENT_16	[p1l953t958r1080b982],
87	Farhat	NNP	ORGANIZATION	Farhat	dep	128	SENT_16	[p1l1092t957r1168b979],
88	Hached	NNP	ORGANIZATION	Hached	dep	128	SENT_16	[p1l1176t957r1262b979],
89	University	NNP	ORGANIZATION	University	dep	128	SENT_16	[p1l1274t957r1390b984],
90	Hospital	NNP	ORGANIZATION	Hospital	dep	128	SENT_16	[p1l1400t957r1500b984],
91	,	,	O	,	_	0	SENT_16	[p1l1400t957r1500b984],
92	Sousse	NNP	LOCATION	Sousse	dep	128	SENT_16	[p1l1510t958r1591b982],
93	,	,	O	,	_	0	SENT_16	[p1l1510t958r1591b982],
94	Tunisia	NNP	LOCATION	Tunisia	dep	128	SENT_16	[p1l1603t957r1685b979],
95	C	NNP	O	C	dep	128	SENT_16	[p1l6t992r14b1002],
96	Cardiac	JJ	O	cardiac	dep	128	SENT_16	[p1l26t993r113b1014],
97	Thrombosis	NNP	O	Thrombosis	dep	128	SENT_16	[p1l123t993r255b1014],
98	Research	NNP	O	Research	dep	128	SENT_16	[p1l264t993r366b1014],
99	Unit	NNP	O	Unit	dep	128	SENT_16	[p1l378t993r430b1018],
100	,	,	O	,	_	0	SENT_16	[p1l378t993r430b1018],
101	Department	NNP	ORGANIZATION	Department	dep	128	SENT_16	[p1l441t994r581b1020],
102	of	IN	ORGANIZATION	of	dep	128	SENT_16	[p1l590t992r615b1020],
103	Cardiology	NNP	ORGANIZATION	Cardiology	dep	128	SENT_16	[p1l621t993r744b1020],
104	A	NNP	ORGANIZATION	A	dep	128	SENT_16	[p1l752t993r773b1018],
105	,	,	O	,	_	0	SENT_16	[p1l752t993r773b1018],
106	Fattouma	NNP	ORGANIZATION	Fattouma	dep	128	SENT_16	[p1l784t994r894b1014],
107	Bourguiba	NNP	ORGANIZATION	Bourguiba	dep	128	SENT_16	[p1l904t993r1023b1020],
108	University	NNP	ORGANIZATION	University	dep	128	SENT_16	[p1l1035t993r1151b1020],
109	Hospital	NNP	ORGANIZATION	Hospital	dep	128	SENT_16	[p1l1161t993r1261b1020],
110	,	,	O	,	_	0	SENT_16	[p1l1161t993r1261b1020],
111	Monastir	NNP	LOCATION	Monastir	dep	128	SENT_16	[p1l1272t993r1381b1018],
112	,	,	O	,	_	0	SENT_16	[p1l1272t993r1381b1018],
113	Tunisia	NNP	LOCATION	Tunisia	dep	128	SENT_16	[p1l1392t993r1474b1014],
114	d	NN	O	d	dep	128	SENT_16	[p1l6t1023r16b1037],
115	Department	NNP	ORGANIZATION	Department	dep	128	SENT_16	[p1l27t1029r167b1055],
116	of	IN	ORGANIZATION	of	dep	128	SENT_16	[p1l176t1028r201b1055],
117	Biological	NNP	ORGANIZATION	Biological	dep	128	SENT_16	[p1l206t1028r318b1055],
118	Haematology	NNP	ORGANIZATION	Haematology	dep	128	SENT_16	[p1l328t1028r486b1055],
119	,	,	O	,	_	0	SENT_16	[p1l328t1028r486b1055],
120	Tenon	NNP	LOCATION	Tenon	dep	128	SENT_16	[p1l498t1029r566b1050],
121	Hospital	NNP	LOCATION	Hospital	dep	128	SENT_16	[p1l577t1028r672b1055],
122	ER2	NN	O	er2	dep	128	SENT_16	[p1l682t1029r735b1049],
123	—	CD	NUMBER	—	dep	128	SENT_16	[p1l682t1029r735b1049],
124	UPMC	NNP	ORGANIZATION	UPMC	dep	128	SENT_16	[p1l747t1029r821b1053],
125	,	,	O	,	_	0	SENT_16	[p1l747t1029r821b1053],
126	Paris	NNP	LOCATION	Paris	dep	128	SENT_16	[p1l831t1028r892b1053],
127	,	,	O	,	_	0	SENT_16	[p1l831t1028r892b1053],
128	France	NNP	LOCATION	France	_	0	SENT_16	[p1l903t1029r979b1050],

1	ARTICLE	NN	O	article	_	0	SENT_17	[p1l6t1164r230b1186],
2	INFO	NN	O	info	nn	3	SENT_17	[p1l278t1164r401b1186],
3	ABSTRACT	NN	O	abstract	dep	1	SENT_17	[p1l691t1164r960b1186],

1	Article	NNP	O	Article	nn	2	SENT_18	[p1l6t1241r82b1263],
2	history	NN	O	history	_	0	SENT_18	[p1l93t1241r179b1268],
3	:	:	O	:	_	0	SENT_18	[p1l93t1241r179b1268],
4	Background	NN	O	background	dep	2	SENT_18	[p1l7t1285r170b1316],
5	:	:	O	:	_	0	SENT_18	[p1l7t1285r170b1316],
6	Various	JJ	O	various	amod	8	SENT_18	[p1l192t1286r294b1310],
7	genetic	JJ	O	genetic	amod	8	SENT_18	[p1l316t1286r415b1316],
8	polymorphisms	NNS	O	polymorphism	nsubjpass	11	SENT_18	[p1l436t1285r649b1316],
9	have	VBP	O	have	aux	11	SENT_18	[p1l671t1286r734b1310],
10	been	VBN	O	be	auxpass	11	SENT_18	[p1l756t1286r821b1310],
11	proposed	VBN	O	propose	dep	2	SENT_18	[p1l843t1286r968b1316],
12	to	TO	O	to	aux	13	SENT_18	[p1l991t1289r1016b1310],
13	explain	VB	O	explain	xcomp	11	SENT_18	[p1l1039t1285r1138b1316],
14	the	DT	O	the	det	16	SENT_18	[p1l1159t1286r1202b1310],
15	persistent	JJ	O	persistent	amod	16	SENT_18	[p1l1225t1286r1360b1316],
16	platelet	NN	O	platelet	dobj	13	SENT_18	[p1l1381t1285r1484b1316],
17	Received	VBN	O	receive	partmod	16	SENT_18	[p1l6t1324r112b1346],
18	23	CD	DATE	23	num	21	SENT_18	[p1l128t1325r156b1346],
19	September	NNP	DATE	September	nn	21	SENT_18	[p1l173t1324r303b1351],
20	2009	CD	DATE	2009	num	21	SENT_18	[p1l319t1325r378b1346],
21	hyperactivity	NN	O	hyperactivity	nsubj	23	SENT_18	[p1l713t1326r892b1356],
22	(	CD	NUMBER	(	num	23	SENT_18	[p1l910t1326r988b1356],
23	HPR	NNP	O	HPR	xcomp	17	SENT_18	[p1l910t1326r988b1356],
24	)	CD	NUMBER	)	num	23	SENT_18	[p1l910t1326r988b1356],
25	under	IN	O	under	_	0	SENT_18	[p1l1007t1326r1087b1350],
26	aspirin	NN	O	aspirin	nn	27	SENT_18	[p1l1102t1326r1194b1356],
27	treatment	NN	O	treatment	prep_under	23	SENT_18	[p1l1211t1329r1352b1350],
28	.	.	O	.	_	0	SENT_18	[p1l1211t1329r1352b1350],

1	PIA	NNP	O	PIA	nn	2	SENT_19	[p1l1370t1326r1414b1350],
2	polymorphism	NN	O	polymorphism	nsubjpass	10	SENT_19	[p1l1429t1326r1628b1356],
3	of	IN	O	of	_	0	SENT_19	[p1l1645t1325r1673b1350],
4	platelet	NN	O	platelet	nn	6	SENT_19	[p1l1686t1326r1788b1356],
5	GPllIa	NN	O	gpllium	nn	6	SENT_19	[p1l1804t1327r1882b1350],
6	receptor	NN	O	receptor	prep_of	2	SENT_19	[p1l1899t1329r2012b1356],
7	has	VBZ	O	have	aux	10	SENT_19	[p1l2028t1326r2072b1350],
8	been	VBN	O	be	auxpass	10	SENT_19	[p1l2089t1326r2154b1350],
9	largely	RB	O	largely	advmod	10	SENT_19	[p1l6t1365r97b1395],
10	Recewed	VBN	O	recew	_	0	SENT_19	[p1l108t1360r214b1381],
11	in	IN	O	in	_	0	SENT_19	[p1l225t1360r247b1381],
12	FeVi5ed	JJ	O	fevi5ed	amod	13	SENT_19	[p1l258t1360r344b1381],
13	form	NN	O	form	prep_in	10	SENT_19	[p1l355t1360r412b1381],
14	17	CD	DATE	17	num	15	SENT_19	[p1l423t1361r450b1381],
15	December	NNP	DATE	December	dobj	10	SENT_19	[p1l462t1360r584b1381],
16	2009	CD	DATE	2009	num	15	SENT_19	[p1l594t1361r653b1381],
17	studied	VBN	O	study	partmod	15	SENT_19	[p1l794t1365r899b1390],
18	.	.	O	.	_	0	SENT_19	[p1l794t1365r899b1390],

1	However	RB	O	however	_	0	SENT_20	[p1l912t1367r1040b1400],
2	.	.	O	.	_	0	SENT_20	[p1l912t1367r1040b1400],

1	its	PRP$	O	its	poss	2	SENT_21	[p1l1053t1366r1083b1390],
2	inﬂuence	NN	O	inﬂuence	nsubj	9	SENT_21	[p1l1095t1365r1219b1390],
3	on	IN	O	on	_	0	SENT_21	[p1l1231t1372r1264b1402],
4	platelet	NN	O	platelet	nn	5	SENT_21	[p1l1276t1365r1378b1392],
5	sensitivity	NN	O	sensitivity	prep_on	2	SENT_21	[p1l1390t1366r1528b1402],
6	to	TO	O	to	_	0	SENT_21	[p1l1539t1369r1565b1390],
7	aspirin	NN	O	aspirin	prep_to	5	SENT_21	[p1l1577t1366r1669b1402],
8	remains	VBZ	O	remain	cop	9	SENT_21	[p1l1681t1366r1789b1390],
9	controversial	JJ	O	controversial	_	0	SENT_21	[p1l1801t1366r1984b1390],
10	.	.	O	.	_	0	SENT_21	[p1l1801t1366r1984b1390],

1	Accepted	JJ	O	accepted	amod	2	SENT_22	[p1l6t1402r116b1429],
2	17J	NN	O	17j	_	0	SENT_22	[p1l137t1403r266b1429],
3	*	CD	NUMBER	*	number	4	SENT_22	[p1l137t1403r266b1429],
4	‘“	CD	NUMBER	‘“	num	5	SENT_22	[p1l137t1403r266b1429],
5	“‘	NN	O	“‘	nsubj	17	SENT_22	[p1l137t1403r266b1429],
6	“	CD	NUMBER	“	num	9	SENT_22	[p1l137t1403r266b1429],
7	V	NN	O	v	nn	9	SENT_22	[p1l137t1403r266b1429],
8	2010	CD	DATE	2010	num	9	SENT_22	[p1l285t1403r344b1423],
9	Objectives	NNS	O	objective	dep	5	SENT_22	[p1l718t1412r857b1442],
10	:	:	O	:	_	0	SENT_22	[p1l718t1412r857b1442],
11	The	DT	O	the	det	12	SENT_22	[p1l877t1412r927b1436],
12	aim	NN	O	aim	dep	5	SENT_22	[p1l947t1412r997b1436],
13	of	IN	O	of	_	0	SENT_22	[p1l1017t1412r1045b1436],
14	this	DT	O	this	det	16	SENT_22	[p1l1053t1412r1102b1436],
15	prospective	JJ	O	prospective	amod	16	SENT_22	[p1l1123t1412r1279b1442],
16	study	NN	O	study	prep_of	12	SENT_22	[p1l1300t1412r1374b1442],
17	is	VBZ	O	be	rcmod	2	SENT_22	[p1l1394t1412r1413b1436],
18	to	TO	O	to	aux	19	SENT_22	[p1l1434t1415r1460b1436],
19	investigate	VB	O	investigate	xcomp	17	SENT_22	[p1l1481t1412r1627b1442],
20	whether	IN	O	whether	complm	25	SENT_22	[p1l1647t1412r1763b1436],
21	this	DT	O	this	det	23	SENT_22	[p1l1782t1412r1831b1436],
22	PIA	NN	O	pium	nn	23	SENT_22	[p1l1852t1412r1895b1436],
23	polymorphism	NN	O	polymorphism	nsubjpass	25	SENT_22	[p1l1915t1412r2114b1442],
24	is	VBZ	O	be	auxpass	25	SENT_22	[p1l2135t1412r2154b1436],
25	associated	VBN	O	associate	ccomp	19	SENT_22	[p1l6t1458r144b1482],
26	with	IN	O	with	_	0	SENT_22	[p1l6t1497r68b1521],
27	a	DT	O	a	det	29	SENT_22	[p1l78t1504r91b1521],
28	greater	JJR	O	greater	amod	29	SENT_22	[p1l100t1501r197b1527],
29	prevalence	NN	O	prevalence	prep_with	25	SENT_22	[p1l207t1497r353b1527],
30	of	IN	O	of	_	0	SENT_22	[p1l364t1497r392b1521],
31	HPR	NNP	ORGANIZATION	HPR	prep_of	29	SENT_22	[p1l398t1499r455b1521],
32	in	IN	O	in	_	0	SENT_22	[p1l463t1497r488b1521],
33	stable	JJ	O	stable	amod	37	SENT_22	[p1l499t1497r577b1521],
34	coronary	JJ	O	coronary	amod	37	SENT_22	[p1l587t1504r707b1527],
35	artery	NN	O	artery	nn	37	SENT_22	[p1l716t1501r797b1527],
36	disease	NN	O	disease	nn	37	SENT_22	[p1l807t1497r903b1521],
37	patients	NNS	O	patient	prep_in	25	SENT_22	[p1l914t1497r1021b1527],
38	Material	NNP	O	Material	dep	2	SENT_22	[p1l1032t1497r1144b1521],
39	and	CC	O	and	_	0	SENT_22	[p1l1154t1497r1203b1521],
40	Methods	NNS	O	method	dep	2	SENT_22	[p1l1213t1497r1339b1521],
41	:	:	O	:	_	0	SENT_22	[p1l1213t1497r1339b1521],
42	188	CD	NUMBER	188	num	46	SENT_22	[p1l1353t1498r1400b1521],
43	stable	JJ	O	stable	amod	46	SENT_22	[p1l1411t1497r1489b1521],
44	coronary	JJ	O	coronary	amod	46	SENT_22	[p1l1500t1504r1620b1527],
45	artery	NN	O	artery	nn	46	SENT_22	[p1l1631t1501r1712b1527],
46	disease	NN	O	disease	dep	2	SENT_22	[p1l1724t1497r1820b1521],
47	patients	NNS	O	patient	nsubjpass	49	SENT_22	[p1l1833t1497r1940b1527],
48	were	VBD	O	be	auxpass	49	SENT_22	[p1l1952t1504r2019b1521],
49	included	VBN	O	include	rcmod	46	SENT_22	[p1l2032t1497r2154b1521],
50	.	.	O	.	_	0	SENT_22	[p1l2032t1497r2154b1521],

1	Platelet	NN	O	platelet	nn	2	SENT_23	[p1l6t1536r107b1561],
2	aspirin	NN	O	aspirin	nsubjpass	6	SENT_23	[p1l119t1536r211b1567],
3	inhibitory	JJ	O	inhibitory	amod	4	SENT_23	[p1l223t1536r357b1567],
4	effect	NN	O	effect	dep	2	SENT_23	[p1l369t1536r444b1561],
5	was	VBD	O	be	auxpass	6	SENT_23	[p1l455t1543r507b1561],
6	determined	VBN	O	determine	_	0	SENT_23	[p1l520t1536r677b1561],
7	with	IN	O	with	_	0	SENT_23	[p1l690t1536r751b1561],
8	PFA	NN	ORGANIZATION	pfa	nn	9	SENT_23	[p1l764t1537r825b1560],
9	—	NN	O	—	prep_with	6	SENT_23	[p1l764t1537r825b1560],
10	100	CD	NUMBER	100	num	9	SENT_23	[p1l837t1538r884b1561],
11	using	VBG	O	use	xcomp	6	SENT_23	[p1l900t1537r972b1567],
12	Collagen/Epinephrine	NNP	O	Collagen/Epinephrine	nn	14	SENT_23	[p1l988t1536r1280b1567],
13	closure	NN	O	closure	nn	14	SENT_23	[p1l1296t1536r1392b1561],
14	time	NN	O	time	nsubj	17	SENT_23	[p1l1408t1537r1469b1561],
15	(	CD	NUMBER	(	num	17	SENT_23	[p1l1486t1537r1622b1567],
16	CEPI-CT	NN	O	cepi-ct	nn	17	SENT_23	[p1l1486t1537r1622b1567],
17	)	NN	O	)	xcomp	11	SENT_23	[p1l1486t1537r1622b1567],
18	.	.	O	.	_	0	SENT_23	[p1l1486t1537r1622b1567],

1	A	DT	O	a	det	3	SENT_24	[p1l1637t1538r1656b1561],
2	CEPI-CT	NN	O	cepi-ct	dep	3	SENT_24	[p1l1671t1538r1851b1561],
3	<	JJR	O	<	nsubj	7	SENT_24	[p1l1671t1538r1851b1561],
4	16O	CD	NUMBER	16o	num	5	SENT_24	[p1l1671t1538r1851b1561],
5	sec	NN	DURATION	sec	dep	3	SENT_24	[p1l1862t1544r1903b1561],
6	was	VBD	O	be	aux	7	SENT_24	[p1l1917t1544r1970b1561],
7	deﬁning	VBG	O	deﬁning	_	0	SENT_24	[p1l1985t1536r2097b1567],
8	the	DT	O	the	det	10	SENT_24	[p1l2112t1537r2154b1561],
9	HPR	NNP	O	HPR	nn	10	SENT_24	[p1l513t1577r569b1600],
10	status	NN	O	status	dobj	7	SENT_24	[p1l583t1579r668b1600],
11	.	.	O	.	_	0	SENT_24	[p1l583t1579r668b1600],

1	GPIIIa	NN	O	gpiium	nn	3	SENT_25	[p1l678t1577r757b1600],
2	PIA	NN	O	pium	nn	3	SENT_25	[p1l766t1576r810b1600],
3	polymorphism	NN	O	polymorphism	nsubjpass	5	SENT_25	[p1l818t1576r1017b1606],
4	was	VBD	O	be	auxpass	5	SENT_25	[p1l1025t1583r1077b1600],
5	established	VBN	O	establish	_	0	SENT_25	[p1l1087t1576r1238b1600],
6	using	VBG	O	use	xcomp	5	SENT_25	[p1l1247t1576r1320b1606],
7	polymerase	NN	O	polymerase	nn	9	SENT_25	[p1l1329t1576r1485b1606],
8	chain	NN	O	chain	nn	9	SENT_25	[p1l1494t1576r1566b1600],
9	reaction	NN	O	reaction	dobj	6	SENT_25	[p1l1575t1576r1685b1600],
10	and	CC	O	and	_	0	SENT_25	[p1l1694t1576r1743b1600],
11	classical	JJ	O	classical	amod	15	SENT_25	[p1l1752t1576r1860b1600],
12	restriction	NN	O	restriction	nn	15	SENT_25	[p1l1870t1576r2009b1600],
13	fragments	NNS	O	fragment	nn	15	SENT_25	[p1l2018t1576r2154b1606],
14	length	NN	O	length	nn	15	SENT_25	[p1l6t1615r91b1645],
15	polymorphism	NN	O	polymorphism	dobj	6	SENT_25	[p1l104t1615r309b1645],
16	.	.	O	.	_	0	SENT_25	[p1l104t1615r309b1645],

1	Results	NNS	O	result	_	0	SENT_26	[p1l6t1655r105b1679],
2	:	:	O	:	_	0	SENT_26	[p1l6t1655r105b1679],
3	The	DT	O	the	det	5	SENT_26	[p1l119t1655r168b1679],
4	observed	VBN	O	observe	amod	5	SENT_26	[p1l184t1655r306b1679],
5	frequencies	NNS	O	frequency	dep	1	SENT_26	[p1l322t1655r477b1685],
6	of	IN	O	of	_	0	SENT_26	[p1l492t1655r520b1679],
7	different	JJ	O	different	amod	8	SENT_26	[p1l532t1655r649b1679],
8	genotypes	NNS	O	genotype	prep_of	5	SENT_26	[p1l663t1658r801b1685],
9	were	VBD	O	be	cop	11	SENT_26	[p1l816t1662r883b1679],
10	not	RB	O	not	neg	11	SENT_26	[p1l899t1658r944b1679],
11	different	JJ	O	different	rcmod	8	SENT_26	[p1l958t1655r1075b1679],
12	from	IN	O	from	_	0	SENT_26	[p1l1089t1655r1153b1679],
13	those	DT	O	those	prep_from	11	SENT_26	[p1l1168t1655r1240b1679],
14	predicted	VBN	O	predict	partmod	13	SENT_26	[p1l1256t1655r1383b1685],
15	by	IN	O	by	_	0	SENT_26	[p1l1399t1655r1431b1685],
16	the	DT	O	the	det	18	SENT_26	[p1l1445t1655r1488b1679],
17	Hardy-Weinberg	JJ	LOCATION	hardy-weinberg	amod	18	SENT_26	[p1l1499t1655r1727b1685],
18	equilibrium	NN	O	equilibrium	agent	14	SENT_26	[p1l1738t1655r1904b1685],
19	:	:	O	:	_	0	SENT_26	[p1l1738t1655r1904b1685],
20	PlA1	NN	O	pla1	dep	1	SENT_26	[p1l1919t1655r1975b1679],
21	/	:	O	/	punct	22	SENT_26	[p1l1980t1655r2031b1683],
22	1A1	NN	O	1a1	dep	20	SENT_26	[p1l1980t1655r2031b1683],
23	(	CD	PERCENT	(	number	24	SENT_26	[p1l2048t1655r2154b1685],
24	55.3	CD	PERCENT	55.3	num	25	SENT_26	[p1l2048t1655r2154b1685],
25	%	NN	PERCENT	%	dep	22	SENT_26	[p1l2048t1655r2154b1685],
26	)	CD	NUMBER	)	dep	22	SENT_26	[p1l2048t1655r2154b1685],
27	,	,	O	,	_	0	SENT_26	[p1l2048t1655r2154b1685],
28	PlA1/PlA2	NN	O	pla1/pla2	dep	20	SENT_26	[p1l6t1695r138b1723],
29	(	CD	PERCENT	(	number	30	SENT_26	[p1l152t1695r250b1725],
30	39.4	CD	PERCENT	39.4	num	31	SENT_26	[p1l152t1695r250b1725],
31	%	NN	PERCENT	%	dep	28	SENT_26	[p1l152t1695r250b1725],
32	)	CD	NUMBER	)	dep	28	SENT_26	[p1l152t1695r250b1725],
33	and	CC	O	and	_	0	SENT_26	[p1l263t1694r312b1719],
34	PlA2/PlA2	NN	O	pla2/pla2	conj_and	22	SENT_26	[p1l325t1694r457b1723],
35	(	CD	PERCENT	(	number	36	SENT_26	[p1l471t1694r560b1725],
36	5.3	CD	PERCENT	5.3	num	37	SENT_26	[p1l471t1694r560b1725],
37	%	NN	PERCENT	%	dep	34	SENT_26	[p1l471t1694r560b1725],
38	)	CD	NUMBER	)	dep	20	SENT_26	[p1l471t1694r560b1725],
39	.	.	O	.	_	0	SENT_26	[p1l471t1694r560b1725],

1	HPR	NN	ORGANIZATION	hpr	nn	2	SENT_27	[p1l573t1696r629b1719],
2	patients	NNS	O	patient	nsubj	12	SENT_27	[p1l639t1695r747b1725],
3	with	IN	O	with	_	0	SENT_27	[p1l758t1694r820b1719],
4	inadequate	JJ	O	inadequate	amod	6	SENT_27	[p1l833t1694r983b1725],
5	aspirin	NN	O	aspirin	nn	6	SENT_27	[p1l1006t1694r1098b1725],
6	inhibition	NN	O	inhibition	prep_with	2	SENT_27	[p1l1121t1694r1254b1719],
7	were	VBD	O	be	cop	12	SENT_27	[p1l1276t1701r1343b1719],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_27	[p1l1366t1694r1532b1725],
9	more	RBR	O	more	advmod	10	SENT_27	[p1l1554t1701r1624b1719],
10	often	RB	O	often	advmod	12	SENT_27	[p1l1647t1694r1716b1719],
11	homozygous	JJ	O	homozygous	amod	12	SENT_27	[p1l1739t1694r1911b1725],
12	PIA1/A1	NN	O	pia1/a1	_	0	SENT_27	[p1l1935t1694r2039b1723],
13	(	CD	PERCENT	(	number	14	SENT_27	[p1l2067t1694r2154b1725],
14	65.4	CD	PERCENT	65.4	num	15	SENT_27	[p1l2067t1694r2154b1725],
15	%	NN	PERCENT	%	dep	12	SENT_27	[p1l2067t1694r2154b1725],
16	vs.	CC	O	vs.	_	0	SENT_27	[p1l529t1741r563b1759],
17	47.7	CD	PERCENT	47.7	num	18	SENT_27	[p1l585t1735r667b1762],
18	%	NN	PERCENT	%	conj_vs.	12	SENT_27	[p1l585t1735r667b1762],
19	,	,	O	,	_	0	SENT_27	[p1l585t1735r667b1762],
20	p	NN	O	p	appos	18	SENT_27	[p1l678t1741r693b1764],
21	=	JJ	O	=	amod	23	SENT_27	[p1l701t1744r725b1753],
22	0.015	CD	NUMBER	0.015	tmod	21	SENT_27	[p1l732t1734r825b1764],
23	)	NN	O	)	dep	20	SENT_27	[p1l732t1734r825b1764],
24	.	.	O	.	_	0	SENT_27	[p1l732t1734r825b1764],

1	After	IN	O	after	_	0	SENT_28	[p1l835t1734r903b1758],
2	multivariate	JJ	O	multivariate	amod	3	SENT_28	[p1l912t1734r1077b1758],
3	analysis	NN	O	analysis	prep_after	12	SENT_28	[p1l1087t1734r1200b1764],
4	,	,	O	,	_	0	SENT_28	[p1l1087t1734r1200b1764],
5	PlA1/A1	NN	O	pla1/a1	nn	6	SENT_28	[p1l1211t1734r1315b1762],
6	genotype	NN	O	genotype	nsubj	12	SENT_28	[p1l1328t1738r1453b1764],
7	was	VBD	O	be	cop	12	SENT_28	[p1l1463t1741r1515b1758],
8	the	DT	O	the	det	12	SENT_28	[p1l1525t1734r1568b1758],
9	only	JJ	O	only	amod	12	SENT_28	[p1l1578t1734r1637b1764],
10	independent	JJ	O	independent	amod	12	SENT_28	[p1l1646t1734r1818b1764],
11	risk	NN	O	risk	nn	12	SENT_28	[p1l1828t1734r1877b1758],
12	factor	NN	O	factor	_	0	SENT_28	[p1l1886t1734r1964b1758],
13	for	IN	O	for	_	0	SENT_28	[p1l1973t1734r2011b1758],
14	persistent	JJ	O	persistent	prep_for	12	SENT_28	[p1l2020t1734r2154b1764],

1	I-IPR	NN	O	i-ipr	nn	3	SENT_29	[p1l749t1775r805b1798],
2	(	CD	NUMBER	(	num	3	SENT_29	[p1l818t1774r875b1804],
3	OR	NN	O	or	_	0	SENT_29	[p1l818t1774r875b1804],
4	:	:	O	:	_	0	SENT_29	[p1l818t1774r875b1804],
5	2.07	CD	NUMBER	2.07	dep	3	SENT_29	[p1l889t1775r954b1802],
6	;	:	O	;	_	0	SENT_29	[p1l889t1775r954b1802],
7	95	CD	PERCENT	95	number	8	SENT_29	[p1l968t1775r1019b1798],
8	%	NN	PERCENT	%	amod	9	SENT_29	[p1l968t1775r1019b1798],
9	Cl	NN	O	cl	dep	3	SENT_29	[p1l1031t1775r1055b1798],
10	[	CD	NUMBER	[	number	11	SENT_29	[p1l1069t1774r1135b1804],
11	1.14	CD	NUMBER	1.14	num	9	SENT_29	[p1l1069t1774r1135b1804],
12	to	TO	O	to	_	0	SENT_29	[p1l1146t1778r1172b1798],
13	3.76	CD	NUMBER	3.76	prep_to	9	SENT_29	[p1l1183t1775r1249b1802],
14	;	:	O	;	_	0	SENT_29	[p1l1183t1775r1249b1802],
15	p	NN	O	p	dep	3	SENT_29	[p1l1263t1774r1410b1804],
16	=	JJ	O	=	amod	18	SENT_29	[p1l1263t1774r1410b1804],
17	0.016	CD	NUMBER	0.016	tmod	16	SENT_29	[p1l1263t1774r1410b1804],
18	)	NN	O	)	dep	15	SENT_29	[p1l1263t1774r1410b1804],
19	.	.	O	.	_	0	SENT_29	[p1l1263t1774r1410b1804],

1	Conclusion	NN	O	conclusion	_	0	SENT_30	[p1l6t1813r155b1837],
2	:	:	O	:	_	0	SENT_30	[p1l6t1813r155b1837],
3	In	IN	O	in	ccomp	14	SENT_30	[p1l175t1815r200b1837],
4	CAD	NN	O	cad	nn	5	SENT_30	[p1l219t1814r275b1837],
5	patients	NNS	O	patient	nsubj	6	SENT_30	[p1l295t1814r402b1843],
6	receiving	VBG	O	receive	pcomp	3	SENT_30	[p1l422t1814r546b1843],
7	daily	RB	SET	daily	advmod	9	SENT_30	[p1l565t1813r630b1843],
8	low	JJ	O	low	amod	9	SENT_30	[p1l648t1813r698b1837],
9	dose	NN	O	dose	dobj	6	SENT_30	[p1l717t1813r778b1837],
10	of	IN	O	of	_	0	SENT_30	[p1l797t1813r825b1837],
11	aspirin	NN	O	aspirin	prep_of	9	SENT_30	[p1l841t1814r939b1843],
12	,	,	O	,	_	0	SENT_30	[p1l841t1814r939b1843],
13	there	EX	O	there	expl	14	SENT_30	[p1l959t1813r1029b1837],
14	is	VBZ	O	be	dep	1	SENT_30	[p1l1048t1814r1068b1837],
15	a	DT	O	a	det	19	SENT_30	[p1l1087t1820r1101b1837],
16	signiﬁcant	NN	O	signiﬁcant	nn	19	SENT_30	[p1l1120t1813r1260b1843],
17	and	CC	O	and	_	0	SENT_30	[p1l1279t1813r1327b1837],
18	independent	JJ	O	independent	nn	19	SENT_30	[p1l1347t1813r1519b1843],
19	association	NN	O	association	nsubj	14	SENT_30	[p1l1533t1813r1681b1837],
20	between	IN	O	between	_	0	SENT_30	[p1l1694t1813r1811b1837],
21	the	DT	O	the	det	22	SENT_30	[p1l1824t1813r1867b1837],
22	expression	NN	O	expression	prep_between	19	SENT_30	[p1l1880t1813r2025b1843],
23	of	IN	O	of	_	0	SENT_30	[p1l2038t1813r2066b1837],
24	GPIIIa	NN	O	gpiium	nn	26	SENT_30	[p1l2076t1814r2154b1837],
25	PIA1	NN	O	pia1	nn	26	SENT_30	[p1l475t1853r586b1900],
26	allele	NN	O	allele	prep_of	22	SENT_30	[p1l613t1853r751b1900],
27	and	CC	O	and	_	0	SENT_30	[p1l773t1853r868b1900],
28	the	DT	O	the	det	29	SENT_30	[p1l889t1853r972b1900],
29	occurrence	NN	O	occurrence	prep_between	19	SENT_30	[p1l994t1867r1283b1900],
30	of	IN	O	of	_	0	SENT_30	[p1l1305t1853r1359b1900],
31	persistent	JJ	O	persistent	amod	32	SENT_30	[p1l1374t1854r1637b1912],
32	HPR	NN	ORGANIZATION	hpr	prep_of	29	SENT_30	[p1l1657t1856r1767b1900],
33	detected	VBN	O	detect	partmod	32	SENT_30	[p1l1785t1853r2012b1900],
34	with	IN	O	with	prep	33	SENT_30	[p1l2032t1853r2154b1900],

1	PFA	NNP	O	PFA	_	0	SENT_31	[p1l1351t1933r1585b1979],
2	—	CD	NUMBER	—	number	3	SENT_31	[p1l1351t1933r1585b1979],
3	100	CD	NUMBER	100	num	1	SENT_31	[p1l1351t1933r1585b1979],
4	.	.	O	.	_	0	SENT_31	[p1l1351t1933r1585b1979],

1	Introduction	NN	O	introduction	_	0	SENT_32	[p1l8t2276r405b2328],

1	Aspirin	NN	O	aspirin	nsubj	8	SENT_33	[p1l104t2447r316b2511],
2	is	VBZ	O	be	cop	8	SENT_33	[p1l352t2447r394b2498],
3	the	DT	O	the	det	8	SENT_33	[p1l431t2446r524b2498],
4	most	RBS	O	most	advmod	6	SENT_33	[p1l562t2454r707b2498],
5	commonly	RB	O	commonly	advmod	6	SENT_33	[p1l742t2446r1056b2511],
6	used	VBN	O	use	amod	8	SENT_33	[p1l1091t2446r1225b2498],
7	antiplatelet	JJ	O	antiplatelet	amod	8	SENT_33	[p1l1262t2446r1600b2511],
8	drug	NN	O	drug	_	0	SENT_33	[p1l1635t2446r1770b2511],
9	for	IN	O	for	_	0	SENT_33	[p1l1807t2446r1888b2498],
10	both	DT	O	both	det	14	SENT_33	[p1l1921t2446r2055b2498],
11	primary	JJ	O	primary	amod	14	SENT_33	[p1l9t2532r244b2596],
12	and	CC	O	and	_	0	SENT_33	[p1l264t2531r370b2583],
13	secondary	JJ	O	secondary	conj_and	11	SENT_33	[p1l393t2531r691b2596],
14	prevention	NN	O	prevention	prep_for	8	SENT_33	[p1l710t2532r1032b2596],
15	in	IN	O	in	_	0	SENT_33	[p1l1052t2532r1107b2583],
16	cardiovascular	JJ	O	cardiovascular	amod	18	SENT_33	[p1l1128t2531r1553b2583],
17	disease	NN	O	disease	nn	18	SENT_33	[p1l1573t2531r1783b2583],
18	patients	NNS	O	patient	prep_in	14	SENT_33	[p1l1805t2532r2054b2596],
19	.	.	O	.	_	0	SENT_33	[p1l1805t2532r2054b2596],

1	“	NN	O	“	nsubj	7	SENT_34	[p1l9t2615r141b2667],
2	The	DT	O	the	det	4	SENT_34	[p1l9t2615r141b2667],
3	antithrombotic	JJ	O	antithrombotic	amod	4	SENT_34	[p1l162t2615r605b2667],
4	Trialists	NNS	MISC	trialist	nsubj	5	SENT_34	[p1l622t2615r879b2667],
5	”	VBP	O	”	rcmod	1	SENT_34	[p1l622t2615r879b2667],
6	collaboration	NN	O	collaboration	dobj	5	SENT_34	[p1l901t2615r1287b2667],
7	compiled	VBD	O	compile	_	0	SENT_34	[p1l1306t2615r1577b2681],
8	a	DT	O	a	det	9	SENT_34	[p1l1597t2631r1627b2667],
9	meta-analysis	NN	O	meta-analysis	dobj	7	SENT_34	[p1l1647t2615r2054b2681],
10	of	IN	O	of	_	0	SENT_34	[p1l9t2700r70b2752],
11	65	CD	NUMBER	65	num	12	SENT_34	[p1l80t2703r147b2752],
12	trials	NNS	O	trial	prep_of	9	SENT_34	[p1l167t2700r312b2752],
13	demonstrating	VBG	O	demonstrate	partmod	12	SENT_34	[p1l330t2700r762b2766],
14	that	IN	O	that	complm	19	SENT_34	[p1l778t2700r896b2752],
15	aspirin	NN	O	aspirin	nsubj	19	SENT_34	[p1l911t2701r1111b2766],
16	in	IN	O	in	_	0	SENT_34	[p1l1129t2701r1182b2752],
17	high-risk	JJ	O	high-risk	amod	18	SENT_34	[p1l1200t2700r1465b2766],
18	patients	NNS	O	patient	prep_in	15	SENT_34	[p1l1481t2701r1715b2766],
19	reduced	VBN	O	reduce	ccomp	13	SENT_34	[p1l1734t2700r1969b2752],
20	by	IN	O	by	_	0	SENT_34	[p1l1986t2700r2056b2766],
21	23	CD	PERCENT	23	number	22	SENT_34	[p1l9t2788r120b2838],
22	%	NN	PERCENT	%	amod	28	SENT_34	[p1l9t2788r120b2838],
23	vascular	JJ	O	vascular	amod	28	SENT_34	[p1l150t2786r394b2838],
24	events	NNS	O	event	nn	28	SENT_34	[p1l424t2794r614b2838],
25	occurrence	NN	O	occurrence	nn	28	SENT_34	[p1l647t2801r969b2838],
26	[	NN	O	[	nn	28	SENT_34	[p1l1005t2785r1094b2851],
27	1	CD	NUMBER	1	num	28	SENT_34	[p1l1005t2785r1094b2851],
28	]	NN	O	]	prep_by	19	SENT_34	[p1l1005t2785r1094b2851],
29	.	.	O	.	_	0	SENT_34	[p1l1005t2785r1094b2851],

1	However	RB	O	however	advmod	9	SENT_35	[p1l1129t2789r1407b2846],
2	,	,	O	,	_	0	SENT_35	[p1l1129t2789r1407b2846],
3	antiplatelet	JJ	O	antiplatelet	amod	4	SENT_35	[p1l1441t2786r1778b2851],
4	effect	NN	O	effect	nsubj	9	SENT_35	[p1l1809t2785r1970b2838],
5	of	IN	O	of	_	0	SENT_35	[p1l2001t2785r2062b2838],
6	aspirin	NN	O	aspirin	prep_of	4	SENT_35	[p1l9t2872r209b2936],
7	is	VBZ	O	be	cop	9	SENT_35	[p1l225t2872r267b2923],
8	not	RB	O	not	neg	9	SENT_35	[p1l285t2879r381b2923],
9	similar	JJ	O	similar	_	0	SENT_35	[p1l397t2871r598b2923],
10	in	IN	O	in	_	0	SENT_35	[p1l613t2872r667b2922],
11	all	DT	O	all	det	12	SENT_35	[p1l683t2871r749b2923],
12	patients	NNS	O	patient	prep_in	9	SENT_35	[p1l766t2872r1001b2936],
13	and	CC	O	and	_	0	SENT_35	[p1l1018t2871r1124b2923],
14	its	PRP$	O	its	poss	16	SENT_35	[p1l1142t2872r1207b2923],
15	optimal	JJ	O	optimal	amod	16	SENT_35	[p1l1225t2871r1450b2936],
16	dosage	NN	O	dosage	nsubj	26	SENT_35	[p1l1466t2871r1667b2936],
17	leading	VBG	O	lead	partmod	16	SENT_35	[p1l1684t2871r1898b2936],
18	to	TO	O	to	_	0	SENT_35	[p1l1913t2879r1969b2923],
19	an	DT	O	a	det	21	SENT_35	[p1l1986t2886r2055b2923],
20	adequate	JJ	O	adequate	amod	21	SENT_35	[p1l9t2955r277b3021],
21	inhibition	NN	O	inhibition	prep_to	17	SENT_35	[p1l308t2955r595b3007],
22	of	IN	O	of	_	0	SENT_35	[p1l625t2955r686b3007],
23	platelet	NN	O	platelet	nn	24	SENT_35	[p1l710t2955r932b3021],
24	response	NN	O	response	prep_of	21	SENT_35	[p1l961t2970r1221b3021],
25	is	VBZ	O	be	cop	26	SENT_35	[p1l1253t2956r1295b3007],
26	subject	JJ	O	subject	conj_and	9	SENT_35	[p1l1327t2955r1536b3021],
27	to	TO	O	to	_	0	SENT_35	[p1l1564t2963r1620b3007],
28	a	DT	O	a	det	31	SENT_35	[p1l1651t2971r1681b3007],
29	great	JJ	O	great	amod	31	SENT_35	[p1l1710t2963r1861b3021],
30	interindividual	JJ	O	interindividual	amod	31	SENT_35	[p1l1891t2956r2054b3007, p1l9t3041r303b3093],
31	variability	NN	O	variability	prep_to	26	SENT_35	[p1l324t3041r636b3106],
32	.	.	O	.	_	0	SENT_35	[p1l324t3041r636b3106],

1	Thus	RB	O	thus	advmod	15	SENT_36	[p1l657t3041r812b3101],
2	,	,	O	,	_	0	SENT_36	[p1l657t3041r812b3101],
3	prevalence	NN	O	prevalence	nsubj	15	SENT_36	[p1l836t3041r1154b3106],
4	of	IN	O	of	_	0	SENT_36	[p1l1177t3041r1238b3093],
5	aspirin	NN	O	aspirin	nn	7	SENT_36	[p1l1253t3042r1453b3106],
6	non	JJ	O	non	amod	7	SENT_36	[p1l1477t3056r1587b3093],
7	responsiveness	NN	O	responsiveness	prep_of	3	SENT_36	[p1l1611t3042r2054b3106],
8	may	MD	O	may	aux	9	SENT_36	[p1l9t3141r134b3191],
9	vary	VB	O	vary	rcmod	7	SENT_36	[p1l172t3141r301b3191],
10	considerably	RB	O	considerably	advmod	9	SENT_36	[p1l340t3125r715b3191],
11	depending	VBG	O	depend	_	0	SENT_36	[p1l754t3125r1067b3191],
12	on	IN	O	on	prepc_depending_on	9	SENT_36	[p1l1107t3141r1178b3177],
13	various	JJ	O	various	amod	14	SENT_36	[p1l1217t3126r1432b3177],
14	mechanisms	NNS	O	mechanism	pobj	9	SENT_36	[p1l1474t3125r1839b3177],
15	[	VBP	O	[	_	0	SENT_36	[p1l1884t3125r1974b3191],
16	2	CD	NUMBER	2	number	17	SENT_36	[p1l1884t3125r1974b3191],
17	]	CD	NUMBER	]	dobj	15	SENT_36	[p1l1884t3125r1974b3191],
18	.	.	O	.	_	0	SENT_36	[p1l1884t3125r1974b3191],

1	A	DT	O	a	det	3	SENT_37	[p1l2014t3128r2056b3177],
2	genetic	JJ	O	genetic	amod	3	SENT_37	[p1l8t3212r221b3276],
3	origin	NN	O	origin	nsubjpass	6	SENT_37	[p1l242t3211r413b3276],
4	has	VBZ	O	have	aux	6	SENT_37	[p1l436t3211r531b3263],
5	been	VBN	O	be	auxpass	6	SENT_37	[p1l554t3211r694b3263],
6	proposed	VBN	O	propose	_	0	SENT_37	[p1l716t3211r989b3276],
7	to	TO	O	to	aux	8	SENT_37	[p1l1011t3219r1067b3263],
8	explain	VB	O	explain	xcomp	6	SENT_37	[p1l1090t3211r1304b3276],
9	the	DT	O	the	det	10	SENT_37	[p1l1326t3211r1418b3263],
10	variability	NN	O	variability	dobj	8	SENT_37	[p1l1439t3211r1739b3276],
11	of	IN	O	of	_	0	SENT_37	[p1l1759t3211r1819b3263],
12	platelet	NN	O	platelet	nn	13	SENT_37	[p1l1834t3211r2056b3276],
13	response	NN	O	response	prep_of	10	SENT_37	[p1l9t3311r270b3361],
14	to	TO	O	to	_	0	SENT_37	[p1l293t3304r349b3348],
15	aspirin	NN	O	aspirin	nn	16	SENT_37	[p1l373t3297r573b3361],
16	[	NN	O	[	prep_to	8	SENT_37	[p1l600t3295r690b3361],
17	3	CD	NUMBER	3	num	18	SENT_37	[p1l600t3295r690b3361],
18	]	NN	O	]	dep	16	SENT_37	[p1l600t3295r690b3361],
19	,	,	O	,	_	0	SENT_37	[p1l600t3295r690b3361],
20	but	CC	O	but	_	0	SENT_37	[p1l714t3296r812b3348],
21	the	DT	O	the	det	24	SENT_37	[p1l834t3296r926b3348],
22	speciﬁc	NN	O	speciﬁc	nn	24	SENT_37	[p1l951t3295r1168b3361],
23	gene	NN	O	gene	nn	24	SENT_37	[p1l1190t3311r1329b3361],
24	variants	NNS	O	variant	nsubj	32	SENT_37	[p1l1351t3296r1587b3348],
25	contributing	VBG	O	contribute	partmod	24	SENT_37	[p1l1611t3296r1976b3361],
26	to	TO	O	to	_	0	SENT_37	[p1l1998t3304r2054b3348],
27	this	DT	O	this	det	29	SENT_37	[p1l8t3380r114b3432],
28	phenotypic	JJ	O	phenotypic	amod	29	SENT_37	[p1l137t3380r467b3446],
29	variation	NN	O	variation	prep_to	25	SENT_37	[p1l486t3381r749b3432],
30	are	VBP	O	be	cop	32	SENT_37	[p1l770t3395r860b3432],
31	still	RB	O	still	advmod	32	SENT_37	[p1l882t3380r986b3432],
32	unknown	JJ	O	unknown	conj_but	6	SENT_37	[p1l1008t3380r1301b3433],
33	.	.	O	.	_	0	SENT_37	[p1l1008t3380r1301b3433],

1	*	NN	O	*	_	0	SENT_38	[p1l51t3608r73b3633],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_38	[p1l107t3608r453b3660],
3	author	NN	O	author	dobj	2	SENT_38	[p1l478t3608r645b3650],
4	.	.	O	.	_	0	SENT_38	[p1l478t3608r645b3650],

1	Regional	NNP	O	Regional	nn	2	SENT_39	[p1l671t3608r872b3660],
2	Center	NNP	O	Center	_	0	SENT_39	[p1l899t3610r1054b3650],
3	of	IN	O	of	_	0	SENT_39	[p1l1078t3608r1126b3650],
4	Blood	NNP	O	Blood	nn	5	SENT_39	[p1l1146t3608r1277b3650],
5	Transfusion	NNP	O	Transfusion	prep_of	2	SENT_39	[p1l1302t3608r1589b3656],
6	,	,	O	,	_	0	SENT_39	[p1l1302t3608r1589b3656],
7	Research	NNP	O	Research	nn	8	SENT_39	[p1l1616t3608r1825b3650],
8	Unit	NNP	O	Unit	appos	5	SENT_39	[p1l1850t3609r1964b3650],
9	:	:	O	:	_	0	SENT_39	[p1l1850t3609r1964b3650],
10	UR	NN	O	ur	nn	11	SENT_39	[p1l1993t3611r2061b3650],
11	06SP05	NN	O	06sp05	dep	2	SENT_39	[p1l8t3680r191b3725],
12	,	,	O	,	_	0	SENT_39	[p1l8t3680r191b3725],
13	Farhat	NNP	ORGANIZATION	Farhat	nn	16	SENT_39	[p1l207t3677r355b3719],
14	Hached	NNP	ORGANIZATION	Hached	nn	16	SENT_39	[p1l368t3677r543b3719],
15	University	NNP	ORGANIZATION	University	nn	16	SENT_39	[p1l557t3678r800b3729],
16	Hospital	NNP	ORGANIZATION	Hospital	appos	11	SENT_39	[p1l813t3677r1018b3730],
17	,	,	O	,	_	0	SENT_39	[p1l813t3677r1018b3730],
18	4000	CD	NUMBER	4000	num	21	SENT_39	[p1l1032t3679r1149b3719],
19	Sousse	NNP	LOCATION	Sousse	nn	21	SENT_39	[p1l1163t3680r1331b3726],
20	,	,	O	,	_	0	SENT_39	[p1l1163t3680r1331b3726],
21	Tunisia	NNP	LOCATION	Tunisia	appos	11	SENT_39	[p1l1344t3678r1524b3719],
22	.	.	O	.	_	0	SENT_39	[p1l1344t3678r1524b3719],

1	Tel.	NNP	O	Tel.	dep	4	SENT_40	[p1l1537t3677r1633b3719],
2	:	:	O	:	_	0	SENT_40	[p1l1537t3677r1633b3719],
3	+	CC	O	+	cc	4	SENT_40	[p1l1654t3683r1693b3721],
4	216 73214200	CD	NUMBER	216 73214200	_	0	SENT_40	[p1l1807t3679r2055b3726],[p1l1705t3680r1791b3719],
5	;	:	O	;	_	0	SENT_40	[p1l1807t3679r2055b3726],
6	fax	NN	O	fax	dep	4	SENT_40	[p1l9t3752r91b3794],
7	:	:	O	:	_	0	SENT_40	[p1l9t3752r91b3794],
8	+216 73224411	CD	NUMBER	+216 73224411	dep	6	SENT_40	[p1l255t3754r500b3794],[p1l102t3754r234b3796],
9	.	.	O	.	_	0	SENT_40	[p1l255t3754r500b3794],

1	E	NN	O	e	nn	4	SENT_41	[p2l104t19r253b61],
2	—	CD	NUMBER	—	num	4	SENT_41	[p2l104t19r253b61],
3	mail	NN	O	mail	nn	4	SENT_41	[p2l104t19r253b61],
4	address	NN	O	address	_	0	SENT_41	[p2l271t19r456b61],
5	:	:	O	:	_	0	SENT_41	[p2l271t19r456b61],
6	chakrount@voila.fr	NN	O	chakrount@voila.fr	dep	4	SENT_41	[p2l476t19r922b61],
7	(	CD	NUMBER	(	num	10	SENT_41	[p2l943t19r1000b71],
8	T.	NNP	PERSON	T.	nn	10	SENT_41	[p2l943t19r1000b71],
9	Chakroun	NNP	PERSON	Chakroun	nn	10	SENT_41	[p2l1020t19r1281b71],
10	)	NN	O	)	dep	6	SENT_41	[p2l1020t19r1281b71],
11	.	.	O	.	_	0	SENT_41	[p2l1020t19r1281b71],

1	0049-3848	CD	DURATION	0049-3848	_	0	SENT_42	[p2l8t157r310b207],
2	/	:	O	/	punct	1	SENT_42	[p2l8t157r310b207],
3	$	$	MONEY	$	nsubj	5	SENT_42	[p2l8t157r310b207],
4	—	CD	MONEY	—	num	3	SENT_42	[p2l332t183r357b187],
5	see	VBP	O	see	dep	1	SENT_42	[p2l380t170r452b200],
6	front	JJ	O	front	amod	7	SENT_42	[p2l473t158r588b200],
7	matter	NN	O	matter	dobj	5	SENT_42	[p2l608t164r767b200],
8	©	CD	NUMBER	©	num	11	SENT_42	[p2l786t161r824b199],
9	2010	CD	DATE	2010	num	11	SENT_42	[p2l844t160r960b200],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_42	[p2l982t158r1165b200],
11	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_42	[p2l1185t158r1268b200],
12	.	.	O	.	_	0	SENT_42	[p2l1185t158r1268b200],

1	All	DT	O	all	det	2	SENT_43	[p2l1287t158r1350b199],
2	rights	NNS	O	rights	nsubj	3	SENT_43	[p2l1372t158r1505b210],
3	reserved	VBN	O	reserve	_	0	SENT_43	[p2l1527t158r1739b200],
4	.	.	O	.	_	0	SENT_43	[p2l1527t158r1739b200],

1	doi	FW	O	doi	_	0	SENT_44	[p2l8t228r853b280],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_44	[p2l8t228r853b280],
3	/	:	O	/	punct	2	SENT_44	[p2l8t228r853b280],
4	j.	NN	O	j.	nsubj	5	SENT_44	[p2l8t228r853b280],
5	thromres	VBZ	O	thromre	dep	2	SENT_44	[p2l8t228r853b280],
6	.2010.01.011	CD	NUMBER	.2010.01.011	dobj	5	SENT_44	[p2l8t228r853b280],

1	©	RB	O	©	advmod	2	SENT_45	[p2l1046t311r1090b356],
2	2010	CD	DATE	2010	_	0	SENT_45	[p2l1113t311r1246b356],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_45	[p2l1271t308r1483b356],
4	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_45	[p2l1506t308r1601b356],
5	.	.	O	.	_	0	SENT_45	[p2l1506t308r1601b356],

1	All	DT	O	all	det	2	SENT_46	[p2l1623t308r1696b355],
2	rights	NNS	O	rights	nsubj	3	SENT_46	[p2l1720t308r1874b368],
3	reserved	VBN	O	reserve	_	0	SENT_46	[p2l1899t308r2144b356],
4	.	.	O	.	_	0	SENT_46	[p2l1899t308r2144b356],

1	Since	IN	O	since	mark	19	SENT_47	[p2l151t610r306b662],
2	the	DT	O	the	det	5	SENT_47	[p2l322t609r417b662],
3	platelet	NN	O	platelet	nn	5	SENT_47	[p2l433t609r660b675],
4	GPIIb-Illa	NN	MISC	gpiib-illum	nn	5	SENT_47	[p2l675t609r954b662],
5	receptor	NN	O	receptor	nsubj	19	SENT_47	[p2l970t617r1234b675],
6	,	,	O	,	_	0	SENT_47	[p2l970t617r1234b675],
7	a	DT	O	a	det	8	SENT_47	[p2l1252t624r1282b662],
8	member	NN	O	member	appos	5	SENT_47	[p2l1298t609r1552b662],
9	of	IN	O	of	_	0	SENT_47	[p2l1566t609r1628b662],
10	the	DT	O	the	det	13	SENT_47	[p2l1635t609r1730b662],
11	large	JJ	O	large	amod	13	SENT_47	[p2l1747t609r1893b675],
12	integrin	NN	O	integrin	nn	13	SENT_47	[p2l1909t610r2146b675],
13	family	NN	O	family	prep_of	8	SENT_47	[p2l51t695r252b761],
14	,	,	O	,	_	0	SENT_47	[p2l51t695r252b761],
15	is	VBZ	O	be	cop	19	SENT_47	[p2l272t696r314b748],
16	a	DT	O	a	det	19	SENT_47	[p2l333t710r363b748],
17	key	JJ	O	key	amod	19	SENT_47	[p2l381t695r486b761],
18	membrane	NN	O	membrane	nn	19	SENT_47	[p2l502t695r827b748],
19	receptor	NN	O	receptor	advcl	38	SENT_47	[p2l845t703r1099b761],
20	for	IN	O	for	_	0	SENT_47	[p2l1114t695r1197b748],
21	both	DT	O	both	det	23	SENT_47	[p2l1213t695r1350b748],
22	platelet	NN	O	platelet	nn	23	SENT_47	[p2l1366t695r1594b761],
23	activation	NN	O	activation	prep_for	19	SENT_47	[p2l1610t696r1905b748],
24	and	CC	O	and	_	0	SENT_47	[p2l1923t695r2032b748],
25	full	JJ	O	full	amod	27	SENT_47	[p2l2051t695r2145b748],
26	platelet	NN	O	platelet	nn	27	SENT_47	[p2l51t780r279b847],
27	aggregation	NN	O	aggregation	advcl	38	SENT_47	[p2l308t781r663b847],
28	[	CD	NUMBER	[	number	29	SENT_47	[p2l697t780r790b847],
29	4	CD	NUMBER	4	num	30	SENT_47	[p2l697t780r790b847],
30	]	NN	O	]	dep	27	SENT_47	[p2l697t780r790b847],
31	,	,	O	,	_	0	SENT_47	[p2l697t780r790b847],
32	polymorphisms	NNS	O	polymorphism	nsubj	38	SENT_47	[p2l822t780r1293b847],
33	of	IN	O	of	_	0	SENT_47	[p2l1325t780r1388b833],
34	its	PRP$	O	its	poss	36	SENT_47	[p2l1412t781r1479b833],
35	encoding	NN	O	encoding	nn	36	SENT_47	[p2l1512t780r1787b847],
36	genes	NNS	O	gene	prep_of	32	SENT_47	[p2l1816t796r1987b847],
37	may	MD	O	may	aux	38	SENT_47	[p2l2019t796r2148b847],
38	affect	VB	O	affect	_	0	SENT_47	[p2l51t866r216b919],
39	its	PRP$	O	its	poss	40	SENT_47	[p2l241t867r308b919],
40	function	NN	O	function	dobj	38	SENT_47	[p2l337t866r600b920],
41	.	.	O	.	_	0	SENT_47	[p2l337t866r600b920],

1	The	DT	O	the	det	3	SENT_48	[p2l625t866r735b919],
2	PIA1/PlA2	NN	O	pia1/pla2	nn	3	SENT_48	[p2l762t866r1058b928],
3	polymorphism	NN	O	polymorphism	nsubj	11	SENT_48	[p2l1086t866r1529b933],
4	of	IN	O	of	_	0	SENT_48	[p2l1556t866r1618b919],
5	GPIlIa	NN	O	gpilium	nn	6	SENT_48	[p2l1638t869r1812b919],
6	subunit	NN	O	subunit	prep_of	3	SENT_48	[p2l1839t866r2066b919],
7	of	IN	O	of	_	0	SENT_48	[p2l2091t866r2153b919],
8	this	DT	O	this	det	9	SENT_48	[p2l51t952r159b1005],
9	receptor	NN	O	receptor	prep_of	6	SENT_48	[p2l188t960r442b1019],
10	is	VBZ	O	be	cop	11	SENT_48	[p2l468t953r511b1005],
11	one	CD	NUMBER	one	_	0	SENT_48	[p2l541t968r648b1005],
12	of	IN	O	of	_	0	SENT_48	[p2l677t952r739b1005],
13	the	DT	O	the	det	17	SENT_48	[p2l759t953r854b1005],
14	most	RBS	O	most	advmod	15	SENT_48	[p2l884t960r1032b1005],
15	studied	VBN	O	study	amod	17	SENT_48	[p2l1059t952r1279b1005],
16	genetic	JJ	O	genetic	amod	17	SENT_48	[p2l1307t953r1526b1019],
17	polymorphism	NN	O	polymorphism	prep_of	11	SENT_48	[p2l1553t952r2009b1019],
18	.	.	O	.	_	0	SENT_48	[p2l1553t952r2009b1019],

1	The	DT	O	the	det	3	SENT_49	[p2l2036t952r2145b1005],
2	genetic	JJ	O	genetic	amod	3	SENT_49	[p2l50t1039r268b1105],
3	background	NN	O	background	nsubjpass	9	SENT_49	[p2l299t1038r655b1105],
4	of	IN	O	of	_	0	SENT_49	[p2l688t1038r750b1091],
5	this	DT	O	this	det	7	SENT_49	[p2l775t1038r883b1091],
6	PIA	NN	O	pium	nn	7	SENT_49	[p2l918t1038r1016b1091],
7	polymorphism	NN	O	polymorphism	prep_of	3	SENT_49	[p2l1046t1038r1489b1105],
8	is	VBZ	O	be	auxpass	9	SENT_49	[p2l1522t1039r1565b1091],
9	based	VBN	O	base	_	0	SENT_49	[p2l1598t1038r1769b1091],
10	on	IN	O	on	_	0	SENT_49	[p2l1803t1054r1876b1091],
11	a	DT	O	a	det	16	SENT_49	[p2l1908t1054r1939b1091],
12	single	JJ	O	single	amod	16	SENT_49	[p2l1972t1038r2145b1105],
13	nucleotide	NN	O	nucleotide	nn	16	SENT_49	[p2l51t1125r366b1178],
14	substitution	NN	O	substitution	nn	16	SENT_49	[p2l386t1125r745b1178],
15	(	CD	NUMBER	(	num	16	SENT_49	[p2l767t1125r962b1191],
16	T	NN	O	t	prep_on	9	SENT_49	[p2l767t1125r962b1191],
17	—	CD	NUMBER	—	num	20	SENT_49	[p2l767t1125r962b1191],
18	>	JJR	O	>	amod	20	SENT_49	[p2l767t1125r962b1191],
19	C	NN	O	c	nn	20	SENT_49	[p2l767t1125r962b1191],
20	)	NN	O	)	dobj	9	SENT_49	[p2l767t1125r962b1191],
21	at	IN	O	at	_	0	SENT_49	[p2l985t1133r1041b1178],
22	position	NN	O	position	prep_at	9	SENT_49	[p2l1057t1125r1299b1191],
23	1565	CD	DATE	1565	num	22	SENT_49	[p2l1320t1128r1463b1178],
24	in	IN	O	in	_	0	SENT_49	[p2l1484t1126r1539b1177],
25	exon	NN	O	exon	prep_in	9	SENT_49	[p2l1557t1140r1702b1178],
26	2	CD	NUMBER	2	num	25	SENT_49	[p2l1720t1127r1752b1177],
27	of	IN	O	of	_	0	SENT_49	[p2l1772t1124r1834b1178],
28	the	DT	O	the	det	31	SENT_49	[p2l1845t1125r1940b1178],
29	GP	NN	O	gp	nn	31	SENT_49	[p2l1958t1127r2039b1178],
30	Illa	NN	O	illum	nn	31	SENT_49	[p2l2056t1128r2146b1178],
31	gene	NN	O	gene	prep_of	25	SENT_49	[p2l50t1226r192b1277],
32	leading	VBG	O	lead	xcomp	9	SENT_49	[p2l209t1211r429b1277],
33	to	TO	O	to	_	0	SENT_49	[p2l442t1219r500b1264],
34	the	DT	O	the	det	35	SENT_49	[p2l516t1211r611b1264],
35	substitution	NN	O	substitution	prep_to	32	SENT_49	[p2l628t1211r987b1264],
36	of	IN	O	of	_	0	SENT_49	[p2l1003t1211r1066b1264],
37	leucine	NN	O	leucine	nn	40	SENT_49	[p2l1074t1211r1288b1264],
38	(	CD	NUMBER	(	num	40	SENT_49	[p2l1308t1211r1493b1277],
39	PIA1	NN	O	pia1	nn	40	SENT_49	[p2l1308t1211r1493b1277],
40	)	NN	O	)	prep_of	35	SENT_49	[p2l1308t1211r1493b1277],
41	for	IN	O	for	_	0	SENT_49	[p2l1514t1210r1597b1264],
42	proline	NN	O	proline	nn	44	SENT_49	[p2l1612t1211r1824b1277],
43	(	CD	NUMBER	(	num	44	SENT_49	[p2l1844t1211r2029b1277],
44	PlA2	NN	O	pla2	prep_for	32	SENT_49	[p2l1844t1211r2029b1277],
45	)	CD	NUMBER	)	num	44	SENT_49	[p2l1844t1211r2029b1277],
46	[	CD	NUMBER	[	number	47	SENT_49	[p2l2053t1211r2145b1277],
47	5	CD	NUMBER	5	num	48	SENT_49	[p2l2053t1211r2145b1277],
48	]	NN	O	]	dep	32	SENT_49	[p2l2053t1211r2145b1277],
49	.	.	O	.	_	0	SENT_49	[p2l2053t1211r2145b1277],

1	Regarding	VBG	O	regard	_	0	SENT_50	[p2l151t1296r455b1363],
2	its	PRP$	O	its	poss	4	SENT_50	[p2l474t1297r542b1349],
3	functional	JJ	O	functional	amod	4	SENT_50	[p2l563t1296r865b1349],
4	consequences	NNS	O	consequence	prep_regarding	23	SENT_50	[p2l885t1312r1315b1363],
5	,	,	O	,	_	0	SENT_50	[p2l885t1312r1315b1363],
6	the	DT	O	the	det	8	SENT_50	[p2l1335t1296r1431b1349],
7	Framingham	NNP	LOCATION	Framingham	nn	8	SENT_50	[p2l1451t1296r1833b1363],
8	study	NN	O	study	nsubj	23	SENT_50	[p2l1853t1296r2030b1363],
9	,	,	O	,	_	0	SENT_50	[p2l1853t1296r2030b1363],
10	the	DT	O	the	det	12	SENT_50	[p2l2050t1296r2145b1349],
11	largest	JJS	O	largest	amod	12	SENT_50	[p2l51t1382r253b1449],
12	study	NN	O	study	appos	8	SENT_50	[p2l290t1382r455b1448],
13	of	IN	O	of	_	0	SENT_50	[p2l490t1382r552b1435],
14	ex	FW	O	ex	nn	17	SENT_50	[p2l583t1398r644b1435],
15	vivo	FW	O	vivo	nn	17	SENT_50	[p2l679t1383r797b1435],
16	platelet	NN	O	platelet	nn	17	SENT_50	[p2l836t1382r1063b1449],
17	function	NN	O	function	prep_of	12	SENT_50	[p2l1099t1382r1349b1435],
18	including	VBG	O	include	_	0	SENT_50	[p2l1386t1382r1667b1449],
19	1422	CD	NUMBER	1422	num	20	SENT_50	[p2l1707t1385r1850b1435],
20	subjects	NNS	O	subject	prep_including	17	SENT_50	[p2l1890t1382r2145b1448],
21	,	,	O	,	_	0	SENT_50	[p2l1890t1382r2145b1448],
22	clearly	RB	O	clearly	advmod	23	SENT_50	[p2l51t1468r252b1535],
23	showed	VBD	O	show	_	0	SENT_50	[p2l297t1469r530b1521],
24	that	IN	O	that	complm	28	SENT_50	[p2l576t1468r697b1522],
25	PIA	NNP	ORGANIZATION	PIA	nn	26	SENT_50	[p2l741t1469r839b1521],
26	polymorphism	NN	O	polymorphism	nsubjpass	28	SENT_50	[p2l883t1468r1330b1535],
27	was	VBD	O	be	auxpass	28	SENT_50	[p2l1372t1484r1490b1521],
28	associated	VBN	O	associate	ccomp	23	SENT_50	[p2l1536t1468r1847b1521],
29	with	IN	O	with	mark	36	SENT_50	[p2l1891t1469r2030b1521],
30	an	DT	O	a	det	32	SENT_50	[p2l2075t1484r2145b1521],
31	interindividual	JJ	O	interindividual	amod	32	SENT_50	[p2l51t1555r498b1608],
32	variability	NN	O	variability	nsubj	36	SENT_50	[p2l529t1555r835b1621],
33	of	IN	O	of	_	0	SENT_50	[p2l866t1555r928b1608],
34	epinephrine	NN	O	epinephrine	nn	35	SENT_50	[p2l953t1555r1587b1621],
35	—	NN	O	—	prep_of	32	SENT_50	[p2l953t1555r1587b1621],
36	induced	VBD	O	induce	advcl	28	SENT_50	[p2l953t1555r1587b1621],
37	platelet	NN	O	platelet	nn	38	SENT_50	[p2l1621t1555r1848b1621],
38	response	NN	O	response	dobj	36	SENT_50	[p2l1879t1570r2146b1621],
39	[	CD	NUMBER	[	number	40	SENT_50	[p2l54t1641r146b1707],
40	6	CD	NUMBER	6	num	41	SENT_50	[p2l54t1641r146b1707],
41	]	NN	O	]	dep	36	SENT_50	[p2l54t1641r146b1707],
42	.	.	O	.	_	0	SENT_50	[p2l54t1641r146b1707],

1	Ever	RB	O	ever	advmod	2	SENT_51	[p2l187t1644r320b1694],
2	since	IN	O	since	advmod	7	SENT_51	[p2l359t1642r523b1702],
3	,	,	O	,	_	0	SENT_51	[p2l359t1642r523b1702],
4	several	JJ	O	several	amod	5	SENT_51	[p2l565t1641r774b1694],
5	studies	NNS	O	study	nsubj	7	SENT_51	[p2l815t1641r1025b1694],
6	have	VBP	O	have	aux	7	SENT_51	[p2l1065t1641r1205b1694],
7	attempted	VBN	O	attempt	_	0	SENT_51	[p2l1245t1641r1557b1707],
8	to	TO	O	to	aux	9	SENT_51	[p2l1597t1649r1654b1694],
9	demonstrate	VB	O	demonstrate	xcomp	7	SENT_51	[p2l1694t1641r2076b1694],
10	a	DT	O	a	det	11	SENT_51	[p2l2116t1656r2146b1694],
11	relationship	NN	O	relationship	dobj	9	SENT_51	[p2l51t1726r411b1793],
12	between	IN	O	between	_	0	SENT_51	[p2l441t1726r702b1779],
13	aspirin	NN	O	aspirin	prep_between	11	SENT_51	[p2l731t1727r936b1793],
14	non	JJ	O	non	amod	16	SENT_51	[p2l967t1727r1566b1793],
15	—	NN	O	—	nn	16	SENT_51	[p2l967t1727r1566b1793],
16	responsiveness	NN	O	responsiveness	dep	13	SENT_51	[p2l967t1727r1566b1793],
17	and	CC	O	and	_	0	SENT_51	[p2l1598t1726r1707b1779],
18	PIA	NN	O	pium	nn	19	SENT_51	[p2l1739t1726r1837b1779],
19	polymorphism	NN	O	polymorphism	dep	13	SENT_51	[p2l1866t1726r2145b1793, p2l51t1812r250b1879],
20	.	.	O	.	_	0	SENT_51	[p2l1866t1726r2145b1793, p2l51t1812r250b1879],

1	However	RB	O	however	advmod	26	SENT_52	[p2l283t1815r569b1873],
2	,	,	O	,	_	0	SENT_52	[p2l283t1815r569b1873],
3	as	IN	O	as	mark	4	SENT_52	[p2l601t1828r659b1865],
4	shown	VBN	O	show	advcl	26	SENT_52	[p2l692t1812r891b1865],
5	in	IN	O	in	_	0	SENT_52	[p2l923t1813r978b1865],
6	a	DT	O	a	det	10	SENT_52	[p2l1009t1828r1040b1865],
7	recent	JJ	O	recent	amod	10	SENT_52	[p2l1071t1820r1260b1865],
8	meta	NN	O	meta	nn	10	SENT_52	[p2l1290t1812r1706b1879],
9	—	NN	O	—	nn	10	SENT_52	[p2l1290t1812r1706b1879],
10	analysis	NN	O	analysis	prep_in	4	SENT_52	[p2l1290t1812r1706b1879],
11	including	VBG	O	include	_	0	SENT_52	[p2l1739t1812r2021b1878],
12	the	DT	O	the	det	15	SENT_52	[p2l2050t1812r2145b1865],
13	most	RBS	O	most	advmod	14	SENT_52	[p2l51t1906r200b1951],
14	relevant	JJ	O	relevant	amod	15	SENT_52	[p2l216t1898r464b1951],
15	studies	NNS	O	study	prep_including	10	SENT_52	[p2l480t1898r690b1951],
16	in	IN	O	in	_	0	SENT_52	[p2l709t1899r764b1951],
17	this	DT	O	this	det	21	SENT_52	[p2l781t1899r889b1951],
18	issue	NN	O	issue	nn	21	SENT_52	[p2l908t1899r1055b1951],
19	[	NN	O	[	nn	21	SENT_52	[p2l1076t1898r1168b1965],
20	7	CD	NUMBER	7	num	21	SENT_52	[p2l1076t1898r1168b1965],
21	]	NN	O	]	prep_in	15	SENT_52	[p2l1076t1898r1168b1965],
22	,	,	O	,	_	0	SENT_52	[p2l1076t1898r1168b1965],
23	published	VBN	O	publish	amod	24	SENT_52	[p2l1187t1898r1481b1965],
24	data	NNS	O	datum	nsubj	26	SENT_52	[p2l1499t1898r1627b1952],
25	are	VBP	O	be	cop	26	SENT_52	[p2l1644t1914r1735b1951],
26	controversial	JJ	O	controversial	_	0	SENT_52	[p2l1753t1898r2145b1951],
27	and	CC	O	and	_	0	SENT_52	[p2l51t1985r160b2037],
28	largely	RB	O	largely	advmod	29	SENT_52	[p2l192t1984r396b2051],
29	depending	VBG	O	depend	conj_and	26	SENT_52	[p2l424t1984r745b2051],
30	on	IN	O	on	_	0	SENT_52	[p2l774t2000r847b2037],
31	study	NN	O	study	nn	33	SENT_52	[p2l879t1985r1044b2051],
32	population	NN	O	population	nn	33	SENT_52	[p2l1073t1984r1400b2051],
33	characteristics	NNS	O	characteristic	prep_on	29	SENT_52	[p2l1430t1984r1860b2037],
34	(	CD	NUMBER	(	num	36	SENT_52	[p2l1896t1984r2147b2051],
35	healthy	JJ	O	healthy	amod	36	SENT_52	[p2l1896t1984r2147b2051],
36	subjects	NNS	O	subject	dobj	29	SENT_52	[p2l52t2071r292b2137],
37	or	CC	O	or	_	0	SENT_52	[p2l313t2086r374b2124],
38	cardiovascular	JJ	O	cardiovascular	amod	40	SENT_52	[p2l392t2071r828b2124],
39	patients	NNS	O	patient	nn	40	SENT_52	[p2l846t2071r1112b2137],
40	)	NN	O	)	conj_or	36	SENT_52	[p2l846t2071r1112b2137],
41	and	CC	O	and	_	0	SENT_52	[p2l1135t2071r1244b2124],
42	the	DT	O	the	det	43	SENT_52	[p2l1264t2071r1359b2124],
43	methods	NNS	O	method	conj_and	36	SENT_52	[p2l1379t2071r1640b2124],
44	used	VBN	O	use	partmod	43	SENT_52	[p2l1661t2071r1799b2124],
45	for	IN	O	for	_	0	SENT_52	[p2l1819t2071r1902b2124],
46	platelet	NN	O	platelet	nn	48	SENT_52	[p2l1920t2071r2147b2137],
47	reactivity	NN	O	reactivity	nn	48	SENT_52	[p2l51t2158r335b2223],
48	evaluation	NN	O	evaluation	prep_for	44	SENT_52	[p2l355t2157r684b2210],
49	.	.	O	.	_	0	SENT_52	[p2l355t2157r684b2210],

1	e266	NN	O	e266	nn	3	SENT_53	[p2l345t2299r403b2320],
2	F.	NNP	PERSON	F.	nn	3	SENT_53	[p2l1036t2299r1052b2320],
3	Abderrazek	NNP	PERSON	Abderrazek	_	0	SENT_53	[p2l1062t2298r1194b2320],
4	et	FW	O	et	nn	5	SENT_53	[p2l1204t2301r1226b2320],
5	al.	FW	O	al.	dep	3	SENT_53	[p2l1235t2298r1259b2320],
6	/	:	O	/	punct	3	SENT_53	[p2l1270t2299r1279b2323],
7	Thrombosis	NNP	O	Thrombosis	nn	8	SENT_53	[p2l1289t2298r1420b2320],
8	Research	NNP	O	Research	dep	3	SENT_53	[p2l1430t2298r1532b2320],
9	125	CD	NUMBER	125	number	10	SENT_53	[p2l1545t2299r1585b2320],
10	(	CD	NUMBER	(	nn	15	SENT_53	[p2l1597t2298r1675b2325],
11	2010	CD	DATE	2010	num	12	SENT_53	[p2l1597t2298r1675b2325],
12	)	CD	NUMBER	)	dep	10	SENT_53	[p2l1597t2298r1675b2325],
13	e265	NN	O	e265	dep	10	SENT_53	[p2l1687t2299r1814b2320],
14	—	CD	NUMBER	—	num	13	SENT_53	[p2l1687t2299r1814b2320],
15	e268	NN	O	e268	dep	8	SENT_53	[p2l1687t2299r1814b2320],

1	The	DT	O	the	det	2	SENT_54	[p2l108t2437r218b2492],
2	aim	NN	O	aim	nsubj	7	SENT_54	[p2l244t2438r356b2492],
3	of	IN	O	of	_	0	SENT_54	[p2l382t2437r444b2492],
4	our	PRP$	O	we	poss	6	SENT_54	[p2l463t2453r566b2492],
5	retrospective	JJ	O	retrospective	amod	6	SENT_54	[p2l590t2438r982b2506],
6	study	NN	O	study	prep_of	2	SENT_54	[p2l1010t2437r1174b2506],
7	is	VBZ	O	be	_	0	SENT_54	[p2l1200t2438r1242b2492],
8	to	TO	O	to	aux	9	SENT_54	[p2l1269t2445r1328b2492],
9	investigate	VB	O	investigate	xcomp	7	SENT_54	[p2l1355t2438r1680b2506],
10	whether	IN	O	whether	complm	11	SENT_54	[p2l1705t2437r1962b2492],
11	PlA1	NN	O	pla1	dep	9	SENT_54	[p2l1987t2437r2148b2501],
12	/	:	O	/	punct	11	SENT_54	[p2l1987t2437r2148b2501],
13	PlA2	NN	O	pla2	nn	14	SENT_54	[p2l9t2526r141b2580],
14	polymorphism	NN	O	polymorphism	nsubjpass	20	SENT_54	[p2l181t2526r624b2595],
15	of	IN	O	of	_	0	SENT_54	[p2l661t2526r723b2581],
16	GPllla	NN	O	gplllum	nn	18	SENT_54	[p2l753t2529r927b2581],
17	platelet	NN	O	platelet	nn	18	SENT_54	[p2l964t2526r1190b2595],
18	receptor	NN	O	receptor	prep_of	14	SENT_54	[p2l1226t2534r1479b2595],
19	is	VBZ	O	be	auxpass	20	SENT_54	[p2l1514t2527r1558b2581],
20	associated	VBN	O	associate	dep	11	SENT_54	[p2l1595t2526r1903b2581],
21	with	IN	O	with	_	0	SENT_54	[p2l1939t2526r2077b2581],
22	a	DT	O	a	det	24	SENT_54	[p2l2115t2542r2146b2581],
23	greater	JJR	O	greater	amod	24	SENT_54	[p2l8t2624r223b2684],
24	prevalence	NN	O	prevalence	prep_with	20	SENT_54	[p2l253t2616r580b2684],
25	of	IN	O	of	_	0	SENT_54	[p2l612t2615r674b2670],
26	HPR	NNP	ORGANIZATION	HPR	prep_of	24	SENT_54	[p2l699t2619r825b2670],
27	in	IN	O	in	_	0	SENT_54	[p2l855t2616r911b2670],
28	stable	JJ	O	stable	amod	32	SENT_54	[p2l943t2616r1117b2670],
29	coronary	JJ	O	coronary	amod	32	SENT_54	[p2l1149t2631r1417b2684],
30	artery	NN	O	artery	nn	32	SENT_54	[p2l1447t2624r1627b2684],
31	disease	NN	O	disease	nn	32	SENT_54	[p2l1657t2615r1872b2670],
32	patients	NNS	O	patient	prep_in	20	SENT_54	[p2l1905t2616r2144b2684],
33	receiving	VBG	O	receive	xcomp	20	SENT_54	[p2l9t2705r284b2773],
34	long	JJ	O	long	amod	35	SENT_54	[p2l316t2705r446b2773],
35	term	NN	O	term	nsubj	38	SENT_54	[p2l478t2713r622b2759],
36	daily	RB	SET	daily	advmod	38	SENT_54	[p2l655t2704r800b2773],
37	low	JJ	O	low	amod	38	SENT_54	[p2l833t2704r943b2759],
38	dose	NN	O	dose	xcomp	33	SENT_54	[p2l975t2705r1112b2759],
39	of	IN	O	of	_	0	SENT_54	[p2l1146t2704r1209b2759],
40	aspirin	NN	O	aspirin	prep_of	38	SENT_54	[p2l1235t2705r1438b2773],
41	for	IN	O	for	_	0	SENT_54	[p2l1472t2704r1556b2759],
42	secondary	JJ	O	secondary	amod	44	SENT_54	[p2l1588t2705r1893b2773],
43	atherothrombotic	JJ	O	atherothrombotic	amod	44	SENT_54	[p2l1925t2705r2144b2759, p2l8t2794r345b2849],
44	prevention	NN	O	prevention	prep_for	40	SENT_54	[p2l366t2795r708b2862],
45	.	.	O	.	_	0	SENT_54	[p2l366t2795r708b2862],

1	Patients	NNS	O	patient	_	0	SENT_55	[p2l8t2972r270b3026],
2	and	CC	O	and	_	0	SENT_55	[p2l294t2972r415b3026],
3	Methods	NNS	O	method	conj_and	1	SENT_55	[p2l440t2972r720b3026],

1	Patients	NNS	O	patient	_	0	SENT_56	[p2l7t3151r242b3204],

1	We	PRP	O	we	nsubj	2	SENT_57	[p2l108t3330r212b3382],
2	enrolled	VBD	O	enrol	ccomp	32	SENT_57	[p2l235t3327r488b3382],
3	188	CD	NUMBER	188	num	4	SENT_57	[p2l514t3330r621b3382],
4	(	NN	O	(	dobj	2	SENT_57	[p2l650t3327r788b3395],
5	169	CD	NUMBER	169	num	7	SENT_57	[p2l650t3327r788b3395],
6	men/19	NN	O	men/19	nn	7	SENT_57	[p2l813t3329r1048b3391],
7	women	NNS	O	woman	nsubj	8	SENT_57	[p2l1070t3327r1326b3395],
8	)	VBP	O	)	rcmod	4	SENT_57	[p2l1070t3327r1326b3395],
9	consecutive	JJ	O	consecutive	amod	10	SENT_57	[p2l1355t3328r1714b3382],
10	patients	NNS	O	patient	dobj	8	SENT_57	[p2l1737t3328r1982b3395],
11	with	IN	O	with	_	0	SENT_57	[p2l2005t3327r2146b3382],
12	stable	JJ	O	stable	amod	14	SENT_57	[p2l10t3415r187b3470],
13	coronary	JJ	O	coronary	amod	14	SENT_57	[p2l230t3431r503b3484],
14	artery	NN	O	artery	prep_with	8	SENT_57	[p2l544t3423r728b3484],
15	disease	NN	O	disease	nn	18	SENT_57	[p2l769t3415r989b3470],
16	(	CD	NUMBER	(	num	18	SENT_57	[p2l1037t3415r1235b3483],
17	CAD	NN	O	cad	nn	18	SENT_57	[p2l1037t3415r1235b3483],
18	)	NN	O	)	tmod	14	SENT_57	[p2l1037t3415r1235b3483],
19	,	,	O	,	_	0	SENT_57	[p2l1037t3415r1235b3483],
20	most	JJS	O	most	nsubj	24	SENT_57	[p2l1280t3423r1432b3470],
21	of	IN	O	of	_	0	SENT_57	[p2l1472t3415r1536b3470],
22	them	PRP	O	they	prep_of	20	SENT_57	[p2l1571t3415r1731b3470],
23	were	VBD	O	be	cop	24	SENT_57	[p2l1771t3431r1925b3470],
24	males	NNS	O	male	rcmod	18	SENT_57	[p2l1969t3415r2144b3470],
25	(	CD	PERCENT	(	number	26	SENT_57	[p2l13t3504r253b3572],
26	89.9	CD	PERCENT	89.9	num	27	SENT_57	[p2l13t3504r253b3572],
27	%	NN	PERCENT	%	dep	24	SENT_57	[p2l13t3504r253b3572],
28	)	CD	NUMBER	)	dep	27	SENT_57	[p2l13t3504r253b3572],
29	,	,	O	,	_	0	SENT_57	[p2l13t3504r253b3572],
30	current	JJ	DATE	current	amod	31	SENT_57	[p2l279t3512r505b3559],
31	smokers	NNS	O	smoker	nsubj	32	SENT_57	[p2l530t3504r784b3559],
32	(	VBP	O	(	_	0	SENT_57	[p2l815t3504r1055b3573],
33	71.3	CD	PERCENT	71.3	num	34	SENT_57	[p2l815t3504r1055b3573],
34	%	NN	PERCENT	%	dobj	32	SENT_57	[p2l815t3504r1055b3573],
35	)	CD	NUMBER	)	nsubj	40	SENT_57	[p2l815t3504r1055b3573],
36	,	,	O	,	_	0	SENT_57	[p2l815t3504r1055b3573],
37	type	NN	O	type	amod	39	SENT_57	[p2l1081t3512r1214b3573],
38	2	CD	NUMBER	2	number	37	SENT_57	[p2l1240t3507r1273b3559],
39	diabetics	NNS	O	diabetic	appos	35	SENT_57	[p2l1301t3504r1570b3559],
40	(	VBP	O	(	rcmod	34	SENT_57	[p2l1601t3504r1822b3572],
41	38.3	CD	PERCENT	38.3	num	42	SENT_57	[p2l1601t3504r1822b3572],
42	%	NN	PERCENT	%	dobj	40	SENT_57	[p2l1601t3504r1822b3572],
43	)	CD	NUMBER	)	dep	42	SENT_57	[p2l1601t3504r1822b3572],
44	or	CC	O	or	_	0	SENT_57	[p2l1853t3520r1916b3559],
45	having	VBG	O	have	dep	42	SENT_57	[p2l1940t3504r2146b3573],
46	hypertension	NN	O	hypertension	dobj	45	SENT_57	[p2l9t3594r415b3662],
47	(	CD	PERCENT	(	num	49	SENT_57	[p2l440t3594r680b3662],
48	26.6	CD	PERCENT	26.6	num	49	SENT_57	[p2l440t3594r680b3662],
49	%	NN	PERCENT	%	dep	42	SENT_57	[p2l440t3594r680b3662],
50	)	CD	NUMBER	)	dep	49	SENT_57	[p2l440t3594r680b3662],
51	.	.	O	.	_	0	SENT_57	[p2l440t3594r680b3662],

1	All	PDT	O	all	predet	3	SENT_58	[p2l699t3594r781b3648],
2	the	DT	O	the	det	3	SENT_58	[p2l801t3594r898b3649],
3	patients	NNS	O	patient	nsubj	4	SENT_58	[p2l920t3595r1165b3662],
4	received	VBD	O	receive	_	0	SENT_58	[p2l1187t3594r1443b3649],
5	daily	JJ	SET	daily	amod	9	SENT_58	[p2l1465t3594r1614b3662],
6	aspirin	NN	O	aspirin	nn	9	SENT_58	[p2l1633t3595r1841b3662],
7	(	NN	O	(	nn	9	SENT_58	[p2l1866t3594r2004b3662],
8	250	CD	NUMBER	250	num	9	SENT_58	[p2l1866t3594r2004b3662],
9	mg	NN	O	mg	dobj	4	SENT_58	[p2l2027t3596r2148b3662],
10	/	:	O	/	punct	11	SENT_58	[p2l2027t3596r2148b3662],
11	day	NN	DURATION	day	dep	4	SENT_58	[p2l9t3682r141b3751],
12	)	CD	NUMBER	)	num	11	SENT_58	[p2l9t3682r141b3751],
13	for	IN	O	for	_	0	SENT_58	[p2l187t3682r271b3737],
14	a	DT	O	a	det	16	SENT_58	[p2l309t3698r340b3737],
15	secondary	JJ	O	secondary	amod	16	SENT_58	[p2l381t3682r693b3751],
16	prevention	NN	O	prevention	prep_for	11	SENT_58	[p2l731t3683r1066b3751],
17	for	IN	O	for	_	0	SENT_58	[p2l1107t3682r1192b3737],
18	at	IN	DURATION	at	quantmod	20	SENT_58	[p2l1230t3691r1287b3737],
19	least	JJS	DURATION	least	mwe	18	SENT_58	[p2l1326t3682r1467b3737],
20	two	CD	DURATION	two	num	21	SENT_58	[p2l1505t3691r1621b3737],
21	months	NNS	NUMBER	month	prep_for	16	SENT_58	[p2l1663t3683r1894b3737],
22	after	IN	O	after	_	0	SENT_58	[p2l1935t3682r2076b3737],
23	a	DT	O	a	det	25	SENT_58	[p2l2115t3698r2146b3737],
24	primary	JJ	O	primary	amod	25	SENT_58	[p3l9t18r255b85],
25	event	NN	O	event	prep_after	21	SENT_58	[p3l284t25r454b72],
26	of	IN	O	of	_	0	SENT_58	[p3l484t17r547b72],
27	cardiovascular	JJ	O	cardiovascular	amod	28	SENT_58	[p3l571t17r1015b72],
28	disease	NN	O	disease	prep_of	25	SENT_58	[p3l1044t17r1264b72],
29	deﬁned	VBN	O	deﬁned	partmod	11	SENT_58	[p3l1295t17r1524b72],
30	by	IN	O	by	_	0	SENT_58	[p3l1555t17r1628b85],
31	previous	JJ	O	previous	agent	29	SENT_58	[p3l1658t18r1920b85],
32	angiographically	RB	O	angiographically	advmod	33	SENT_58	[p3l1951t18r2145b85, p3l8t106r348b174],
33	documented	VBN	O	document	amod	31	SENT_58	[p3l391t106r775b161],
34	coronary	JJ	O	coronary	amod	35	SENT_58	[p3l819t122r1092b174],
35	stenosis	NN	O	stenosis	dobj	4	SENT_58	[p3l1135t107r1376b161],
36	or	CC	O	or	_	0	SENT_58	[p3l1421t122r1484b161],
37	previous	JJ	O	previous	amod	38	SENT_58	[p3l1526t107r1789b174],
38	history	NN	O	history	dobj	4	SENT_58	[p3l1833t106r2048b174],
39	of	IN	O	of	_	0	SENT_58	[p3l2089t106r2153b161],
40	myocardial	JJ	O	myocardial	amod	41	SENT_58	[p3l9t194r349b263],
41	infarction	NN	O	infarction	prep_of	35	SENT_58	[p3l374t194r670b249],
42	(	CD	NUMBER	(	num	43	SENT_58	[p3l698t194r847b263],
43	MI	NNP	O	MI	dep	41	SENT_58	[p3l698t194r847b263],
44	)	CD	NUMBER	)	num	43	SENT_58	[p3l698t194r847b263],
45	.	.	O	.	_	0	SENT_58	[p3l698t194r847b263],

1	Exclusion	NN	MISC	exclusion	nn	2	SENT_59	[p3l873t194r1164b249],
2	criteria	NNS	O	criterion	nsubj	3	SENT_59	[p3l1188t195r1405b249],
3	included	VBD	O	include	_	0	SENT_59	[p3l1429t194r1692b249],
4	current	JJ	DATE	current	amod	5	SENT_59	[p3l1717t202r1942b249],
5	use	NN	O	use	dobj	3	SENT_59	[p3l1964t210r2065b249],
6	of	IN	O	of	_	0	SENT_59	[p3l2089t194r2153b249],
7	other	JJ	O	other	amod	8	SENT_59	[p3l9t283r173b338],
8	drugs	NNS	O	drug	prep_of	5	SENT_59	[p3l208t283r377b352],
9	that	WDT	O	that	nsubj	11	SENT_59	[p3l414t283r537b338],
10	might	MD	O	might	aux	11	SENT_59	[p3l573t283r754b352],
11	inﬂuence	VB	O	inﬂuence	rcmod	8	SENT_59	[p3l790t283r1071b338],
12	platelet	NN	O	platelet	nn	13	SENT_59	[p3l1108t283r1340b352],
13	aggregation	NN	O	aggregation	dobj	11	SENT_59	[p3l1375t284r1737b352],
14	(	CD	NUMBER	(	num	22	SENT_59	[p3l1777t283r2144b352],
15	ticlopidine	NN	O	ticlopidine	nn	19	SENT_59	[p3l1777t283r2144b352],
16	,	,	O	,	_	0	SENT_59	[p3l1777t283r2144b352],
17	clopidogrel	NN	O	clopidogrel	nn	22	SENT_59	[p3l9t373r366b441],
18	,	,	O	,	_	0	SENT_59	[p3l9t373r366b441],
19	dipyridamole	NN	O	dipyridamole	nn	22	SENT_59	[p3l393t373r802b441],
20	and	CC	O	and	_	0	SENT_59	[p3l828t373r938b428],
21	anti-inﬂammatory	JJ	O	anti-inﬂammatory	conj_and	19	SENT_59	[p3l964t373r1533b441],
22	drugs	NNS	O	drug	tmod	11	SENT_59	[p3l1555t373r1770b441],
23	)	RB	O	)	advmod	22	SENT_59	[p3l1555t373r1770b441],
24	,	,	O	,	_	0	SENT_59	[p3l1555t373r1770b441],
25	a	DT	O	a	det	26	SENT_59	[p3l1796t389r1827b428],
26	history	NN	O	history	appos	8	SENT_59	[p3l1852t373r2066b441],
27	of	IN	O	of	_	0	SENT_59	[p3l2089t373r2153b428],
28	bleeding	VBG	O	bleed	prepc_of	26	SENT_59	[p3l8t462r272b530],
29	diathesis	NN	O	diathesis	nn	34	SENT_59	[p3l309t462r593b525],
30	,	,	O	,	_	0	SENT_59	[p3l309t462r593b525],
31	drug	NN	O	drug	nn	34	SENT_59	[p3l631t462r773b530],
32	or	CC	O	or	_	0	SENT_59	[p3l809t478r872b517],
33	alcohol	NN	O	alcohol	nn	34	SENT_59	[p3l907t462r1126b517],
34	abuse	NN	O	abuse	dobj	28	SENT_59	[p3l1162t462r1352b525],
35	,	,	O	,	_	0	SENT_59	[p3l1162t462r1352b525],
36	prothrombin	NN	O	prothrombin	nn	37	SENT_59	[p3l1389t462r1785b530],
37	time	NN	O	time	appos	8	SENT_59	[p3l1820t463r1959b517],
38	>	JJR	O	>	amod	41	SENT_59	[p3l1997t465r2143b517],
39	1.5	CD	NUMBER	1.5	num	40	SENT_59	[p3l1997t465r2143b517],
40	times	NNS	O	time	dep	38	SENT_59	[p3l8t551r175b605],
41	control	NN	O	control	dep	37	SENT_59	[p3l211t550r443b613],
42	,	,	O	,	_	0	SENT_59	[p3l211t550r443b613],
43	thrombocytopenia	NN	O	thrombocytopenia	appos	8	SENT_59	[p3l479t550r1048b619],
44	with	IN	O	with	_	0	SENT_59	[p3l1081t550r1222b605],
45	platelet	NN	O	platelet	nn	46	SENT_59	[p3l1257t550r1489b619],
46	count	NN	O	count	prep_with	43	SENT_59	[p3l1522t558r1696b605],
47	<	JJR	O	<	dep	43	SENT_59	[p3l1731t564r1777b603],
48	100	CD	NUMBER	100	num	49	SENT_59	[p3l1817t553r1926b605],
49	giga/l	NN	O	giga/l	dep	47	SENT_59	[p3l1961t550r2144b619],
50	,	,	O	,	_	0	SENT_59	[p3l1961t550r2144b619],
51	hematocrit	NN	O	hematocrit	appos	8	SENT_59	[p3l9t640r345b695],
52	<	JJR	O	<	amod	51	SENT_59	[p3l371t643r545b695],
53	25	CD	PERCENT	25	num	54	SENT_59	[p3l371t643r545b695],
54	%	NN	PERCENT	%	dep	52	SENT_59	[p3l371t643r545b695],
55	and	CC	O	and	_	0	SENT_59	[p3l569t640r680b695],
56	creatininemia	NN	O	creatininemia	npadvmod	57	SENT_59	[p3l706t641r1129b695],
57	>	JJR	O	>	amod	51	SENT_59	[p3l1154t643r1302b695],
58	4.0	CD	NUMBER	4.0	num	59	SENT_59	[p3l1154t643r1302b695],
59	mg/dL	NN	O	mg/dl	dep	52	SENT_59	[p3l1324t640r1531b708],
60	.	.	O	.	_	0	SENT_59	[p3l1324t640r1531b708],

1	Patient	NN	O	patient	nn	2	SENT_60	[p3l1557t641r1772b695],
2	compliance	NN	O	compliance	nsubjpass	7	SENT_60	[p3l1795t640r2145b708],
3	to	TO	O	to	_	0	SENT_60	[p3l8t736r67b783],
4	aspirin	NN	O	aspirin	nn	5	SENT_60	[p3l99t729r308b797],
5	treatment	NN	O	treatment	prep_to	2	SENT_60	[p3l338t736r647b783],
6	was	VBD	O	be	auxpass	7	SENT_60	[p3l675t744r793b783],
7	ascertained	VBN	O	ascertain	_	0	SENT_60	[p3l826t728r1176b783],
8	by	IN	O	by	_	0	SENT_60	[p3l1207t728r1280b797],
9	a	DT	O	a	det	11	SENT_60	[p3l1310t744r1341b783],
10	well	RB	O	well	advmod	11	SENT_60	[p3l1371t728r1851b783],
11	—	JJ	O	—	agent	7	SENT_60	[p3l1371t728r1851b783],
12	conducted	VBN	O	conduct	partmod	11	SENT_60	[p3l1371t728r1851b783],
13	personal	JJ	O	personal	amod	14	SENT_60	[p3l1884t728r2145b797],
14	interview	NN	O	interview	dobj	12	SENT_60	[p3l9t818r317b872],
15	.	.	O	.	_	0	SENT_60	[p3l9t818r317b872],

1	The	DT	O	the	det	2	SENT_61	[p3l108t906r220b961],
2	study	NN	O	study	nsubjpass	17	SENT_61	[p3l249t906r418b974],
3	was	VBD	O	be	auxpass	4	SENT_61	[p3l443t922r562b961],
4	approved	VBN	O	approve	rcmod	2	SENT_61	[p3l590t906r879b974],
5	by	IN	O	by	_	0	SENT_61	[p3l907t906r981b974],
6	the	DT	O	the	det	10	SENT_61	[p3l1008t906r1104b961],
7	Local	JJ	ORGANIZATION	local	amod	10	SENT_61	[p3l1134t906r1286b961],
8	Institutional	JJ	ORGANIZATION	institutional	amod	10	SENT_61	[p3l1315t906r1689b961],
9	Review	NNP	ORGANIZATION	Review	nn	10	SENT_61	[p3l1718t907r1942b961],
10	Board	NNP	ORGANIZATION	Board	agent	4	SENT_61	[p3l1969t906r2144b961],
11	and	CC	O	and	_	0	SENT_61	[p3l9t995r120b1049],
12	an	DT	O	a	det	15	SENT_61	[p3l145t1010r217b1049],
13	informed	VBN	O	inform	amod	15	SENT_61	[p3l241t995r522b1049],
14	written	VBN	O	write	amod	15	SENT_61	[p3l545t996r774b1049],
15	consent	NN	O	consent	conj_and	10	SENT_61	[p3l798t1003r1038b1049],
16	was	VBD	O	be	auxpass	17	SENT_61	[p3l1059t1010r1177b1049],
17	obtained	VBN	O	obtain	_	0	SENT_61	[p3l1202t995r1470b1049],
18	from	IN	O	from	_	0	SENT_61	[p3l1496t995r1642b1049],
19	all	DT	O	all	dep	20	SENT_61	[p3l1665t995r1735b1049],
20	the	DT	O	the	prep_from	17	SENT_61	[p3l1759t995r1856b1049],
21	included	VBN	O	include	partmod	20	SENT_61	[p3l1881t995r2145b1049],
22	patients	NNS	O	patient	dobj	21	SENT_61	[p3l9t1083r269b1151],
23	.	.	O	.	_	0	SENT_61	[p3l9t1083r269b1151],

1	Genetic	JJ	O	genetic	amod	2	SENT_62	[p3l9t1262r228b1315],
2	analysis	NN	O	analysis	_	0	SENT_62	[p3l252t1260r487b1329],

1	Genomic	JJ	O	genomic	amod	2	SENT_63	[p3l111t1440r383b1494],
2	DNA	NN	O	dna	nsubjpass	4	SENT_63	[p3l407t1441r547b1493],
3	was	VBD	O	be	auxpass	4	SENT_63	[p3l567t1455r686b1494],
4	extracted	VBN	O	extract	_	0	SENT_63	[p3l712t1439r998b1494],
5	from	IN	O	from	_	0	SENT_63	[p3l1024t1439r1170b1494],
6	whole	JJ	O	whole	prep_from	4	SENT_63	[p3l1192t1439r1381b1494],
7	citrated	VBN	O	citrate	partmod	6	SENT_63	[p3l1406t1439r1639b1494],
8	blood	NN	O	blood	dobj	7	SENT_63	[p3l1664t1439r1835b1494],
9	using	VBG	O	use	xcomp	7	SENT_63	[p3l1861t1440r2025b1507],
10	the	DT	O	the	nsubj	11	SENT_63	[p3l2048t1439r2145b1494],
11	salting	VBG	O	salt	dep	9	SENT_63	[p3l10t1527r212b1596],
12	out	RP	O	out	prt	11	SENT_63	[p3l235t1535r336b1582],
13	method	NN	O	method	dobj	11	SENT_63	[p3l359t1527r611b1583],
14	.	.	O	.	_	0	SENT_63	[p3l359t1527r611b1583],

1	The	DT	O	the	det	2	SENT_64	[p3l633t1527r745b1582],
2	quality	NN	O	quality	nsubjpass	6	SENT_64	[p3l770t1527r982b1596],
3	of	IN	O	of	_	0	SENT_64	[p3l1005t1527r1068b1582],
4	DNA	NN	MISC	dna	prep_of	2	SENT_64	[p3l1086t1530r1226b1582],
5	was	VBD	O	be	auxpass	6	SENT_64	[p3l1246t1543r1365b1582],
6	controlled	VBN	O	control	_	0	SENT_64	[p3l1390t1527r1702b1582],
7	by	IN	O	by	_	0	SENT_64	[p3l1726t1527r1800b1596],
8	measuring	VBG	O	measure	agent	6	SENT_64	[p3l1823t1528r2147b1596],
9	the	DT	O	the	det	11	SENT_64	[p3l8t1616r107b1671],
10	optical	JJ	O	optical	amod	11	SENT_64	[p3l158t1616r369b1685],
11	density	NN	O	density	dobj	8	SENT_64	[p3l419t1616r650b1685],
12	at	IN	O	at	_	0	SENT_64	[p3l698t1624r756b1671],
13	260	CD	NUMBER	260	num	16	SENT_64	[p3l804t1619r919b1671],
14	nm	NN	O	nm	nn	16	SENT_64	[p3l942t1632r1042b1670],
15	(	NN	O	(	nn	16	SENT_64	[p3l1095t1616r1281b1684],
16	D01	NN	O	d01	prep_at	8	SENT_64	[p3l1095t1616r1281b1684],
17	)	CD	NUMBER	)	dep	16	SENT_64	[p3l1095t1616r1281b1684],
18	and	CC	O	and	_	0	SENT_64	[p3l1336t1616r1449b1671],
19	280	CD	NUMBER	280	conj_and	17	SENT_64	[p3l1500t1619r1614b1671],
20	nm	NN	O	nm	nn	23	SENT_64	[p3l1637t1632r1737b1670],
21	(	CD	NUMBER	(	num	23	SENT_64	[p3l1791t1616r1977b1684],
22	D02	NN	O	d02	nn	23	SENT_64	[p3l1791t1616r1977b1684],
23	)	NN	O	)	dep	17	SENT_64	[p3l1791t1616r1977b1684],
24	and	CC	O	and	_	0	SENT_64	[p3l2032t1616r2145b1671],
25	calculating	VBG	O	calculate	conj_and	8	SENT_64	[p3l9t1705r341b1774],
26	the	DT	O	the	det	28	SENT_64	[p3l370t1705r467b1760],
27	D01/D02	NN	O	d01/d02	nn	28	SENT_64	[p3l499t1708r787b1769],
28	ratio	NN	O	ratio	dobj	25	SENT_64	[p3l820t1706r975b1761],
29	.	.	O	.	_	0	SENT_64	[p3l820t1706r975b1761],

1	PIA	NNP	O	PIA	nn	2	SENT_65	[p3l1008t1705r1108b1760],
2	polymorphism	NN	O	polymorphism	nsubjpass	8	SENT_65	[p3l1137t1705r1589b1774],
3	of	IN	O	of	_	0	SENT_65	[p3l1620t1705r1683b1760],
4	platelet	NN	O	platelet	nn	6	SENT_65	[p3l1707t1705r1938b1774],
5	GPIIIa	NN	O	gpiium	nn	6	SENT_65	[p3l1969t1708r2146b1760],
6	receptor	NN	O	receptor	prep_of	2	SENT_65	[p3l9t1803r269b1863],
7	was	VBD	O	be	auxpass	8	SENT_65	[p3l313t1810r432b1849],
8	determined	VBN	O	determine	_	0	SENT_65	[p3l481t1795r839b1849],
9	using	VBG	O	use	xcomp	8	SENT_65	[p3l888t1795r1054b1863],
10	polymerase	NN	O	polymerase	nn	12	SENT_65	[p3l1101t1794r1457b1863],
11	chain	NN	O	chain	nn	12	SENT_65	[p3l1506t1794r1671b1849],
12	reaction	NN	O	reaction	dobj	9	SENT_65	[p3l1720t1795r1984b1858],
13	,	,	O	,	_	0	SENT_65	[p3l1720t1795r1984b1858],
14	and	CC	O	and	_	0	SENT_65	[p3l2033t1795r2144b1849],
15	restriction	NN	O	restriction	nn	19	SENT_65	[p3l9t1885r324b1939],
16	fragment	NN	O	fragment	nn	19	SENT_65	[p3l366t1884r647b1952],
17	length	NN	O	length	nn	19	SENT_65	[p3l687t1884r881b1952],
18	polymorphism	NN	O	polymorphism	nn	19	SENT_65	[p3l922t1884r1373b1952],
19	analysis	NN	O	analysis	conj_and	12	SENT_65	[p3l1414t1884r1656b1952],
20	(	CD	NUMBER	(	num	21	SENT_65	[p3l1701t1884r2039b1952],
21	PCR	NN	O	pcr	dep	19	SENT_65	[p3l1701t1884r2039b1952],
22	.	.	O	.	_	0	SENT_65	[p3l1701t1884r2039b1952],

1	—	NN	O	—	_	0	SENT_66	[p3l1701t1884r2039b1952],
2	.	.	O	.	_	0	SENT_66	[p3l1701t1884r2039b1952],

1	PFLP	NN	ORGANIZATION	pflp	nsubj	5	SENT_67	[p3l1701t1884r2039b1952],
2	)	CD	NUMBER	)	num	1	SENT_67	[p3l1701t1884r2039b1952],
3	as	IN	O	as	prep	1	SENT_67	[p3l2085t1900r2144b1939],
4	previously	RB	DATE	previously	pcomp	3	SENT_67	[p3l9t1973r330b2041],
5	published	VBN	O	publish	_	0	SENT_67	[p3l369t1973r668b2041],
6	[	NN	O	[	nn	8	SENT_67	[p3l712t1973r806b2041],
7	8	CD	NUMBER	8	num	8	SENT_67	[p3l712t1973r806b2041],
8	]	NN	O	]	dobj	5	SENT_67	[p3l712t1973r806b2041],
9	.	.	O	.	_	0	SENT_67	[p3l712t1973r806b2041],

1	A	DT	O	a	det	4	SENT_68	[p3l845t1975r890b2027],
2	266-bp	JJ	O	266-bp	amod	4	SENT_68	[p3l928t1973r1147b2041],
3	DNA	NN	MISC	dna	nn	4	SENT_68	[p3l1188t1975r1327b2027],
4	fragment	NN	O	fragment	_	0	SENT_68	[p3l1365t1973r1646b2041],
5	containing	VBG	O	contain	partmod	4	SENT_68	[p3l1684t1974r2010b2041],
6	the	DT	O	the	det	9	SENT_68	[p3l2048t1973r2145b2028],
7	C1565T	NN	O	c1565t	nn	9	SENT_68	[p3l9t2064r240b2116],
8	polymorphism	NN	O	polymorphism	nn	9	SENT_68	[p3l261t2061r712b2130],
9	site	NN	O	site	nsubjpass	11	SENT_68	[p3l736t2062r840b2116],
10	was	VBD	O	be	auxpass	11	SENT_68	[p3l862t2077r980b2116],
11	ampliﬁed	VBN	O	ampliﬁed	ccomp	5	SENT_68	[p3l1004t2061r1293b2130],
12	by	IN	O	by	_	0	SENT_68	[p3l1316t2061r1390b2130],
13	PCR	NN	O	pcr	agent	11	SENT_68	[p3l1412t2064r1530b2116],
14	using	VBG	O	use	xcomp	11	SENT_68	[p3l1550t2062r1715b2130],
15	the	DT	O	the	det	17	SENT_68	[p3l1736t2061r1833b2116],
16	following	VBG	O	follow	amod	17	SENT_68	[p3l1857t2061r2147b2130],
17	primers	NNS	O	primer	dobj	14	SENT_68	[p3l9t2151r269b2219],
18	:	:	O	:	_	0	SENT_68	[p3l9t2151r269b2219],
19	forward	RB	O	forward	advmod	4	SENT_68	[p3l323t2150r569b2205],
20	primers	NNS	O	primer	dep	4	SENT_68	[p3l618t2151r859b2219],
21	5	CD	NUMBER	5	num	22	SENT_68	[p3l909t2152r1981b2205],
22	’	NN	O	’	dep	20	SENT_68	[p3l909t2152r1981b2205],
23	.	.	O	.	_	0	SENT_68	[p3l909t2152r1981b2205],

1	—	NN	O	—	_	0	SENT_69	[p3l909t2152r1981b2205],
2	.	.	O	.	_	0	SENT_69	[p3l909t2152r1981b2205],

1	TTCTGATTGCTGGACTTCTCTT	NNP	O	TTCTGATTGCTGGACTTCTCTT	_	0	SENT_70	[p3l909t2152r1981b2205],
2	.	.	O	.	_	0	SENT_70	[p3l909t2152r1981b2205],

1	—	NN	O	—	_	0	SENT_71	[p3l909t2152r1981b2205],
2	.	.	O	.	_	0	SENT_71	[p3l909t2152r1981b2205],

1	3	CD	NUMBER	3	num	2	SENT_72	[p3l909t2152r1981b2205],
2	’	NN	O	’	_	0	SENT_72	[p3l909t2152r1981b2205],
3	and	CC	O	and	_	0	SENT_72	[p3l2032t2150r2144b2205],
4	reverse	VB	O	reverse	conj_and	2	SENT_72	[p3l9t2255r231b2294],
5	primers	NNS	O	primer	dobj	4	SENT_72	[p3l263t2240r500b2308],
6	5	CD	NUMBER	5	number	7	SENT_72	[p3l532t2242r1568b2295],
7	’	CD	NUMBER	’	num	8	SENT_72	[p3l532t2242r1568b2295],
8	TCTCTCCCCATGGCAAAGAGT	NN	O	tctctccccatggcaaagagt	dep	5	SENT_72	[p3l532t2242r1568b2295],
9	—	CD	NUMBER	—	number	10	SENT_72	[p3l532t2242r1568b2295],
10	3	CD	NUMBER	3	num	11	SENT_72	[p3l532t2242r1568b2295],
11	’	NN	O	’	dep	8	SENT_72	[p3l532t2242r1568b2295],
12	.	.	O	.	_	0	SENT_72	[p3l532t2242r1568b2295],

1	The	DT	O	the	det	2	SENT_73	[p3l1597t2240r1708b2294],
2	conditions	NNS	O	condition	nsubj	5	SENT_73	[p3l1739t2240r2058b2294],
3	of	IN	O	of	_	0	SENT_73	[p3l2090t2239r2153b2294],
4	ampliﬁcation	NN	O	ampliﬁcation	prep_of	2	SENT_73	[p3l9t2328r413b2397],
5	comprised	VBD	O	comprise	_	0	SENT_73	[p3l432t2328r752b2397],
6	an	DT	O	a	det	8	SENT_73	[p3l771t2344r843b2383],
7	initial	JJ	O	initial	amod	8	SENT_73	[p3l863t2329r1037b2383],
8	denaturation	NN	O	denaturation	dobj	5	SENT_73	[p3l1057t2328r1454b2383],
9	at	IN	O	at	_	0	SENT_73	[p3l1473t2337r1530b2383],
10	94	CD	NUMBER	94	number	11	SENT_73	[p3l1548t2331r1622b2383],
11	°	CD	NUMBER	°	num	12	SENT_73	[p3l1644t2328r1706b2383],
12	C	NN	O	c	prep_at	5	SENT_73	[p3l1644t2328r1706b2383],
13	for	IN	O	for	_	0	SENT_73	[p3l1725t2328r1810b2383],
14	4	CD	DURATION	4	num	15	SENT_73	[p3l1825t2331r1863b2383],
15	minutes	NNS	NUMBER	minute	prep_for	5	SENT_73	[p3l1882t2329r2144b2392],
16	,	,	O	,	_	0	SENT_73	[p3l1882t2329r2144b2392],
17	followed	VBN	O	follow	partmod	5	SENT_73	[p3l9t2418r275b2473],
18	by	IN	O	by	_	0	SENT_73	[p3l297t2418r371b2486],
19	35	CD	NUMBER	35	num	21	SENT_73	[p3l390t2421r462b2473],
20	denaturation	NN	O	denaturation	nn	21	SENT_73	[p3l487t2418r884b2473],
21	cycles	NNS	O	cycle	agent	17	SENT_73	[p3l906t2418r1086b2486],
22	at	IN	O	at	_	0	SENT_73	[p3l1109t2426r1166b2473],
23	94	CD	NUMBER	94	number	24	SENT_73	[p3l1186t2421r1260b2473],
24	°	CD	NUMBER	°	num	25	SENT_73	[p3l1283t2418r1345b2473],
25	C	NN	O	c	prep_at	21	SENT_73	[p3l1283t2418r1345b2473],
26	for	IN	O	for	_	0	SENT_73	[p3l1366t2418r1451b2473],
27	30	CD	DURATION	30	num	28	SENT_73	[p3l1470t2421r1544b2473],
28	seconds	NNS	NUMBER	seconds	prep_for	17	SENT_73	[p3l1568t2418r1823b2481],
29	,	,	O	,	_	0	SENT_73	[p3l1568t2418r1823b2481],
30	annealing	NN	O	annealing	appos	28	SENT_73	[p3l1846t2418r2147b2486],
31	for	IN	O	for	_	0	SENT_73	[p3l9t2507r94b2562],
32	30	CD	NUMBER	30	num	33	SENT_73	[p3l118t2510r192b2562],
33	s	NNS	O	s	prep_for	30	SENT_73	[p3l214t2523r238b2562],
34	at	IN	O	at	_	0	SENT_73	[p3l265t2515r322b2562],
35	55	CD	NUMBER	55	number	36	SENT_73	[p3l348t2510r418b2562],
36	°	CD	NUMBER	°	num	37	SENT_73	[p3l443t2507r519b2570],
37	C	NN	O	c	prep_at	33	SENT_73	[p3l443t2507r519b2570],
38	,	,	O	,	_	0	SENT_73	[p3l443t2507r519b2570],
39	then	RB	O	then	advmod	40	SENT_73	[p3l546t2507r685b2562],
40	extending	VBG	O	extend	xcomp	17	SENT_73	[p3l711t2507r1020b2575],
41	at	IN	O	at	_	0	SENT_73	[p3l1045t2515r1102b2562],
42	72	CD	NUMBER	72	number	43	SENT_73	[p3l1128t2510r1198b2561],
43	°	CD	NUMBER	°	num	44	SENT_73	[p3l1223t2507r1285b2562],
44	C	NN	O	c	prep_at	40	SENT_73	[p3l1223t2507r1285b2562],
45	for	IN	O	for	_	0	SENT_73	[p3l1312t2507r1396b2562],
46	30	CD	NUMBER	30	num	47	SENT_73	[p3l1420t2510r1494b2562],
47	s	NNS	O	s	prep_for	44	SENT_73	[p3l1516t2523r1555b2570],
48	,	,	O	,	_	0	SENT_73	[p3l1516t2523r1555b2570],
49	and	CC	O	and	_	0	SENT_73	[p3l1583t2507r1694b2562],
50	a	DT	O	a	det	52	SENT_73	[p3l1721t2523r1752b2562],
51	ﬁnal	JJ	O	ﬁnal	amod	52	SENT_73	[p3l1779t2507r1911b2562],
52	step	NN	O	step	conj_and	44	SENT_73	[p3l1939t2515r2063b2575],
53	at	IN	O	at	_	0	SENT_73	[p3l2090t2515r2147b2562],
54	72	CD	NUMBER	72	number	55	SENT_73	[p3l10t2598r80b2650],
55	°	CD	NUMBER	°	num	56	SENT_73	[p3l105t2595r167b2650],
56	C	NN	O	c	prep_at	52	SENT_73	[p3l105t2595r167b2650],
57	for	IN	O	for	_	0	SENT_73	[p3l194t2595r279b2650],
58	7	CD	DURATION	7	num	59	SENT_73	[p3l306t2599r338b2650],
59	min	NN	DURATION	min	prep_for	56	SENT_73	[p3l361t2596r494b2651],
60	.	.	O	.	_	0	SENT_73	[p3l361t2596r494b2651],

1	Subsequently	RB	O	subsequently	advmod	7	SENT_74	[p3l523t2595r949b2664],
2	,	,	O	,	_	0	SENT_74	[p3l523t2595r949b2664],
3	the	DT	O	the	det	5	SENT_74	[p3l978t2595r1075b2650],
4	PCR	NN	MISC	pcr	nn	5	SENT_74	[p3l1103t2598r1221b2650],
5	products	NNS	O	product	nsubjpass	7	SENT_74	[p3l1246t2595r1513b2664],
6	were	VBD	O	be	auxpass	7	SENT_74	[p3l1540t2611r1693b2650],
7	digested	VBN	O	digest	_	0	SENT_74	[p3l1721t2595r1978b2664],
8	with	IN	O	with	_	0	SENT_74	[p3l2005t2595r2146b2650],
9	the	DT	O	the	det	12	SENT_74	[p3l8t2684r105b2739],
10	restriction	NN	O	restriction	nn	12	SENT_74	[p3l150t2685r465b2739],
11	enzyme	NN	O	enzyme	nn	12	SENT_74	[p3l509t2700r748b2753],
12	Mspl	NN	O	mspl	prep_with	7	SENT_74	[p3l790t2684r932b2753],
13	.	.	O	.	_	0	SENT_74	[p3l975t2730r985b2740],

1	Then	RB	O	then	advmod	7	SENT_75	[p3l1027t2684r1195b2748],
2	,	,	O	,	_	0	SENT_75	[p3l1027t2684r1195b2748],
3	the	DT	O	the	det	5	SENT_75	[p3l1239t2684r1336b2739],
4	digested	VBN	O	digest	amod	5	SENT_75	[p3l1380t2684r1637b2753],
5	products	NNS	O	product	nsubjpass	17	SENT_75	[p3l1682t2684r1949b2753],
6	were	VBD	O	be	auxpass	7	SENT_75	[p3l1992t2700r2145b2739],
7	separated	VBN	O	separate	_	0	SENT_75	[p3l10t2774r306b2842],
8	by	IN	O	by	_	0	SENT_75	[p3l326t2774r400b2842],
9	classical	JJ	O	classical	amod	10	SENT_75	[p3l418t2774r665b2829],
10	electrophoresis	NN	O	electrophoresis	agent	7	SENT_75	[p3l685t2774r1154b2842],
11	in	IN	O	in	_	0	SENT_75	[p3l1176t2775r1232b2828],
12	2	CD	PERCENT	2	number	13	SENT_75	[p3l1252t2777r1329b2829],
13	%	NN	PERCENT	%	amod	15	SENT_75	[p3l1252t2777r1329b2829],
14	agarose	NN	O	agarose	nn	15	SENT_75	[p3l1348t2789r1580b2842],
15	gel	NN	O	gel	prep_in	10	SENT_75	[p3l1599t2774r1688b2842],
16	and	CC	O	and	_	0	SENT_75	[p3l1708t2774r1819b2829],
17	visualized	VBN	O	visualize	conj_and	7	SENT_75	[p3l1839t2774r2145b2829],
18	after	IN	O	after	_	0	SENT_75	[p3l9t2862r150b2917],
19	ethidium	NN	O	ethidium	nn	21	SENT_75	[p3l173t2862r453b2917],
20	bromide	NN	O	bromide	nn	21	SENT_75	[p3l476t2863r734b2917],
21	staining	NN	O	staining	prep_after	17	SENT_75	[p3l760t2863r1017b2931],
22	.	.	O	.	_	0	SENT_75	[p3l760t2863r1017b2931],

1	Platelet	NN	O	platelet	_	0	SENT_76	[p3l8t3041r255b3096],
2	reactivity	NN	O	reactivity	nn	3	SENT_76	[p3l279t3041r586b3110],
3	assessment	NN	O	assessment	dep	1	SENT_76	[p3l608t3049r973b3096],

1	Aspirin-inhibition	NN	O	aspirin-inhibition	nsubjpass	6	SENT_77	[p3l108t3220r660b3288],
2	of	IN	O	of	_	0	SENT_77	[p3l686t3220r750b3275],
3	platelet	NN	O	platelet	nn	4	SENT_77	[p3l769t3220r1001b3288],
4	response	NN	O	response	prep_of	1	SENT_77	[p3l1027t3236r1299b3288],
5	was	VBD	O	be	auxpass	6	SENT_77	[p3l1324t3236r1443b3275],
6	studied	VBN	O	study	_	0	SENT_77	[p3l1471t3220r1695b3275],
7	with	IN	O	with	_	0	SENT_77	[p3l1721t3220r1862b3275],
8	PFA	NN	O	pfa	nn	11	SENT_77	[p3l1890t3222r2145b3275],
9	—	CD	NUMBER	—	num	11	SENT_77	[p3l1890t3222r2145b3275],
10	1OO	NN	O	1oo	nn	11	SENT_77	[p3l1890t3222r2145b3275],
11	device	NN	O	device	prep_with	6	SENT_77	[p3l9t3309r203b3364],
12	using	VBG	O	use	xcomp	6	SENT_77	[p3l248t3310r412b3377],
13	Collagene/Epinephrine	NNP	O	Collagene/Epinephrine	nn	14	SENT_77	[p3l456t3309r1155b3377],
14	cartridges	NNS	O	cartridge	dobj	12	SENT_77	[p3l1200t3309r1503b3377],
15	for	IN	O	for	_	0	SENT_77	[p3l1549t3309r1633b3364],
16	citrated	JJ	O	citrated	amod	17	SENT_77	[p3l1676t3309r1910b3364],
17	(	NN	O	(	prep_for	12	SENT_77	[p3l1959t3309r2141b3377],
18	3.2	CD	PERCENT	3.2	num	19	SENT_77	[p3l1959t3309r2141b3377],
19	%	NN	PERCENT	%	dep	17	SENT_77	[p3l1959t3309r2141b3377],
20	)	CD	NUMBER	)	num	22	SENT_77	[p3l1959t3309r2141b3377],
21	whole	JJ	O	whole	amod	22	SENT_77	[p3l7t3397r196b3452],
22	blood	NN	O	blood	tmod	12	SENT_77	[p3l223t3397r393b3452],
23	Closure	NNP	O	Closure	nn	25	SENT_77	[p3l421t3397r648b3452],
24	Time	NNP	O	Time	nn	25	SENT_77	[p3l672t3398r825b3452],
25	determination	NN	O	determination	dep	22	SENT_77	[p3l852t3397r1306b3453],
26	.	.	O	.	_	0	SENT_77	[p3l852t3397r1306b3453],

1	According	VBG	O	accord	_	0	SENT_78	[p3l1331t3397r1642b3466],
2	to	TO	O	to	prepc_according_to	18	SENT_78	[p3l1667t3405r1726b3452],
3	our	PRP$	O	we	poss	5	SENT_78	[p3l1754t3413r1857b3452],
4	previous	JJ	O	previous	amod	5	SENT_78	[p3l1883t3398r2145b3466],
5	study	NN	O	study	pobj	18	SENT_78	[p3l10t3486r178b3554],
6	[	CD	NUMBER	[	number	7	SENT_78	[p3l200t3486r294b3555],
7	9	CD	NUMBER	9	num	8	SENT_78	[p3l200t3486r294b3555],
8	]	NN	O	]	dep	5	SENT_78	[p3l200t3486r294b3555],
9	,	,	O	,	_	0	SENT_78	[p3l200t3486r294b3555],
10	a	DT	O	a	det	16	SENT_78	[p3l317t3502r347b3541],
11	high	JJ	O	high	amod	16	SENT_78	[p3l368t3486r502b3555],
12	platelet	NN	O	platelet	nn	16	SENT_78	[p3l524t3486r755b3555],
13	reactivity	NN	O	reactivity	nn	16	SENT_78	[p3l776t3487r1064b3555],
14	(	CD	NUMBER	(	num	16	SENT_78	[p3l1088t3486r1265b3554],
15	HPR	NN	O	hpr	nn	16	SENT_78	[p3l1088t3486r1265b3554],
16	)	NN	O	)	nsubjpass	18	SENT_78	[p3l1088t3486r1265b3554],
17	was	VBD	O	be	auxpass	18	SENT_78	[p3l1289t3502r1408b3541],
18	deﬁned	VBN	O	deﬁned	_	0	SENT_78	[p3l1430t3486r1658b3541],
19	by	IN	O	by	_	0	SENT_78	[p3l1680t3486r1753b3555],
20	a	DT	O	a	det	27	SENT_78	[p3l1772t3502r1803b3541],
21	Collagene	NNP	O	Collagene	nn	27	SENT_78	[p3l1824t3486r2148b3555],
22	/	:	O	/	punct	26	SENT_78	[p3l1824t3486r2148b3555],
23	Epinephrine	NNP	O	Epinephrine	nn	25	SENT_78	[p3l9t3576r383b3644],
24	Closure	NNP	O	Closure	nn	25	SENT_78	[p3l417t3576r644b3630],
25	Time	NNP	O	Time	dep	26	SENT_78	[p3l675t3576r828b3630],
26	(	JJ	O	(	dep	27	SENT_78	[p3l866t3575r1156b3644],
27	CEPl	NN	O	cepl	agent	18	SENT_78	[p3l866t3575r1156b3644],
28	.	.	O	.	_	0	SENT_78	[p3l866t3575r1156b3644],

1	—	NN	O	—	_	0	SENT_79	[p3l866t3575r1156b3644],
2	.	.	O	.	_	0	SENT_79	[p3l866t3575r1156b3644],

1	CT	NN	O	ct	nn	2	SENT_80	[p3l866t3575r1156b3644],
2	)	NN	O	)	_	0	SENT_80	[p3l866t3575r1156b3644],
3	below	IN	O	below	_	0	SENT_80	[p3l1193t3575r1381b3630],
4	160	CD	DURATION	160	num	5	SENT_80	[p3l1417t3578r1525b3630],
5	sec	NN	DURATION	sec	prep_below	2	SENT_80	[p3l1548t3591r1640b3630],
6	despite	IN	O	despite	_	0	SENT_80	[p3l1674t3575r1894b3644],
7	regular	JJ	O	regular	amod	9	SENT_80	[p3l1929t3576r2148b3644],
8	oral	JJ	O	oral	amod	9	SENT_80	[p3l9t3664r124b3719],
9	intake	NN	O	intake	prep_despite	2	SENT_80	[p3l149t3664r338b3719],
10	of	IN	O	of	_	0	SENT_80	[p3l362t3664r426b3719],
11	aspirin	NN	O	aspirin	nn	12	SENT_80	[p3l443t3665r652b3733],
12	treatment	NN	O	treatment	prep_of	2	SENT_80	[p3l675t3672r996b3720],
13	.	.	O	.	_	0	SENT_80	[p3l675t3672r996b3720],

1	Statistical	JJ	O	statistical	amod	2	SENT_81	[p4l7t66r323b121],
2	analysis	NN	O	analysis	_	0	SENT_81	[p4l348t66r605b134],

1	Continuous	JJ	O	continuous	amod	2	SENT_82	[p4l111t245r458b299],
2	variables	NNS	O	variable	nsubjpass	4	SENT_82	[p4l484t244r757b299],
3	are	VBP	O	be	auxpass	4	SENT_82	[p4l784t260r876b299],
4	presented	VBN	O	present	_	0	SENT_82	[p4l903t244r1208b313],
5	as	IN	O	as	_	0	SENT_82	[p4l1234t260r1293b299],
6	meani	JJ	O	meani	amod	7	SENT_82	[p4l1321t252r1555b302],
7	SD	NN	O	sd	prep_as	4	SENT_82	[p4l1573t247r1651b299],
8	and	CC	O	and	_	0	SENT_82	[p4l1677t244r1788b299],
9	categorical	JJ	O	categorical	amod	10	SENT_82	[p4l1815t244r2145b312],
10	variables	NNS	O	variable	nsubjpass	12	SENT_82	[p4l7t333r280b388],
11	are	VBP	O	be	auxpass	12	SENT_82	[p4l308t349r401b388],
12	presented	VBN	O	present	conj_and	4	SENT_82	[p4l429t333r733b402],
13	as	IN	O	as	_	0	SENT_82	[p4l761t349r820b388],
14	frequencies	NNS	O	frequency	prep_as	12	SENT_82	[p4l848t333r1200b402],
15	and	CC	O	and	_	0	SENT_82	[p4l1228t333r1339b388],
16	percentages	NNS	O	percentage	prep_as	12	SENT_82	[p4l1367t342r1749b402],
17	.	.	O	.	_	0	SENT_82	[p4l1367t342r1749b402],

1	Distribution	NN	O	distribution	nsubjpass	6	SENT_83	[p4l1778t334r2145b388],
2	of	IN	O	of	_	0	SENT_83	[p4l9t422r72b477],
3	continuous	JJ	O	continuous	amod	4	SENT_83	[p4l95t423r434b477],
4	variables	NNS	O	variable	prep_of	1	SENT_83	[p4l464t422r738b477],
5	was	VBD	O	be	auxpass	6	SENT_83	[p4l766t438r885b477],
6	assessed	VBN	O	assess	_	0	SENT_83	[p4l917t423r1175b477],
7	by	IN	O	by	_	0	SENT_83	[p4l1206t422r1280b491],
8	Skewness	NNP	MISC	Skewness	nn	9	SENT_83	[p4l1309t422r1605b477],
9	test	NN	O	test	agent	6	SENT_83	[p4l1635t431r1760b478],
10	.	.	O	.	_	0	SENT_83	[p4l1635t431r1760b478],

1	The	DT	O	the	det	3	SENT_84	[p4l1789t422r1901b477],
2	clinical	JJ	O	clinical	amod	3	SENT_84	[p4l1932t422r2145b477],
3	characteristics	NNS	O	characteristic	nsubjpass	12	SENT_84	[p4l9t512r447b567],
4	according	VBG	O	accord	_	0	SENT_84	[p4l483t512r782b580],
5	to	TO	O	to	prepc_according_to	3	SENT_84	[p4l814t520r873b567],
6	the	DT	O	the	det	7	SENT_84	[p4l907t512r1004b567],
7	patient	NN	O	patient	poss	10	SENT_84	[p4l1040t513r1299b580],
8	's	POS	O	's	_	0	SENT_84	[p4l1040t513r1299b580],
9	genetic	JJ	O	genetic	amod	10	SENT_84	[p4l1334t513r1556b580],
10	status	NN	O	status	pobj	3	SENT_84	[p4l1591t520r1768b567],
11	were	VBD	O	be	auxpass	12	SENT_84	[p4l1802t528r1955b567],
12	compared	VBN	O	compare	_	0	SENT_84	[p4l1990t528r2145b567, p4l9t601r182b669],
13	using	VBG	O	use	xcomp	12	SENT_84	[p4l200t602r365b669],
14	the	DT	O	the	det	16	SENT_84	[p4l382t601r479b656],
15	variance	NN	O	variance	nn	16	SENT_84	[p4l496t602r754b656],
16	analysis	NN	O	analysis	dobj	13	SENT_84	[p4l773t601r1014b669],
17	for	IN	O	for	_	0	SENT_84	[p4l1033t600r1118b656],
18	continuous	JJ	O	continuous	amod	19	SENT_84	[p4l1135t602r1474b656],
19	variables	NNS	O	variable	prep_for	16	SENT_84	[p4l1492t601r1765b656],
20	and	CC	O	and	_	0	SENT_84	[p4l1784t601r1895b656],
21	the	DT	O	the	det	23	SENT_84	[p4l1914t601r2011b656],
22	chisquare	JJ	O	chisquare	amod	23	SENT_84	[p4l2030t601r2145b656, p4l10t705r211b758],
23	test	NN	O	test	dobj	13	SENT_84	[p4l230t697r343b744],
24	for	IN	O	for	_	0	SENT_84	[p4l360t689r445b744],
25	categorical	JJ	O	categorical	amod	26	SENT_84	[p4l462t689r792b757],
26	variables	NNS	O	variable	prep_for	23	SENT_84	[p4l810t689r1099b745],
27	.	.	O	.	_	0	SENT_84	[p4l810t689r1099b745],

1	A	DT	O	a	det	6	SENT_85	[p4l1116t691r1162b743],
2	logistic	JJ	O	logistic	amod	6	SENT_85	[p4l1179t689r1396b758],
3	non	JJ	O	non	amod	6	SENT_85	[p4l1414t705r1530b744],
4	adjusted	JJ	O	adjusted	amod	6	SENT_85	[p4l1548t689r1809b757],
5	regression	NN	O	regression	nn	6	SENT_85	[p4l1829t690r2146b758],
6	analysis	NN	O	analysis	nsubjpass	8	SENT_85	[p4l10t779r251b847],
7	was	VBD	O	be	auxpass	8	SENT_85	[p4l287t795r406b834],
8	used	VBN	O	use	_	0	SENT_85	[p4l445t779r585b834],
9	to	TO	O	to	aux	10	SENT_85	[p4l624t787r682b834],
10	determine	VB	O	determine	xcomp	8	SENT_85	[p4l720t779r1037b834],
11	which	WDT	O	which	dobj	14	SENT_85	[p4l1073t779r1263b834],
12	variable	NN	O	variable	nsubjpass	14	SENT_85	[p4l1298t779r1542b834],
13	was	VBD	O	be	auxpass	14	SENT_85	[p4l1579t795r1697b834],
14	associated	VBN	O	associate	ccomp	10	SENT_85	[p4l1736t779r2050b834],
15	to	TO	O	to	_	0	SENT_85	[p4l2087t787r2146b834],
16	signiﬁcant	JJ	O	signiﬁcant	amod	17	SENT_85	[p4l11t867r328b936],
17	predictors	NNS	O	predictor	prep_to	14	SENT_85	[p4l348t868r658b936],
18	of	IN	O	of	_	0	SENT_85	[p4l680t868r744b923],
19	residual	JJ	O	residual	amod	20	SENT_85	[p4l758t868r1001b923],
20	HPR	NNP	O	HPR	prep_of	17	SENT_85	[p4l1023t871r1151b922],
21	despite	IN	O	despite	_	0	SENT_85	[p4l1170t868r1391b936],
22	aspirin	NN	O	aspirin	nn	23	SENT_85	[p4l1413t869r1621b936],
23	intake	NN	O	intake	prep_despite	14	SENT_85	[p4l1643t868r1846b923],
24	.	.	O	.	_	0	SENT_85	[p4l1643t868r1846b923],

1	A	DT	O	a	det	4	SENT_86	[p4l1866t870r1911b922],
2	logistic	JJ	O	logistic	amod	4	SENT_86	[p4l1931t868r2148b936],
3	step	NN	O	step	nn	4	SENT_86	[p4l11t964r135b1025],
4	way	NN	O	way	nsubjpass	9	SENT_86	[p4l160t972r289b1025],
5	adjusted	VBN	O	adjust	partmod	4	SENT_86	[p4l313t956r574b1024],
6	regression	NN	O	regression	nn	7	SENT_86	[p4l601t957r917b1025],
7	analysis	NN	O	analysis	dobj	5	SENT_86	[p4l943t956r1184b1024],
8	was	VBD	O	be	auxpass	9	SENT_86	[p4l1209t972r1327b1011],
9	done	VBN	O	do	_	0	SENT_86	[p4l1355t956r1505b1011],
10	to	TO	O	to	aux	11	SENT_86	[p4l1531t964r1589b1011],
11	determine	VB	O	determine	xcomp	9	SENT_86	[p4l1616t956r1933b1011],
12	which	WDT	O	which	dobj	16	SENT_86	[p4l1958t956r2147b1011],
13	variable	NN	O	variable	nsubjpass	16	SENT_86	[p4l8t1046r253b1101],
14	was	VBD	O	be	auxpass	16	SENT_86	[p4l270t1062r389b1101],
15	independently	RB	O	independently	advmod	16	SENT_86	[p4l409t1046r856b1114],
16	associated	VBN	O	associate	ccomp	11	SENT_86	[p4l874t1046r1187b1101],
17	to	TO	O	to	_	0	SENT_86	[p4l1206t1054r1265b1101],
18	HPR	NNP	ORGANIZATION	HPR	prep_to	16	SENT_86	[p4l1284t1049r1424b1101],
19	.	.	O	.	_	0	SENT_86	[p4l1284t1049r1424b1101],

1	The	DT	O	the	det	2	SENT_87	[p4l1441t1046r1553b1101],
2	results	NNS	O	result	nsubjpass	4	SENT_87	[p4l1573t1046r1774b1101],
3	are	VBP	O	be	auxpass	4	SENT_87	[p4l1794t1062r1887b1101],
4	given	VBN	O	give	_	0	SENT_87	[p4l1905t1047r2071b1114],
5	in	IN	O	in	_	0	SENT_87	[p4l2090t1047r2146b1100],
6	odds	NNS	O	odds	prep_in	4	SENT_87	[p4l10t1134r153b1189],
7	ratio	NN	O	ratio	nn	11	SENT_87	[p4l179t1135r319b1189],
8	(	CD	NUMBER	(	num	11	SENT_87	[p4l348t1134r485b1202],
9	OR	NN	O	or	nn	11	SENT_87	[p4l348t1134r485b1202],
10	)	NN	O	)	nn	11	SENT_87	[p4l348t1134r485b1202],
11	estimation	NN	O	estimation	npadvmod	6	SENT_87	[p4l514t1135r840b1189],
12	of	IN	O	of	_	0	SENT_87	[p4l865t1134r928b1189],
13	the	DT	O	the	det	15	SENT_87	[p4l944t1134r1042b1189],
14	relative	JJ	O	relative	amod	15	SENT_87	[p4l1067t1134r1296b1189],
15	risk	NN	O	risk	prep_of	6	SENT_87	[p4l1321t1134r1433b1189],
16	with	IN	O	with	_	0	SENT_87	[p4l1454t1134r1595b1189],
17	a	DT	O	a	det	25	SENT_87	[p4l1619t1150r1650b1189],
18	95	CD	PERCENT	95	number	19	SENT_87	[p4l1675t1137r1791b1189],
19	%	NN	PERCENT	%	amod	25	SENT_87	[p4l1675t1137r1791b1189],
20	conﬁdence	NN	O	conﬁdence	nn	25	SENT_87	[p4l1815t1134r2146b1189],
21	interval	NN	O	interval	nn	25	SENT_87	[p4l11t1223r245b1278],
22	(	CD	PERCENT	(	num	25	SENT_87	[p4l270t1223r412b1291],
23	95	CD	PERCENT	95	number	24	SENT_87	[p4l270t1223r412b1291],
24	%	NN	PERCENT	%	amod	25	SENT_87	[p4l270t1223r412b1291],
25	Cl	NN	O	cl	prep_with	15	SENT_87	[p4l432t1224r532b1291],
26	)	NN	O	)	dep	25	SENT_87	[p4l432t1224r532b1291],
27	.	.	O	.	_	0	SENT_87	[p4l432t1224r532b1291],

1	Results	NNS	O	result	nsubjpass	3	SENT_88	[p4l554t1223r770b1278],
2	were	VBD	O	be	auxpass	3	SENT_88	[p4l790t1239r943b1278],
3	considered	VBN	O	consider	_	0	SENT_88	[p4l964t1223r1298b1278],
4	as	IN	O	as	_	0	SENT_88	[p4l1319t1239r1378b1278],
5	signiﬁcant	NN	O	signiﬁcant	prep_as	3	SENT_88	[p4l1401t1223r1717b1292],
6	when	WRB	O	when	advmod	9	SENT_88	[p4l1734t1223r1907b1278],
7	p	NN	O	p	nn	8	SENT_88	[p4l1928t1239r1963b1292],
8	value	NN	O	value	nsubj	9	SENT_88	[p4l1982t1223r2146b1278],
9	was	VBD	O	be	advcl	3	SENT_88	[p4l8t1329r127b1368],
10	below	IN	O	below	_	0	SENT_88	[p4l147t1313r336b1368],
11	0.05	CD	NUMBER	0.05	prep_below	9	SENT_88	[p4l355t1316r497b1368],
12	.	.	O	.	_	0	SENT_88	[p4l355t1316r497b1368],

1	All	DT	O	all	det	3	SENT_89	[p4l516t1313r598b1367],
2	statistical	JJ	O	statistical	amod	3	SENT_89	[p4l620t1313r908b1368],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_89	[p4l929t1313r1170b1381],
4	was	VBD	O	be	auxpass	5	SENT_89	[p4l1190t1329r1309b1368],
5	performed	VBN	O	perform	_	0	SENT_89	[p4l1330t1312r1653b1381],
6	using	VBG	O	use	xcomp	5	SENT_89	[p4l1674t1314r1839b1381],
7	SPSS	NNP	ORGANIZATION	SPSS	nsubj	9	SENT_89	[p4l1858t1316r1997b1368],
8	11.0	CD	NUMBER	11.0	num	9	SENT_89	[p4l2022t1316r2146b1368],
9	software	NN	O	software	xcomp	6	SENT_89	[p4l11t1401r290b1456],
10	.	.	O	.	_	0	SENT_89	[p4l11t1401r290b1456],

1	Results	NNS	O	result	_	0	SENT_90	[p4l9t1578r240b1633],

1	Prevalence	NN	O	prevalence	_	0	SENT_91	[p4l8t1756r324b1811],
2	of	IN	O	of	_	0	SENT_91	[p4l351t1756r414b1824],
3	PlA2	NN	O	pla2	nn	5	SENT_91	[p4l427t1756r557b1811],
4	haplotype	NN	O	haplotype	nn	5	SENT_91	[p4l585t1756r876b1824],
5	carriers	NNS	O	carrier	prep_of	1	SENT_91	[p4l902t1757r1124b1811],

1	The	DT	O	the	det	2	SENT_92	[p4l109t1934r221b1989],
2	frequency	NN	O	frequency	nsubj	10	SENT_92	[p4l251t1934r558b2003],
3	of	IN	O	of	_	0	SENT_92	[p4l586t1934r649b1989],
4	PlAl	NN	O	plal	nn	7	SENT_92	[p4l672t1934r800b1988],
5	and	CC	O	and	_	0	SENT_92	[p4l838t1934r949b1989],
6	PlA2	NN	O	pla2	nn	7	SENT_92	[p4l980t1934r1114b1988],
7	alleles	NNS	O	allele	prep_of	2	SENT_92	[p4l1145t1934r1335b1989],
8	were	VBD	O	be	cop	10	SENT_92	[p4l1364t1950r1517b1989],
9	75	CD	PERCENT	75	num	10	SENT_92	[p4l1548t1937r1662b1989],
10	%	NN	PERCENT	%	_	0	SENT_92	[p4l1548t1937r1662b1989],
11	(	CD	NUMBER	(	number	12	SENT_92	[p4l1696t1934r2001b2002],
12	282/376	CD	NUMBER	282/376	num	13	SENT_92	[p4l1696t1934r2001b2002],
13	)	NN	O	)	dep	10	SENT_92	[p4l1696t1934r2001b2002],
14	and	CC	O	and	_	0	SENT_92	[p4l2035t1934r2146b1989],
15	25	CD	PERCENT	25	num	16	SENT_92	[p4l10t2026r125b2078],
16	%	NN	PERCENT	%	conj_and	10	SENT_92	[p4l10t2026r125b2078],
17	(	CD	NUMBER	(	number	18	SENT_92	[p4l155t2023r440b2091],
18	94/376	CD	NUMBER	94/376	num	19	SENT_92	[p4l155t2023r440b2091],
19	)	NN	O	)	dep	16	SENT_92	[p4l155t2023r440b2091],
20	,	,	O	,	_	0	SENT_92	[p4l155t2023r440b2091],
21	respectively	RB	O	respectively	advmod	10	SENT_92	[p4l467t2023r850b2092],
22	.	.	O	.	_	0	SENT_92	[p4l467t2023r850b2092],

1	The	DT	O	the	det	3	SENT_93	[p4l875t2023r987b2078],
2	observed	VBN	O	observe	amod	3	SENT_93	[p4l1013t2023r1290b2078],
3	prevalence	NN	O	prevalence	nsubj	28	SENT_93	[p4l1316t2023r1649b2092],
4	of	IN	O	of	_	0	SENT_93	[p4l1675t2023r1739b2078],
5	homozygous	JJ	O	homozygous	amod	6	SENT_93	[p4l1757t2023r2145b2092],
6	PlA1/PlAl	NN	O	pla1/plal	prep_of	3	SENT_93	[p4l10t2112r305b2176],
7	(	CD	PERCENT	(	number	8	SENT_93	[p4l347t2113r587b2181],
8	55.3	CD	PERCENT	55.3	num	9	SENT_93	[p4l347t2113r587b2181],
9	%	NN	PERCENT	%	dep	6	SENT_93	[p4l347t2113r587b2181],
10	)	CD	NUMBER	)	dep	6	SENT_93	[p4l347t2113r587b2181],
11	,	,	O	,	_	0	SENT_93	[p4l347t2113r587b2181],
12	homozygous	JJ	O	homozygous	amod	13	SENT_93	[p4l619t2112r1008b2181],
13	PlA2/PlA2	NN	O	pla2/pla2	prep_of	3	SENT_93	[p4l1039t2112r1340b2177],
14	(	CD	PERCENT	(	number	15	SENT_93	[p4l1376t2112r1558b2181],
15	5.3	CD	PERCENT	5.3	num	16	SENT_93	[p4l1376t2112r1558b2181],
16	%	NN	PERCENT	%	dep	13	SENT_93	[p4l1376t2112r1558b2181],
17	)	CD	NUMBER	)	dep	13	SENT_93	[p4l1376t2112r1558b2181],
18	and	CC	O	and	_	0	SENT_93	[p4l1592t2113r1703b2167],
19	heterozygous	JJ	O	heterozygous	amod	20	SENT_93	[p4l1734t2113r2145b2181],
20	PlA1/PlA2	NN	O	pla1/pla2	conj_and	6	SENT_93	[p4l10t2201r311b2265],
21	(	CD	PERCENT	(	number	22	SENT_93	[p4l339t2202r560b2270],
22	39.4	CD	PERCENT	39.4	num	23	SENT_93	[p4l339t2202r560b2270],
23	%	NN	PERCENT	%	dep	20	SENT_93	[p4l339t2202r560b2270],
24	)	CD	NUMBER	)	num	25	SENT_93	[p4l339t2202r560b2270],
25	genotypes	NNS	O	genotype	dep	20	SENT_93	[p4l585t2210r898b2270],
26	were	VBD	O	be	cop	28	SENT_93	[p4l920t2217r1073b2256],
27	not	RB	O	not	neg	28	SENT_93	[p4l1096t2210r1196b2256],
28	different	JJ	O	different	_	0	SENT_93	[p4l1217t2201r1482b2256],
29	from	IN	O	from	_	0	SENT_93	[p4l1503t2201r1648b2256],
30	those	DT	O	those	prep_from	28	SENT_93	[p4l1669t2201r1834b2256],
31	predicted	VBN	O	predict	partmod	30	SENT_93	[p4l1856t2201r2146b2270],
32	by	IN	O	by	_	0	SENT_93	[p4l9t2291r83b2359],
33	the	DT	O	the	det	34	SENT_93	[p4l105t2290r202b2345],
34	Hardy	NNP	PERSON	Hardy	agent	31	SENT_93	[p4l227t2290r746b2359],
35	.	.	O	.	_	0	SENT_93	[p4l227t2290r746b2359],

1	—	NN	O	—	_	0	SENT_94	[p4l227t2290r746b2359],
2	.	.	O	.	_	0	SENT_94	[p4l227t2290r746b2359],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_95	[p4l227t2290r746b2359],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_95	[p4l769t2290r1142b2359],
3	.	.	O	.	_	0	SENT_95	[p4l769t2290r1142b2359],

1	No	DT	O	no	dep	99	SENT_96	[p4l112t2382r194b2434],
2	statistically	RB	O	statistically	dep	99	SENT_96	[p4l224t2379r571b2448],
3	signiﬁcant	JJ	O	signiﬁcant	dep	99	SENT_96	[p4l598t2379r915b2448],
4	difference	NN	O	difference	dep	99	SENT_96	[p4l941t2379r1247b2434],
5	was	VBD	O	be	dep	99	SENT_96	[p4l1274t2395r1393b2434],
6	noted	VBN	O	note	dep	99	SENT_96	[p4l1422t2379r1596b2434],
7	between	IN	O	between	dep	99	SENT_96	[p4l1624t2379r1889b2434],
8	carriers	NNS	O	carrier	dep	99	SENT_96	[p4l1917t2380r2146b2434],
9	of	IN	O	of	dep	99	SENT_96	[p4l10t2468r73b2522],
10	the	DT	O	the	dep	99	SENT_96	[p4l83t2469r179b2523],
11	PlAl	NN	O	plal	dep	99	SENT_96	[p4l199t2469r327b2522],
12	or	CC	O	or	dep	99	SENT_96	[p4l353t2484r416b2522],
13	PlA2	NN	O	pla2	dep	99	SENT_96	[p4l433t2468r568b2522],
14	allele	NN	O	allele	dep	99	SENT_96	[p4l587t2468r747b2522],
15	for	IN	O	for	dep	99	SENT_96	[p4l766t2468r851b2522],
16	all	PDT	O	all	dep	99	SENT_96	[p4l867t2468r936b2522],
17	the	DT	O	the	dep	99	SENT_96	[p4l954t2469r1051b2523],
18	considered	VBN	O	consider	dep	99	SENT_96	[p4l1070t2468r1404b2522],
19	characteristic	JJ	O	characteristic	dep	99	SENT_96	[p4l1422t2468r1834b2523],
20	variables	NNS	O	variable	dep	99	SENT_96	[p4l1849t2468r2142b2523],
21	:	:	O	:	_	0	SENT_96	[p4l1849t2468r2142b2523],
22	demographic	JJ	O	demographic	dep	99	SENT_96	[p4l10t2556r414b2625],
23	(	JJ	O	(	dep	99	SENT_96	[p4l437t2557r565b2625],
24	age	NN	O	age	dep	99	SENT_96	[p4l437t2557r565b2625],
25	and	CC	O	and	dep	99	SENT_96	[p4l584t2557r695b2611],
26	gender	NN	O	gender	dep	99	SENT_96	[p4l714t2556r971b2625],
27	)	NN	O	)	dep	99	SENT_96	[p4l714t2556r971b2625],
28	,	,	O	,	_	0	SENT_96	[p4l714t2556r971b2625],
29	clinical	JJ	O	clinical	dep	99	SENT_96	[p4l992t2556r1205b2611],
30	(	NN	O	(	dep	99	SENT_96	[p4l1229t2556r1517b2625],
31	smoking	NN	O	smoking	dep	99	SENT_96	[p4l1229t2556r1517b2625],
32	habit	NN	O	habit	dep	99	SENT_96	[p4l1536t2556r1704b2620],
33	,	,	O	,	_	0	SENT_96	[p4l1536t2556r1704b2620],
34	hypertension	NN	O	hypertension	dep	99	SENT_96	[p4l1725t2557r2145b2625],
35	,	,	O	,	_	0	SENT_96	[p4l1725t2557r2145b2625],
36	diabetes	NN	O	diabetes	dep	99	SENT_96	[p4l10t2646r282b2709],
37	,	,	O	,	_	0	SENT_96	[p4l10t2646r282b2709],
38	previous	JJ	O	previous	dep	99	SENT_96	[p4l333t2647r599b2714],
39	myocardial	JJ	O	myocardial	dep	99	SENT_96	[p4l649t2646r995b2714],
40	infarction	NN	O	infarction	dep	99	SENT_96	[p4l1044t2646r1359b2709],
41	,	,	O	,	_	0	SENT_96	[p4l1044t2646r1359b2709],
42	previous	JJ	O	previous	dep	99	SENT_96	[p4l1410t2647r1676b2714],
43	percutaneous	JJ	O	percutaneous	dep	99	SENT_96	[p4l1725t2654r2145b2714],
44	coronary	JJ	O	coronary	dep	99	SENT_96	[p4l10t2750r283b2803],
45	intervention	NN	O	intervention	dep	99	SENT_96	[p4l330t2735r726b2798],
46	,	,	O	,	_	0	SENT_96	[p4l330t2735r726b2798],
47	previous	JJ	O	previous	dep	99	SENT_96	[p4l775t2735r1038b2803],
48	coronary	JJ	O	coronary	dep	99	SENT_96	[p4l1087t2750r1361b2803],
49	artery	NN	O	artery	dep	99	SENT_96	[p4l1406t2742r1590b2803],
50	bypass	NN	O	bypass	dep	99	SENT_96	[p4l1636t2734r1842b2803],
51	grafting	NN	O	grafting	dep	99	SENT_96	[p4l1890t2734r2145b2803],
52	,	,	O	,	_	0	SENT_96	[p4l1890t2734r2145b2803],
53	stable	JJ	O	stable	dep	99	SENT_96	[p4l11t2823r188b2878],
54	angina	NN	O	angina	dep	99	SENT_96	[p4l225t2824r443b2892],
55	,	,	O	,	_	0	SENT_96	[p4l225t2824r443b2892],
56	unstable	JJ	O	unstable	dep	99	SENT_96	[p4l480t2823r740b2878],
57	angina	NN	O	angina	dep	99	SENT_96	[p4l776t2824r995b2892],
58	,	,	O	,	_	0	SENT_96	[p4l776t2824r995b2892],
59	acute	JJ	O	acute	dep	99	SENT_96	[p4l1031t2831r1194b2878],
60	myocardial	JJ	O	myocardial	dep	99	SENT_96	[p4l1232t2823r1571b2892],
61	infarction	NN	O	infarction	dep	99	SENT_96	[p4l1609t2823r1919b2887],
62	,	,	O	,	_	0	SENT_96	[p4l1609t2823r1919b2887],
63	multivessel	JJ	O	multivessel	dep	99	SENT_96	[p4l1957t2823r2145b2878, p4l8t2913r199b2968],
64	disease	NN	O	disease	dep	99	SENT_96	[p4l250t2913r495b2976],
65	,	,	O	,	_	0	SENT_96	[p4l250t2913r495b2976],
66	left	VBD	O	leave	dep	99	SENT_96	[p4l548t2913r651b2968],
67	ventricular	JJ	O	ventricular	dep	99	SENT_96	[p4l698t2913r1051b2968],
68	ejection	NN	O	ejection	dep	99	SENT_96	[p4l1100t2914r1352b2981],
69	fraction	NN	O	fraction	dep	99	SENT_96	[p4l1404t2913r1664b2976],
70	,	,	O	,	_	0	SENT_96	[p4l1404t2913r1664b2976],
71	chronic	JJ	O	chronic	dep	99	SENT_96	[p4l1717t2913r1953b2968],
72	total	JJ	O	total	dep	99	SENT_96	[p4l2002t2913r2146b2968],
73	occlusion	NN	O	occlusion	dep	99	SENT_96	[p4l10t3002r310b3065],
74	,	,	O	,	_	0	SENT_96	[p4l10t3002r310b3065],
75	bifurcation	NN	O	bifurcation	dep	99	SENT_96	[p4l336t3001r671b3056],
76	lesion	NN	O	lesion	dep	99	SENT_96	[p4l697t3001r890b3065],
77	,	,	O	,	_	0	SENT_96	[p4l697t3001r890b3065],
78	and	CC	O	and	dep	99	SENT_96	[p4l917t3001r1027b3056],
79	total	JJ	O	total	dep	99	SENT_96	[p4l1053t3001r1191b3056],
80	stent	JJ	O	stent	dep	99	SENT_96	[p4l1218t3010r1370b3056],
81	length	NN	O	length	dep	99	SENT_96	[p4l1394t3002r1632b3070],
82	)	NN	O	)	dep	99	SENT_96	[p4l1394t3002r1632b3070],
83	,	,	O	,	_	0	SENT_96	[p4l1394t3002r1632b3070],
84	and	CC	O	and	dep	99	SENT_96	[p4l1658t3001r1769b3056],
85	therapeutic	JJ	O	therapeutic	dep	99	SENT_96	[p4l1795t3002r2147b3070],
86	(	NN	O	(	dep	99	SENT_96	[p4l14t3090r379b3158],
87	B	NN	O	b	dep	99	SENT_96	[p4l14t3090r379b3158],
88	—	CD	NUMBER	—	dep	99	SENT_96	[p4l14t3090r379b3158],
89	blockers	NNS	O	blocker	dep	99	SENT_96	[p4l14t3090r379b3158],
90	,	,	O	,	_	0	SENT_96	[p4l14t3090r379b3158],
91	calcium	NN	O	calcium	dep	99	SENT_96	[p4l412t3090r648b3145],
92	statins	NNS	O	statin	dep	99	SENT_96	[p4l679t3091r892b3153],
93	,	,	O	,	_	0	SENT_96	[p4l679t3091r892b3153],
94	angiotensin	NN	O	angiotensin	dep	99	SENT_96	[p4l924t3091r1643b3159],
95	—	CD	NUMBER	—	dep	99	SENT_96	[p4l924t3091r1643b3159],
96	converting	VBG	O	convert	dep	99	SENT_96	[p4l924t3091r1643b3159],
97	enzyme	NN	O	enzyme	dep	99	SENT_96	[p4l1673t3106r1911b3159],
98	inhibitors	NNS	O	inhibitor	dep	99	SENT_96	[p4l1944t3090r2146b3145, p4l9t3180r170b3248],
99	)	NN	O	)	_	0	SENT_96	[p4l1944t3090r2146b3145, p4l9t3180r170b3248],
100	.	.	O	.	_	0	SENT_96	[p4l1944t3090r2146b3145, p4l9t3180r170b3248],

1	Furthermore	RB	O	furthermore	advmod	11	SENT_97	[p4l196t3180r599b3243],
2	,	,	O	,	_	0	SENT_97	[p4l196t3180r599b3243],
3	a	DT	O	a	det	6	SENT_97	[p4l626t3196r656b3235],
4	signiﬁcantly	RB	O	signiﬁcantly	advmod	5	SENT_97	[p4l682t3180r1056b3248],
5	higher	JJR	O	higher	amod	6	SENT_97	[p4l1079t3180r1278b3248],
6	level	NN	O	level	nsubjpass	11	SENT_97	[p4l1301t3180r1443b3235],
7	of	IN	O	of	_	0	SENT_97	[p4l1469t3180r1532b3235],
8	serum	NN	O	serum	nn	9	SENT_97	[p4l1551t3196r1742b3235],
9	triglycerides	NNS	O	triglyceride	prep_of	6	SENT_97	[p4l1765t3180r2146b3248],
10	was	VBD	O	be	auxpass	11	SENT_97	[p4l8t3284r127b3323],
11	found	VBN	O	find	_	0	SENT_97	[p4l153t3268r329b3323],
12	in	IN	O	in	_	0	SENT_97	[p4l355t3269r410b3323],
13	CAD	NN	O	cad	nn	14	SENT_97	[p4l436t3271r563b3323],
14	patients	NNS	O	patient	prep_in	11	SENT_97	[p4l589t3269r833b3337],
15	carrying	VBG	O	carry	partmod	14	SENT_97	[p4l859t3269r1111b3337],
16	PlA2	NN	O	pla2	dobj	15	SENT_97	[p4l1135t3268r1269b3323],
17	allele	NN	O	allele	nn	19	SENT_97	[p4l1296t3268r1456b3323],
18	(	CD	NUMBER	(	num	19	SENT_97	[p4l1485t3268r1673b3336],
19	Table	NNP	O	Table	dep	16	SENT_97	[p4l1485t3268r1673b3336],
20	1	CD	NUMBER	1	number	21	SENT_97	[p4l1701t3268r1776b3336],
21	)	CD	NUMBER	)	dep	19	SENT_97	[p4l1701t3268r1776b3336],
22	.	.	O	.	_	0	SENT_97	[p4l1701t3268r1776b3336],

1	PlA1haplotype	NN	O	pla1haplotype	nn	2	SENT_98	[p4l8t3447r433b3515],
2	expression	NN	O	expression	_	0	SENT_98	[p4l459t3448r766b3515],
3	and	CC	O	and	_	0	SENT_98	[p4l794t3447r902b3502],
4	residual	JJ	O	residual	amod	6	SENT_98	[p4l929t3447r1162b3502],
5	HPR	NN	O	hpr	nn	6	SENT_98	[p4l1186t3450r1308b3501],
6	association	NN	O	association	conj_and	2	SENT_98	[p4l1333t3448r1659b3502],

1	With	IN	O	with	_	0	SENT_99	[p4l109t3625r264b3680],
2	PFA	NN	O	pfa	nn	3	SENT_99	[p4l308t3627r578b3688],
3	—	NN	O	—	prep_with	30	SENT_99	[p4l308t3627r578b3688],
4	100	CD	NUMBER	100	dep	3	SENT_99	[p4l308t3627r578b3688],
5	,	,	O	,	_	0	SENT_99	[p4l308t3627r578b3688],
6	a	DT	O	a	det	8	SENT_99	[p4l623t3641r654b3680],
7	point	NN	O	point	nn	8	SENT_99	[p4l698t3625r1100b3694],
8	—	NN	O	—	appos	3	SENT_99	[p4l698t3625r1100b3694],
9	of	IN	O	of	_	0	SENT_99	[p4l698t3625r1100b3694],
10	—	CD	NUMBER	—	num	12	SENT_99	[p4l698t3625r1100b3694],
11	care	NN	O	care	nn	12	SENT_99	[p4l698t3625r1100b3694],
12	apparatus	NN	O	apparatus	conj_and	12	SENT_99	[p4l1145t3633r1446b3694],
13	for	IN	O	for	_	0	SENT_99	[p4l1492t3625r1576b3680],
14	platelet	NN	O	platelet	nn	16	SENT_99	[p4l1619t3625r1850b3694],
15	function	NN	O	function	nn	16	SENT_99	[p4l1893t3625r2146b3680],
16	analysis	NN	O	analysis	prep_for	12	SENT_99	[p4l10t3714r251b3782],
17	in	IN	O	in	_	0	SENT_99	[p4l270t3715r326b3768],
18	high	JJ	O	high	amod	20	SENT_99	[p4l344t3714r675b3782],
19	—	NN	O	—	nn	20	SENT_99	[p4l344t3714r675b3782],
20	shear	NN	O	shear	prep_in	16	SENT_99	[p4l344t3714r675b3782],
21	and	CC	O	and	_	0	SENT_99	[p4l691t3714r802b3769],
22	in	IN	O	in	_	0	SENT_99	[p4l821t3715r877b3768],
23	citrated	JJ	O	citrated	amod	26	SENT_99	[p4l895t3714r1129b3769],
24	whole	JJ	O	whole	amod	26	SENT_99	[p4l1146t3714r1335b3769],
25	blood	NN	O	blood	nn	26	SENT_99	[p4l1353t3714r1524b3769],
26	conditions	NNS	O	condition	prep_in	12	SENT_99	[p4l1543t3714r1877b3777],
27	,	,	O	,	_	0	SENT_99	[p4l1543t3714r1877b3777],
28	we	PRP	O	we	nsubj	30	SENT_99	[p4l1895t3730r1985b3769],
29	have	VBP	O	have	aux	30	SENT_99	[p4l2003t3714r2146b3769],
30	found	VBN	O	find	_	0	SENT_99	[p5l10t17r186b72],
31	a	DT	O	a	det	33	SENT_99	[p5l208t33r239b72],
32	residual	JJ	O	residual	amod	33	SENT_99	[p5l261t17r503b72],
33	HPR	NNP	O	HPR	dobj	30	SENT_99	[p5l525t21r653b72],
34	in	IN	O	in	_	0	SENT_99	[p5l672t18r728b72],
35	81	CD	NUMBER	81	num	36	SENT_99	[p5l750t20r815b72],
36	patients	NNS	O	patient	prep_in	33	SENT_99	[p5l845t18r1089b86],
37	(	IN	O	(	_	0	SENT_99	[p5l1116t17r1337b86],
38	43.1	CD	PERCENT	43.1	number	39	SENT_99	[p5l1116t17r1337b86],
39	%	NN	PERCENT	%	num	40	SENT_99	[p5l1116t17r1337b86],
40	)	CD	NUMBER	)	prep_(	30	SENT_99	[p5l1116t17r1337b86],
41	with	IN	O	with	_	0	SENT_99	[p5l1361t17r1502b72],
42	a	DT	O	a	det	43	SENT_99	[p5l1523t33r1554b72],
43	CEPI	NN	O	cepus	prep_with	30	SENT_99	[p5l1575t20r1815b72],
44	.	.	O	.	_	0	SENT_99	[p5l1575t20r1815b72],

1	—	NN	O	—	_	0	SENT_100	[p5l1575t20r1815b72],
2	.	.	O	.	_	0	SENT_100	[p5l1575t20r1815b72],

1	CT	NN	O	ct	_	0	SENT_101	[p5l1575t20r1815b72],
2	<	JJR	O	<	dep	1	SENT_101	[p5l1836t31r1881b71],
3	160	CD	DURATION	160	num	4	SENT_101	[p5l1908t20r2017b72],
4	sec	NN	DURATION	sec	dep	2	SENT_101	[p5l2039t33r2145b73],
5	.	.	O	.	_	0	SENT_101	[p5l2039t33r2145b73],

1	Considering	VBG	O	consider	_	0	SENT_102	[p5l10t107r384b175],
2	demographic	JJ	O	demographic	amod	7	SENT_102	[p5l432t107r858b175],
3	,	,	O	,	_	0	SENT_102	[p5l432t107r858b175],
4	biological	JJ	O	biological	amod	7	SENT_102	[p5l907t107r1207b175],
5	and	CC	O	and	_	0	SENT_102	[p5l1256t107r1369b162],
6	angiographic	JJ	O	angiographic	amod	7	SENT_102	[p5l1418t107r1825b175],
7	data	NNS	O	datum	pobj	1	SENT_102	[p5l1873t107r2020b170],
8	,	,	O	,	_	0	SENT_102	[p5l1873t107r2020b170],
9	no	DT	O	no	appos	7	SENT_102	[p5l2072t123r2146b162],

1	Table	NNP	O	Table	nn	3	SENT_103	[p5l7t327r145b370],
2	1	CD	NUMBER	1	num	3	SENT_103	[p5l166t329r188b370],
3	Characteristics	NNS	O	characteristic	_	0	SENT_103	[p5l9t398r368b442],
4	of	IN	O	of	_	0	SENT_103	[p5l389t398r440b442],
5	patients	NNS	O	patient	prep_of	3	SENT_103	[p5l453t399r649b453],
6	according	VBG	O	accord	_	0	SENT_103	[p5l670t398r909b452],
7	to	TO	O	to	prepc_according_to	5	SENT_103	[p5l928t405r975b442],
8	platelet	NN	O	platelet	nn	11	SENT_103	[p5l995t398r1181b453],
9	GPIIIa	NN	O	gpiium	nn	11	SENT_103	[p5l1200t401r1342b442],
10	PIA	NN	O	pium	nn	11	SENT_103	[p5l1362t398r1442b441],
11	polymorphism	NN	O	polymorphism	pobj	5	SENT_103	[p5l1460t398r1833b453],
12	.	.	O	.	_	0	SENT_103	[p5l1460t398r1833b453],

1	GPIIIa	NN	O	gpiium	_	0	SENT_104	[p5l60t541r203b583],
2	A1	NN	O	a1	dep	1	SENT_104	[p5l222t541r281b582],
3	/	:	O	/	punct	1	SENT_104	[p5l289t541r372b590],
4	A2	NN	O	a2	dep	1	SENT_104	[p5l289t541r372b590],
5	genotype	NN	O	genotype	nn	6	SENT_104	[p5l395t546r622b594],
6	A1	NN	O	a1	dep	4	SENT_104	[p5l875t541r934b582],
7	/	:	O	/	punct	4	SENT_104	[p5l942t541r1020b590],
8	A1	NN	O	a1	dep	4	SENT_104	[p5l942t541r1020b590],
9	A1	NN	O	a1	dep	8	SENT_104	[p5l1339t541r1398b582],
10	/	:	O	/	punct	8	SENT_104	[p5l1407t541r1490b590],
11	A2	NN	O	a2	dep	8	SENT_104	[p5l1407t541r1490b590],
12	and	CC	O	and	_	0	SENT_104	[p5l1513t539r1602b583],
13	A2/A2	NN	O	a2/a2	nn	14	SENT_104	[p5l1622t541r1772b590],
14	p	NN	O	p	conj_and	11	SENT_104	[p5l1967t552r1995b594],

1	(	NN	O	(	nn	2	SENT_105	[p5l880t611r1111b665],
2	n	NN	O	n	_	0	SENT_105	[p5l880t611r1111b665],
3	=	JJ	O	=	dep	2	SENT_105	[p5l880t611r1111b665],
4	104	CD	NUMBER	104	number	5	SENT_105	[p5l880t611r1111b665],
5	)	CD	NUMBER	)	num	10	SENT_105	[p5l880t611r1111b665],
6	(	NN	O	(	nn	10	SENT_105	[p5l1344t611r1544b665],
7	n	NN	O	n	nn	10	SENT_105	[p5l1344t611r1544b665],
8	=	JJ	O	=	amod	10	SENT_105	[p5l1344t611r1544b665],
9	84	CD	NUMBER	84	num	10	SENT_105	[p5l1344t611r1544b665],
10	)	NN	O	)	dep	3	SENT_105	[p5l1344t611r1544b665],

1	Demographic	JJ	MISC	demographic	dep	143	SENT_106	[p5l58t752r376b807],
2	Characteristics	NNS	MISC	characteristic	dep	143	SENT_106	[p5l394t752r740b796],
3	Age	NNP	MISC	Age	dep	143	SENT_106	[p5l58t826r150b878],
4	(	CD	NUMBER	(	dep	143	SENT_106	[p5l173t824r343b878],
5	years	NNS	NUMBER	year	dep	143	SENT_106	[p5l173t824r343b878],
6	)	VBP	O	)	dep	143	SENT_106	[p5l173t824r343b878],
7	59.3	CD	NUMBER	59.3	dep	143	SENT_106	[p5l877t826r977b868],
8	:1	CD	NUMBER	:1	dep	143	SENT_106	[p5l992t830r1033b870],
9	:	:	O	:	_	0	SENT_106	[p5l992t830r1033b870],
10	11.6	CD	NUMBER	11.6	dep	143	SENT_106	[p5l1049t826r1148b868],
11	57.3	CD	NUMBER	57.3	dep	143	SENT_106	[p5l1342t826r1441b868],
12	:	:	O	:	_	0	SENT_106	[p5l1456t830r1496b870],
13	I	PRP	O	I	dep	143	SENT_106	[p5l1456t830r1496b870],
14	:	:	O	:	_	0	SENT_106	[p5l1456t830r1496b870],
15	8.6	CD	NUMBER	8.6	dep	143	SENT_106	[p5l1511t826r1582b868],
16	0.18	CD	NUMBER	0.18	dep	143	SENT_106	[p5l1967t826r2067b868],
17	Age	NNP	O	Age	dep	143	SENT_106	[p5l58t897r150b950],
18	265	CD	DURATION	265	dep	143	SENT_106	[p5l171t898r276b940],
19	years	NNS	NUMBER	year	dep	143	SENT_106	[p5l293t908r422b950],
20	34	CD	PERCENT	34	dep	143	SENT_106	[p5l876t898r936b939],
21	(	CD	PERCENT	(	dep	143	SENT_106	[p5l959t896r1136b949],
22	32.7	CD	PERCENT	32.7	dep	143	SENT_106	[p5l959t896r1136b949],
23	%	NN	PERCENT	%	dep	143	SENT_106	[p5l959t896r1136b949],
24	)	CD	NUMBER	)	dep	143	SENT_106	[p5l959t896r1136b949],
25	19	CD	NUMBER	19	dep	143	SENT_106	[p5l1344t898r1399b939],
26	(	NN	O	(	dep	143	SENT_106	[p5l1423t895r1600b950],
27	22.6	CD	PERCENT	22.6	dep	143	SENT_106	[p5l1423t895r1600b950],
28	%	NN	PERCENT	%	dep	143	SENT_106	[p5l1423t895r1600b950],
29	)	CD	NUMBER	)	dep	143	SENT_106	[p5l1423t895r1600b950],
30	0.08	CD	NUMBER	0.08	dep	143	SENT_106	[p5l1967t898r2067b939],
31	Female	JJ	O	female	dep	143	SENT_106	[p5l60t967r233b1010],
32	9	CD	NUMBER	9	dep	143	SENT_106	[p5l877t969r904b1010],
33	(	NN	O	(	dep	143	SENT_106	[p5l927t967r1073b1021],
34	8.6	CD	PERCENT	8.6	dep	143	SENT_106	[p5l927t967r1073b1021],
35	%	NN	PERCENT	%	dep	143	SENT_106	[p5l927t967r1073b1021],
36	)	CD	NUMBER	)	dep	143	SENT_106	[p5l927t967r1073b1021],
37	10	CD	NUMBER	10	dep	143	SENT_106	[p5l1344t969r1400b1010],
38	(	NN	O	(	dep	143	SENT_106	[p5l1423t967r1600b1021],
39	11.9	CD	PERCENT	11.9	dep	143	SENT_106	[p5l1423t967r1600b1021],
40	%	NN	PERCENT	%	dep	143	SENT_106	[p5l1423t967r1600b1021],
41	)	CD	NUMBER	)	dep	143	SENT_106	[p5l1423t967r1600b1021],
42	0.31	CD	NUMBER	0.31	dep	143	SENT_106	[p5l1967t969r2062b1011],
43	Diabetes	NNP	O	Diabetes	dep	143	SENT_106	[p5l60t1038r269b1082],
44	34	CD	PERCENT	34	dep	143	SENT_106	[p5l876t1040r936b1082],
45	(	CD	PERCENT	(	dep	143	SENT_106	[p5l959t1038r1136b1092],
46	32.7	CD	PERCENT	32.7	dep	143	SENT_106	[p5l959t1038r1136b1092],
47	%	NN	PERCENT	%	dep	143	SENT_106	[p5l959t1038r1136b1092],
48	)	CD	NUMBER	)	dep	143	SENT_106	[p5l959t1038r1136b1092],
49	38	CD	NUMBER	38	dep	143	SENT_106	[p5l1340t1040r1399b1082],
50	(	NN	O	(	dep	143	SENT_106	[p5l1423t1038r1600b1092],
51	45.2	CD	PERCENT	45.2	dep	143	SENT_106	[p5l1423t1038r1600b1092],
52	%	NN	PERCENT	%	dep	143	SENT_106	[p5l1423t1038r1600b1092],
53	)	CD	NUMBER	)	dep	143	SENT_106	[p5l1423t1038r1600b1092],
54	0.07	CD	NUMBER	0.07	dep	143	SENT_106	[p5l1967t1040r2067b1082],
55	dyslipedimia	NN	O	dyslipedimium	dep	143	SENT_106	[p5l60t1109r376b1164],
56	28	CD	PERCENT	28	dep	143	SENT_106	[p5l877t1112r934b1153],
57	(	CD	PERCENT	(	dep	143	SENT_106	[p5l959t1110r1136b1163],
58	26.9	CD	PERCENT	26.9	dep	143	SENT_106	[p5l959t1110r1136b1163],
59	%	NN	PERCENT	%	dep	143	SENT_106	[p5l959t1110r1136b1163],
60	)	CD	NUMBER	)	dep	143	SENT_106	[p5l959t1110r1136b1163],
61	28	CD	NUMBER	28	dep	143	SENT_106	[p5l1341t1112r1399b1153],
62	(	NN	O	(	dep	143	SENT_106	[p5l1423t1109r1600b1164],
63	33.3	CD	PERCENT	33.3	dep	143	SENT_106	[p5l1423t1109r1600b1164],
64	%	NN	PERCENT	%	dep	143	SENT_106	[p5l1423t1109r1600b1164],
65	)	CD	NUMBER	)	dep	143	SENT_106	[p5l1423t1109r1600b1164],
66	0.42	CD	NUMBER	0.42	dep	143	SENT_106	[p5l1967t1112r2067b1153],
67	Triglyceride	NN	O	triglyceride	dep	143	SENT_106	[p5l58t1181r351b1235],
68	(	CD	NUMBER	(	dep	143	SENT_106	[p5l375t1181r595b1235],
69	mmol/l	NN	O	mmol/l	dep	143	SENT_106	[p5l375t1181r595b1235],
70	)	CD	NUMBER	)	dep	143	SENT_106	[p5l375t1181r595b1235],
71	1.69	CD	NUMBER	1.69	dep	143	SENT_106	[p5l879t1183r978b1225],
72	j	NN	O	j	dep	143	SENT_106	[p5l992t1187r1033b1227],
73	:	:	O	:	_	0	SENT_106	[p5l992t1187r1033b1227],
74	0.81	CD	NUMBER	0.81	dep	143	SENT_106	[p5l1046t1183r1142b1225],
75	2.06	CD	NUMBER	2.06	dep	143	SENT_106	[p5l1341t1183r1444b1225],
76	A	DT	O	a	dep	143	SENT_106	[p5l1456t1187r1496b1227],
77	:	:	O	:	_	0	SENT_106	[p5l1456t1187r1496b1227],
78	1.48	CD	NUMBER	1.48	dep	143	SENT_106	[p5l1513t1183r1612b1225],
79	0.038	CD	NUMBER	0.038	dep	143	SENT_106	[p5l1967t1183r2098b1225],
80	Hypertension	NN	O	hypertension	dep	143	SENT_106	[p5l60t1253r394b1307],
81	27	CD	PERCENT	27	dep	143	SENT_106	[p5l877t1254r934b1295],
82	(	CD	PERCENT	(	dep	143	SENT_106	[p5l959t1252r1092b1306],
83	26	CD	PERCENT	26	dep	143	SENT_106	[p5l959t1252r1092b1306],
84	%	NN	PERCENT	%	dep	143	SENT_106	[p5l959t1252r1092b1306],
85	)	CD	NUMBER	)	dep	143	SENT_106	[p5l959t1252r1092b1306],
86	23	CD	NUMBER	23	dep	143	SENT_106	[p5l1341t1254r1398b1296],
87	(	NN	O	(	dep	143	SENT_106	[p5l1423t1252r1600b1306],
88	27.4	CD	PERCENT	27.4	dep	143	SENT_106	[p5l1423t1252r1600b1306],
89	%	NN	PERCENT	%	dep	143	SENT_106	[p5l1423t1252r1600b1306],
90	)	CD	NUMBER	)	dep	143	SENT_106	[p5l1423t1252r1600b1306],
91	0.47	CD	NUMBER	0.47	dep	143	SENT_106	[p5l1967t1254r2067b1296],
92	Current	JJ	O	current	dep	143	SENT_106	[p5l60t1326r248b1367],
93	Smokers	NNS	O	smoker	dep	143	SENT_106	[p5l267t1324r475b1367],
94	79	CD	PERCENT	79	dep	143	SENT_106	[p5l878t1326r935b1367],
95	(	CD	PERCENT	(	dep	143	SENT_106	[p5l959t1324r1092b1377],
96	76	CD	PERCENT	76	dep	143	SENT_106	[p5l959t1324r1092b1377],
97	%	NN	PERCENT	%	dep	143	SENT_106	[p5l959t1324r1092b1377],
98	)	CD	NUMBER	)	dep	143	SENT_106	[p5l959t1324r1092b1377],
99	65	CD	NUMBER	65	dep	143	SENT_106	[p5l1341t1326r1398b1367],
100	(	NN	O	(	dep	143	SENT_106	[p5l1423t1323r1600b1378],
101	65.5	CD	PERCENT	65.5	dep	143	SENT_106	[p5l1423t1323r1600b1378],
102	%	NN	PERCENT	%	dep	143	SENT_106	[p5l1423t1323r1600b1378],
103	)	CD	NUMBER	)	dep	143	SENT_106	[p5l1423t1323r1600b1378],
104	0.11	CD	NUMBER	0.11	dep	143	SENT_106	[p5l1967t1326r2062b1367],
105	Prior	JJ	O	prior	dep	143	SENT_106	[p5l60t1396r179b1438],
106	MI	NN	O	mi	dep	143	SENT_106	[p5l198t1398r261b1438],
107	78	CD	PERCENT	78	dep	143	SENT_106	[p5l878t1397r934b1438],
108	(	CD	PERCENT	(	dep	143	SENT_106	[p5l959t1395r1092b1449],
109	75	CD	PERCENT	75	dep	143	SENT_106	[p5l959t1395r1092b1449],
110	%	NN	PERCENT	%	dep	143	SENT_106	[p5l959t1395r1092b1449],
111	)	CD	NUMBER	)	dep	143	SENT_106	[p5l959t1395r1092b1449],
112	53	CD	NUMBER	53	dep	143	SENT_106	[p5l1342t1397r1398b1438],
113	(	NN	O	(	dep	143	SENT_106	[p5l1423t1395r1600b1449],
114	63.1	CD	PERCENT	63.1	dep	143	SENT_106	[p5l1423t1395r1600b1449],
115	%	NN	PERCENT	%	dep	143	SENT_106	[p5l1423t1395r1600b1449],
116	)	CD	NUMBER	)	dep	143	SENT_106	[p5l1423t1395r1600b1449],
117	0.13	CD	NUMBER	0.13	dep	143	SENT_106	[p5l1967t1397r2066b1439],
118	Prior	JJ	O	prior	dep	143	SENT_106	[p5l60t1467r179b1510],
119	PCI	NN	O	pcus	dep	143	SENT_106	[p5l198t1469r273b1510],
120	69	CD	PERCENT	69	dep	143	SENT_106	[p5l877t1469r935b1510],
121	(	CD	PERCENT	(	dep	143	SENT_106	[p5l959t1467r1136b1521],
122	66.3	CD	PERCENT	66.3	dep	143	SENT_106	[p5l959t1467r1136b1521],
123	%	NN	PERCENT	%	dep	143	SENT_106	[p5l959t1467r1136b1521],
124	)	CD	NUMBER	)	dep	143	SENT_106	[p5l959t1467r1136b1521],
125	63	CD	NUMBER	63	dep	143	SENT_106	[p5l1341t1469r1398b1510],
126	(	NN	O	(	dep	143	SENT_106	[p5l1423t1467r1556b1521],
127	75	CD	PERCENT	75	dep	143	SENT_106	[p5l1423t1467r1556b1521],
128	%	NN	PERCENT	%	dep	143	SENT_106	[p5l1423t1467r1556b1521],
129	)	CD	NUMBER	)	dep	143	SENT_106	[p5l1423t1467r1556b1521],
130	0.12	CD	NUMBER	0.12	dep	143	SENT_106	[p5l1967t1469r2067b1511],
131	Stent	NN	O	stent	dep	143	SENT_106	[p5l60t1540r187b1582],
132	placement	NN	O	placement	dep	143	SENT_106	[p5l205t1538r464b1592],
133	41	CD	PERCENT	41	dep	143	SENT_106	[p5l875t1540r929b1581],
134	(	CD	PERCENT	(	dep	143	SENT_106	[p5l959t1538r1136b1592],
135	39.4	CD	PERCENT	39.4	dep	143	SENT_106	[p5l959t1538r1136b1592],
136	%	NN	PERCENT	%	dep	143	SENT_106	[p5l959t1538r1136b1592],
137	)	CD	NUMBER	)	dep	143	SENT_106	[p5l959t1538r1136b1592],
138	43	CD	NUMBER	43	dep	143	SENT_106	[p5l1340t1540r1398b1582],
139	(	NN	O	(	dep	143	SENT_106	[p5l1423t1538r1600b1592],
140	51.2	CD	PERCENT	51.2	dep	143	SENT_106	[p5l1423t1538r1600b1592],
141	%	NN	PERCENT	%	dep	143	SENT_106	[p5l1423t1538r1600b1592],
142	)	CD	NUMBER	)	dep	143	SENT_106	[p5l1423t1538r1600b1592],
143	0.22	CD	NUMBER	0.22	_	0	SENT_106	[p5l1967t1540r2067b1582],

1	Medication	NN	O	medication	nn	3	SENT_107	[p5l58t1684r323b1727],
2	[	CD	NUMBER	[	num	3	SENT_107	[p5l60t1755r300b1809],
3	3-Blocker	NN	O	3-blocker	dep	16	SENT_107	[p5l60t1755r300b1809],
4	66	CD	PERCENT	66	num	5	SENT_107	[p5l877t1757r935b1799],
5	(	CD	PERCENT	(	dep	3	SENT_107	[p5l959t1755r1136b1809],
6	63.4	CD	PERCENT	63.4	num	7	SENT_107	[p5l959t1755r1136b1809],
7	%	NN	PERCENT	%	dep	5	SENT_107	[p5l959t1755r1136b1809],
8	)	CD	PERCENT	)	number	9	SENT_107	[p5l959t1755r1136b1809],
9	50	CD	PERCENT	50	num	7	SENT_107	[p5l1342t1757r1400b1799],
10	(	CD	PERCENT	(	number	11	SENT_107	[p5l1423t1755r1600b1809],
11	59.5	CD	PERCENT	59.5	dep	12	SENT_107	[p5l1423t1755r1600b1809],
12	%	NN	PERCENT	%	dep	7	SENT_107	[p5l1423t1755r1600b1809],
13	)	CD	NUMBER	)	dep	16	SENT_107	[p5l1423t1755r1600b1809],
14	0.57	CD	NUMBER	0.57	num	16	SENT_107	[p5l1967t1757r2067b1799],
15	ACE	NN	O	ace	nn	16	SENT_107	[p5l58t1828r155b1870],
16	inhibitors	NNS	O	inhibitor	dep	23	SENT_107	[p5l175t1826r411b1870],
17	89	CD	PERCENT	89	number	18	SENT_107	[p5l877t1829r935b1870],
18	(	CD	PERCENT	(	dep	16	SENT_107	[p5l959t1827r1136b1880],
19	85.6	CD	PERCENT	85.6	num	20	SENT_107	[p5l959t1827r1136b1880],
20	%	NN	PERCENT	%	dep	18	SENT_107	[p5l959t1827r1136b1880],
21	)	CD	NUMBER	)	number	22	SENT_107	[p5l959t1827r1136b1880],
22	69	CD	NUMBER	69	num	23	SENT_107	[p5l1341t1829r1399b1870],
23	(	NN	O	(	dep	26	SENT_107	[p5l1423t1827r1600b1881],
24	82.1	CD	PERCENT	82.1	num	25	SENT_107	[p5l1423t1827r1600b1881],
25	%	NN	PERCENT	%	dep	23	SENT_107	[p5l1423t1827r1600b1881],
26	)	CD	NUMBER	)	dep	27	SENT_107	[p5l1423t1827r1600b1881],
27	Statin	NN	ORGANIZATION	statin	dep	31	SENT_107	[p5l60t1899r201b1941],
28	91	CD	PERCENT	91	num	27	SENT_107	[p5l877t1900r929b1941],
29	(	CD	PERCENT	(	num	31	SENT_107	[p5l959t1898r1136b1952],
30	87.5	CD	PERCENT	87.5	num	31	SENT_107	[p5l959t1898r1136b1952],
31	%	NN	PERCENT	%	dep	37	SENT_107	[p5l959t1898r1136b1952],
32	)	CD	NUMBER	)	number	33	SENT_107	[p5l959t1898r1136b1952],
33	75	CD	NUMBER	75	num	34	SENT_107	[p5l1342t1898r1584b1952],
34	(	NN	O	(	dep	31	SENT_107	[p5l1342t1898r1584b1952],
35	89.2	CD	PERCENT	89.2	number	36	SENT_107	[p5l1342t1898r1584b1952],
36	%	NN	PERCENT	%	amod	34	SENT_107	[p5l1342t1898r1584b1952],
37	)	CD	NUMBER	)	_	0	SENT_107	[p5l1342t1898r1584b1952],

1	Angiographic	NNP	O	Angiographic	nn	2	SENT_108	[p5l55t2044r374b2098],
2	Data	NNP	O	Data	dep	23	SENT_108	[p5l389t2047r501b2087],
3	Normal	JJ	O	normal	amod	5	SENT_108	[p5l60t2115r242b2159],
4	coronary	JJ	O	coronary	amod	5	SENT_108	[p5l263t2128r481b2170],
5	arteries	NNS	O	artery	dep	2	SENT_108	[p5l499t2116r683b2159],
6	6	CD	PERCENT	6	number	7	SENT_108	[p5l877t2118r904b2159],
7	(	CD	PERCENT	(	dep	5	SENT_108	[p5l927t2115r1073b2169],
8	5.8	CD	PERCENT	5.8	num	9	SENT_108	[p5l927t2115r1073b2169],
9	%	NN	PERCENT	%	dep	5	SENT_108	[p5l927t2115r1073b2169],
10	)	CD	PERCENT	)	number	11	SENT_108	[p5l927t2115r1073b2169],
11	2	CD	PERCENT	2	num	9	SENT_108	[p5l1341t2115r1522b2169],
12	(	CD	PERCENT	(	number	13	SENT_108	[p5l1341t2115r1522b2169],
13	2.4	CD	PERCENT	2.4	dep	14	SENT_108	[p5l1341t2115r1522b2169],
14	%	NN	PERCENT	%	dep	19	SENT_108	[p5l1341t2115r1522b2169],
15	)	CD	NUMBER	)	number	16	SENT_108	[p5l1341t2115r1522b2169],
16	0.55	CD	NUMBER	0.55	num	17	SENT_108	[p5l1967t2117r2067b2159],
17	Non	NN	O	non	npadvmod	18	SENT_108	[p5l60t2189r160b2230],
18	signiﬁcant	JJ	O	signiﬁcant	amod	19	SENT_108	[p5l180t2186r435b2241],
19	stenosis	NN	O	stenosis	dep	9	SENT_108	[p5l454t2187r648b2230],
20	6	CD	NUMBER	6	num	21	SENT_108	[p5l877t2189r904b2230],
21	(	NN	O	(	dep	23	SENT_108	[p5l927t2187r1073b2241],
22	5.8	CD	PERCENT	5.8	num	23	SENT_108	[p5l927t2187r1073b2241],
23	%	NN	PERCENT	%	dep	29	SENT_108	[p5l927t2187r1073b2241],
24	)	CD	NUMBER	)	number	25	SENT_108	[p5l927t2187r1073b2241],
25	3	CD	NUMBER	3	num	26	SENT_108	[p5l1340t2189r1366b2230],
26	(	NN	O	(	dep	23	SENT_108	[p5l1392t2187r1538b2241],
27	3.6	CD	PERCENT	3.6	number	28	SENT_108	[p5l1392t2187r1538b2241],
28	%	NN	PERCENT	%	amod	26	SENT_108	[p5l1392t2187r1538b2241],
29	)	CD	NUMBER	)	_	0	SENT_108	[p5l1392t2187r1538b2241],
30	Left	VBN	O	leave	partmod	29	SENT_108	[p5l60t2258r150b2302],
31	main	JJ	O	main	amod	32	SENT_108	[p5l169t2259r292b2302],
32	stenosis	NN	O	stenosis	dobj	30	SENT_108	[p5l312t2259r506b2302],
33	3	CD	NUMBER	3	num	34	SENT_108	[p5l876t2260r902b2302],
34	(	NN	O	(	dep	32	SENT_108	[p5l927t2258r1073b2312],
35	2.9	CD	PERCENT	2.9	num	36	SENT_108	[p5l927t2258r1073b2312],
36	%	NN	PERCENT	%	dep	48	SENT_108	[p5l927t2258r1073b2312],
37	)	CD	NUMBER	)	number	38	SENT_108	[p5l927t2258r1073b2312],
38	1	CD	NUMBER	1	num	39	SENT_108	[p5l1344t2260r1363b2301],
39	(	NN	O	(	dep	36	SENT_108	[p5l1392t2258r1538b2312],
40	1.2	CD	PERCENT	1.2	number	41	SENT_108	[p5l1392t2258r1538b2312],
41	%	NN	PERCENT	%	amod	39	SENT_108	[p5l1392t2258r1538b2312],
42	)	CD	NUMBER	)	num	43	SENT_108	[p5l1392t2258r1538b2312],
43	One-vessel	NN	O	one-vessel	dep	39	SENT_108	[p5l60t2329r327b2373],
44	disease	NN	O	disease	dep	48	SENT_108	[p5l348t2329r524b2373],
45	53	CD	PERCENT	53	num	44	SENT_108	[p5l877t2330r1076b2383],
46	(	CD	PERCENT	(	num	48	SENT_108	[p5l877t2330r1076b2383],
47	51	CD	PERCENT	51	num	48	SENT_108	[p5l877t2330r1076b2383],
48	%	NN	PERCENT	%	dep	55	SENT_108	[p5l877t2330r1076b2383],
49	)	CD	NUMBER	)	number	50	SENT_108	[p5l877t2330r1076b2383],
50	51	CD	NUMBER	51	num	51	SENT_108	[p5l1342t2332r1394b2373],
51	(	NN	O	(	dep	48	SENT_108	[p5l1407t2330r1584b2384],
52	60.7	CD	PERCENT	60.7	number	53	SENT_108	[p5l1407t2330r1584b2384],
53	%	NN	PERCENT	%	amod	51	SENT_108	[p5l1407t2330r1584b2384],
54	)	CD	NUMBER	)	num	55	SENT_108	[p5l1407t2330r1584b2384],
55	Two-vessel	NN	O	two-vessel	dep	56	SENT_108	[p5l58t2401r335b2444],
56	disease	NN	O	disease	dep	60	SENT_108	[p5l356t2401r532b2444],
57	20	CD	PERCENT	20	num	56	SENT_108	[p5l877t2403r935b2444],
58	(	CD	PERCENT	(	num	60	SENT_108	[p5l959t2401r1136b2455],
59	19.2	CD	PERCENT	19.2	num	60	SENT_108	[p5l959t2401r1136b2455],
60	%	NN	PERCENT	%	dep	67	SENT_108	[p5l959t2401r1136b2455],
61	)	CD	NUMBER	)	number	62	SENT_108	[p5l959t2401r1136b2455],
62	12	CD	NUMBER	12	num	63	SENT_108	[p5l1344t2403r1398b2444],
63	(	NN	O	(	dep	60	SENT_108	[p5l1423t2401r1600b2455],
64	14.3	CD	PERCENT	14.3	num	65	SENT_108	[p5l1423t2401r1600b2455],
65	%	NN	PERCENT	%	dep	63	SENT_108	[p5l1423t2401r1600b2455],
66	)	CD	NUMBER	)	num	67	SENT_108	[p5l1423t2401r1600b2455],
67	Three-vessel	NN	O	three-vessel	dep	68	SENT_108	[p5l58t2472r369b2516],
68	disease	NN	O	disease	dep	72	SENT_108	[p5l390t2472r566b2516],
69	16	CD	PERCENT	16	num	68	SENT_108	[p5l879t2474r935b2516],
70	(	CD	PERCENT	(	num	72	SENT_108	[p5l959t2472r1136b2526],
71	15.4	CD	PERCENT	15.4	num	72	SENT_108	[p5l959t2472r1136b2526],
72	%	NN	PERCENT	%	dep	91	SENT_108	[p5l959t2472r1136b2526],
73	)	CD	NUMBER	)	number	74	SENT_108	[p5l959t2472r1136b2526],
74	15	CD	NUMBER	15	num	75	SENT_108	[p5l1344t2474r1398b2516],
75	(	NN	O	(	dep	72	SENT_108	[p5l1423t2472r1600b2526],
76	17.9	CD	PERCENT	17.9	number	77	SENT_108	[p5l1423t2472r1600b2526],
77	%	NN	PERCENT	%	amod	75	SENT_108	[p5l1423t2472r1600b2526],
78	)	CD	NUMBER	)	num	79	SENT_108	[p5l1423t2472r1600b2526],
79	LVEF	NN	O	lvef	npadvmod	80	SENT_108	[p5l60t2546r329b2587],
80	<	JJR	O	<	amod	75	SENT_108	[p5l60t2546r329b2587],
81	50	CD	PERCENT	50	num	82	SENT_108	[p5l60t2546r329b2587],
82	%	NN	PERCENT	%	dep	80	SENT_108	[p5l60t2546r329b2587],
83	23	CD	PERCENT	23	number	84	SENT_108	[p5l877t2544r1119b2598],
84	(	CD	PERCENT	(	prep	80	SENT_108	[p5l877t2544r1119b2598],
85	22.1	CD	PERCENT	22.1	num	86	SENT_108	[p5l877t2544r1119b2598],
86	%	NN	PERCENT	%	dep	84	SENT_108	[p5l877t2544r1119b2598],
87	)	CD	PERCENT	)	number	88	SENT_108	[p5l877t2544r1119b2598],
88	15	CD	PERCENT	15	prep	80	SENT_108	[p5l1344t2544r1478b2597],
89	(	CD	PERCENT	(	num	90	SENT_108	[p5l1344t2544r1478b2597],
90	%	NN	PERCENT	%	dep	88	SENT_108	[p5l1344t2544r1478b2597],
91	)	CD	NUMBER	)	dep	32	SENT_108	[p5l1344t2544r1478b2597],

1	Values	NNS	O	value	nsubj	3	SENT_109	[p5l7t2654r169b2697],
2	are	VBP	O	be	cop	3	SENT_109	[p5l189t2666r263b2697],
3	mean	JJ	O	mean	_	0	SENT_109	[p5l283t2660r471b2700],
4	;	:	O	;	_	0	SENT_109	[p5l283t2660r471b2700],
5	|	NN	O	|	dep	3	SENT_109	[p5l283t2660r471b2700],
6	:	:	O	:	_	0	SENT_109	[p5l283t2660r471b2700],
7	SD	NN	O	sd	dep	3	SENT_109	[p5l485t2656r547b2697],
8	or	CC	O	or	_	0	SENT_109	[p5l567t2666r617b2697],
9	n	NN	O	n	dep	3	SENT_109	[p5l636t2666r665b2697],
10	(	CD	PERCENT	(	num	11	SENT_109	[p5l687t2654r774b2708],
11	%	NN	PERCENT	%	dep	7	SENT_109	[p5l687t2654r774b2708],
12	)	CD	NUMBER	)	dep	7	SENT_109	[p5l687t2654r774b2708],
13	.	.	O	.	_	0	SENT_109	[p5l687t2654r774b2708],

1	MI	NNP	O	MI	_	0	SENT_110	[p5l794t2656r871b2698],
2	:	:	O	:	_	0	SENT_110	[p5l794t2656r871b2698],
3	Myocardial	JJ	O	myocardial	amod	4	SENT_110	[p5l894t2654r1169b2708],
4	Infarction	NN	O	infarction	dep	1	SENT_110	[p5l1188t2654r1440b2704],
5	;	:	O	;	_	0	SENT_110	[p5l1188t2654r1440b2704],
6	PCI	NNP	O	PCI	dep	4	SENT_110	[p5l1464t2656r1554b2698],
7	:	:	O	:	_	0	SENT_110	[p5l1464t2656r1554b2698],
8	Percutaneous	JJ	O	percutaneous	amod	10	SENT_110	[p5l1577t2656r1907b2697],
9	Coronary	JJ	O	coronary	amod	10	SENT_110	[p5l1927t2656r2152b2708],
10	Intervention	NN	O	intervention	dep	6	SENT_110	[p5l10t2726r330b2775],
11	;	:	O	;	_	0	SENT_110	[p5l10t2726r330b2775],
12	LVEF	NNP	O	LVEF	dep	4	SENT_110	[p5l363t2728r493b2769],
13	:	:	O	:	_	0	SENT_110	[p5l363t2728r493b2769],
14	Left	VBN	O	leave	dep	1	SENT_110	[p5l526t2725r616b2768],
15	Ventricular	JJ	O	ventricular	amod	17	SENT_110	[p5l640t2725r919b2768],
16	Ejection	NN	O	ejection	nn	17	SENT_110	[p5l946t2726r1142b2779],
17	Fraction	NN	O	fraction	dobj	14	SENT_110	[p5l1171t2726r1384b2775],
18	;	:	O	;	_	0	SENT_110	[p5l1171t2726r1384b2775],
19	ACE	NN	O	ace	dep	14	SENT_110	[p5l1414t2727r1526b2769],
20	:	:	O	:	_	0	SENT_110	[p5l1414t2727r1526b2769],
21	Angiotensin	NN	O	angiotensin	nsubj	22	SENT_110	[p5l1556t2726r1852b2779],
22	Converting	VBG	O	convert	dep	19	SENT_110	[p5l1881t2726r2152b2779],
23	Enzyme	NN	O	enzyme	nn	24	SENT_110	[p5l10t2799r203b2850],
24	inhibitor	NN	O	inhibitor	dobj	22	SENT_110	[p5l224t2796r448b2840],
25	.	.	O	.	_	0	SENT_110	[p5l224t2796r448b2840],

1	F.	NNP	PERSON	F.	nn	2	SENT_111	[p5l345t2927r362b2948],
2	Abderrazek	NNP	PERSON	Abderrazek	_	0	SENT_111	[p5l371t2926r504b2948],
3	et	FW	O	et	nn	4	SENT_111	[p5l513t2929r535b2948],
4	al.	FW	O	al.	dep	2	SENT_111	[p5l544t2926r569b2948],
5	/	:	O	/	punct	2	SENT_111	[p5l579t2927r588b2951],
6	Thrombosis	NNP	O	Thrombosis	nn	7	SENT_111	[p5l598t2926r729b2948],
7	Research	NNP	O	Research	dep	2	SENT_111	[p5l739t2926r841b2948],
8	125	CD	NUMBER	125	number	9	SENT_111	[p5l855t2927r894b2948],
9	(	CD	NUMBER	(	nn	15	SENT_111	[p5l906t2926r984b2953],
10	2010	CD	DATE	2010	num	12	SENT_111	[p5l906t2926r984b2953],
11	)	CD	NUMBER	)	num	12	SENT_111	[p5l906t2926r984b2953],
12	e265	NN	O	e265	dep	9	SENT_111	[p5l996t2927r1123b2948],
13	—	CD	NUMBER	—	num	14	SENT_111	[p5l996t2927r1123b2948],
14	e268	NN	O	e268	dep	9	SENT_111	[p5l996t2927r1123b2948],
15	e267	NN	O	e267	dep	7	SENT_111	[p5l1757t2927r1814b2948],

1	Table	NNP	O	Table	nn	3	SENT_112	[p5l6t3068r144b3111],
2	2	CD	NUMBER	2	num	3	SENT_112	[p5l163t3070r192b3111],
3	Prevalence	NN	O	prevalence	_	0	SENT_112	[p5l9t3139r273b3183],
4	of	IN	O	of	_	0	SENT_112	[p5l294t3139r345b3183],
5	high	JJ	O	high	amod	7	SENT_112	[p5l360t3139r467b3193],
6	platelet	NN	O	platelet	nn	7	SENT_112	[p5l487t3139r672b3194],
7	reactivity	NN	O	reactivity	prep_of	3	SENT_112	[p5l692t3140r924b3193],
8	among	IN	O	among	_	0	SENT_112	[p5l942t3152r1110b3193],
9	patients	NNS	O	patient	prep_among	7	SENT_112	[p5l1130t3140r1326b3194],
10	with	IN	O	with	_	0	SENT_112	[p5l1346t3139r1458b3183],
11	the	DT	O	the	det	13	SENT_112	[p5l1478t3139r1556b3183],
12	common	JJ	O	common	amod	13	SENT_112	[p5l1577t3152r1792b3183],
13	genotype	NN	O	genotype	prep_with	9	SENT_112	[p5l1812t3146r2040b3194],
14	and	CC	O	and	_	0	SENT_112	[p5l2061t3139r2149b3183],
15	patients	NNS	O	patient	nn	16	SENT_112	[p5l9t3211r205b3265],
16	carriers	NNS	O	carrier	conj_and	13	SENT_112	[p5l226t3211r408b3254],
17	of	IN	O	of	_	0	SENT_112	[p5l429t3211r480b3254],
18	mutant	JJ	O	mutant	amod	20	SENT_112	[p5l494t3217r674b3254],
19	PlA2	NN	O	pla2	nn	20	SENT_112	[p5l693t3211r800b3254],
20	allele	NN	O	allele	prep_of	3	SENT_112	[p5l822t3211r962b3255],
21	.	.	O	.	_	0	SENT_112	[p5l822t3211r962b3255],

1	Patients	NNS	O	patient	_	0	SENT_113	[p5l883t3336r1078b3379],
2	with	IN	O	with	_	0	SENT_113	[p5l1098t3335r1211b3379],
3	HPR1	NN	O	hpr1	nn	4	SENT_113	[p5l1233t3327r1352b3378],
4	Patients	NNS	O	patient	prep_with	1	SENT_113	[p5l1565t3336r1760b3379],
5	without	IN	O	without	_	0	SENT_113	[p5l1781t3335r1977b3379],
6	HPR	NNP	O	HPR	prep_without	1	SENT_113	[p5l1998t3338r2101b3378],

1	n	NN	O	n	_	0	SENT_114	[p5l883t3458r912b3489],
2	=	JJ	O	=	amod	4	SENT_114	[p5l926t3464r969b3481],
3	81	CD	NUMBER	81	tmod	2	SENT_114	[p5l983t3448r1035b3489],
4	n	NN	O	n	dep	1	SENT_114	[p5l1565t3458r1594b3489],
5	=	JJ	O	=	amod	4	SENT_114	[p5l1608t3464r1651b3481],
6	107	CD	NUMBER	107	tmod	5	SENT_114	[p5l1668t3448r1754b3489],

1	PlA1/PlA1	NN	O	pla1/pla1	dep	12	SENT_115	[p5l59t3556r296b3607],
2	53	CD	PERCENT	53	num	1	SENT_115	[p5l883t3558r939b3600],
3	(	CD	PERCENT	(	number	4	SENT_115	[p5l965t3556r1142b3610],
4	65.4	CD	PERCENT	65.4	num	5	SENT_115	[p5l965t3556r1142b3610],
5	%	NN	PERCENT	%	dep	1	SENT_115	[p5l965t3556r1142b3610],
6	)	CD	NUMBER	)	num	8	SENT_115	[p5l965t3556r1142b3610],
7	51	CD	NUMBER	51	num	8	SENT_115	[p5l1566t3559r1618b3600],
8	(	NN	O	(	dep	5	SENT_115	[p5l1647t3556r1824b3610],
9	47.7	CD	PERCENT	47.7	num	10	SENT_115	[p5l1647t3556r1824b3610],
10	%	NN	PERCENT	%	dep	12	SENT_115	[p5l1647t3556r1824b3610],
11	)	CD	NUMBER	)	num	12	SENT_115	[p5l1647t3556r1824b3610],
12	PlA1/PlA2	NN	O	pla1/pla2	dep	18	SENT_115	[p5l59t3628r300b3678],
13	and	CC	O	and	_	0	SENT_115	[p5l322t3628r411b3671],
14	PlA2/PlA2	NN	O	pla2/pla2	conj_and	12	SENT_115	[p5l432t3628r672b3678],
15	28	CD	PERCENT	28	num	14	SENT_115	[p5l882t3630r940b3671],
16	(	CD	PERCENT	(	num	18	SENT_115	[p5l965t3628r1142b3682],
17	34.6	CD	PERCENT	34.6	num	18	SENT_115	[p5l965t3628r1142b3682],
18	%	NN	PERCENT	%	dep	24	SENT_115	[p5l965t3628r1142b3682],
19	)	CD	NUMBER	)	number	20	SENT_115	[p5l965t3628r1142b3682],
20	56	CD	NUMBER	56	num	21	SENT_115	[p5l1566t3630r1624b3671],
21	(	NN	O	(	dep	18	SENT_115	[p5l1647t3628r1824b3682],
22	52.3	CD	PERCENT	52.3	num	23	SENT_115	[p5l1647t3628r1824b3682],
23	%	NN	PERCENT	%	dep	21	SENT_115	[p5l1647t3628r1824b3682],
24	)	CD	NUMBER	)	_	0	SENT_115	[p5l1647t3628r1824b3682],

1	Cross-tabulations	NNS	O	cross-tabulation	nn	2	SENT_116	[p6l9t25r436b69],
2	p	NN	O	p	_	0	SENT_116	[p6l466t28r710b80],
3	=	JJ	O	=	amod	2	SENT_116	[p6l466t28r710b80],
4	0.015	CD	NUMBER	0.015	tmod	3	SENT_116	[p6l466t28r710b80],
5	,	,	O	,	_	0	SENT_116	[p6l466t28r710b80],
6	HPR	NNP	O	HPR	appos	2	SENT_116	[p6l741t28r856b69],
7	:	:	O	:	_	0	SENT_116	[p6l741t28r856b69],
8	high	JJ	O	high	amod	10	SENT_116	[p6l890t25r997b79],
9	platelet	NN	O	platelet	nn	10	SENT_116	[p6l1026t25r1211b80],
10	reactivity	NN	O	reactivity	dep	2	SENT_116	[p6l1240t26r1481b79],
11	,	,	O	,	_	0	SENT_116	[p6l1240t26r1481b79],
12	‘	CD	NUMBER	‘	num	13	SENT_116	[p6l1512t17r1729b69],
13	Patients	NNS	O	patient	appos	10	SENT_116	[p6l1512t17r1729b69],
14	with	IN	O	with	_	0	SENT_116	[p6l1757t25r1870b69],
15	collagene	NN	O	collagene	prep_with	13	SENT_116	[p6l1899t25r2151b80],
16	/	:	O	/	punct	20	SENT_116	[p6l1899t25r2151b80],
17	Epinephrine	NNP	O	Epinephrine	nn	19	SENT_116	[p6l9t97r308b151],
18	Closure	NNP	O	Closure	nn	19	SENT_116	[p6l329t97r510b141],
19	time	NN	O	time	dep	20	SENT_116	[p6l530t98r641b141],
20	<	JJR	O	<	dep	13	SENT_116	[p6l663t108r699b139],
21	160	CD	DURATION	160	num	22	SENT_116	[p6l722t99r810b141],
22	sec	NN	DURATION	sec	dep	13	SENT_116	[p6l828t110r913b141],
23	.	.	O	.	_	0	SENT_116	[p6l828t110r913b141],

1	statistically	RB	O	statistically	advmod	2	SENT_117	[p6l10t305r356b374],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_117	[p6l400t305r716b374],
3	difference	NN	O	difference	nsubjpass	5	SENT_117	[p6l759t305r1064b360],
4	was	VBD	O	be	auxpass	5	SENT_117	[p6l1107t321r1226b360],
5	observed	VBN	O	observe	_	0	SENT_117	[p6l1270t305r1547b360],
6	between	IN	O	between	_	0	SENT_117	[p6l1591t305r1856b360],
7	patients	NNS	O	patient	prep_between	5	SENT_117	[p6l1900t306r2145b374],
8	with	IN	O	with	_	0	SENT_117	[p6l7t394r148b449],
9	or	CC	O	or	_	0	SENT_117	[p6l173t410r236b449],
10	without	IN	O	without	_	0	SENT_117	[p6l257t394r503b449],
11	such	PDT	O	such	predet	12	SENT_117	[p6l526t394r664b449],
12	a	DT	O	a	prep_without	7	SENT_117	[p6l688t410r719b449],
13	HPR	NNP	O	HPR	prep_with	7	SENT_117	[p6l744t397r872b448],
14	(	CD	NUMBER	(	num	15	SENT_117	[p6l898t394r1054b462],
15	data	NNS	O	datum	npadvmod	16	SENT_117	[p6l898t394r1054b462],
16	not	RB	O	not	neg	17	SENT_117	[p6l1079t402r1180b449],
17	shown	VBN	O	show	partmod	7	SENT_117	[p6l1203t394r1450b462],
18	)	NN	O	)	dobj	17	SENT_117	[p6l1203t394r1450b462],
19	.	.	O	.	_	0	SENT_117	[p6l1203t394r1450b462],

1	Considering	VBG	O	consider	_	0	SENT_118	[p6l111t483r478b552],
2	PIA	NN	O	pium	nn	4	SENT_118	[p6l502t484r602b538],
3	polymorphism	NN	O	polymorphism	nn	4	SENT_118	[p6l626t483r1078b552],
4	determination	NN	O	determination	pobj	1	SENT_118	[p6l1103t483r1557b547],
5	,	,	O	,	_	0	SENT_118	[p6l1103t483r1557b547],
6	the	DT	O	the	det	8	SENT_118	[p6l1584t483r1680b538],
7	mean	JJ	O	mean	amod	8	SENT_118	[p6l1707t499r1876b538],
8	value	NN	O	value	appos	4	SENT_118	[p6l1900t483r2064b538],
9	of	IN	O	of	_	0	SENT_118	[p6l2090t483r2153b538],
10	CEPl	NN	O	cepl	prep_of	8	SENT_118	[p6l9t575r250b627],
11	.	.	O	.	_	0	SENT_118	[p6l9t575r250b627],

1	—	NN	O	—	_	0	SENT_119	[p6l9t575r250b627],
2	.	.	O	.	_	0	SENT_119	[p6l9t575r250b627],

1	CT	NN	O	ct	nsubj	2	SENT_120	[p6l9t575r250b627],
2	was	VBD	O	be	_	0	SENT_120	[p6l285t588r403b627],
3	signiﬁcantly	RB	O	signiﬁcantly	advmod	2	SENT_120	[p6l445t572r819b641],
4	longer	RBR	O	longer	advmod	2	SENT_120	[p6l857t573r1053b641],
5	in	IN	O	in	_	0	SENT_120	[p6l1091t573r1147b627],
6	PIA2	NN	O	pia2	nn	8	SENT_120	[p6l1187t572r1321b627],
7	allele	NN	O	allele	nn	8	SENT_120	[p6l1363t572r1523b627],
8	carriers	NNS	O	carrier	prep_in	4	SENT_120	[p6l1563t573r1792b627],
9	than	IN	O	than	mark	15	SENT_120	[p6l1832t573r1969b627],
10	PIAI	NN	O	piaus	nn	12	SENT_120	[p6l2009t572r2138b627],
11	(	CD	NUMBER	(	num	12	SENT_120	[p6l13t662r362b730],
12	l90	NN	O	l90	nsubj	15	SENT_120	[p6l13t662r362b730],
13	.6	CD	NUMBER	.6	num	14	SENT_120	[p6l13t662r362b730],
14	i79	NNS	O	i79	dep	12	SENT_120	[p6l13t662r362b730],
15	sec	VBP	DURATION	sec	dep	4	SENT_120	[p6l385t678r478b717],
16	vs.	CC	O	vs.	nsubj	17	SENT_120	[p6l518t678r588b717],
17	2l4	VBP	O	2l4	ccomp	15	SENT_120	[p6l633t665r1008b720],
18	.7	CD	NUMBER	.7	num	21	SENT_120	[p6l633t665r1008b720],
19	i78	NN	O	i78	nn	21	SENT_120	[p6l633t665r1008b720],
20	.3	NN	DURATION	.3	nn	21	SENT_120	[p6l633t665r1008b720],
21	sec	NN	DURATION	sec	dobj	17	SENT_120	[p6l1033t678r1143b725],
22	;	:	O	;	_	0	SENT_120	[p6l1033t678r1143b725],
23	P	NN	O	p	dep	21	SENT_120	[p6l1190t662r1523b730],
24	=	JJ	O	=	amod	26	SENT_120	[p6l1190t662r1523b730],
25	0.038	CD	NUMBER	0.038	tmod	24	SENT_120	[p6l1190t662r1523b730],
26	)	NN	O	)	dep	23	SENT_120	[p6l1190t662r1523b730],
27	.	.	O	.	_	0	SENT_120	[p6l1190t662r1523b730],

1	The	DT	O	the	det	2	SENT_121	[p6l1563t662r1675b717],
2	proportion	NN	O	proportion	nsubj	8	SENT_121	[p6l1717t663r2048b730],
3	of	IN	O	of	_	0	SENT_121	[p6l2090t662r2153b717],
4	PIAI/PIA1	NN	O	piai/pia1	nn	6	SENT_121	[p6l9t751r304b815],
5	genotype	NN	O	genotype	nn	6	SENT_121	[p6l344t759r629b819],
6	carriers	NNS	O	carrier	prep_of	2	SENT_121	[p6l663t752r892b806],
7	was	VBD	O	be	cop	8	SENT_121	[p6l924t767r1043b806],
8	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_121	[p6l1078t751r1396b819],
9	higher	JJR	O	higher	dep	8	SENT_121	[p6l1428t751r1626b819],
10	among	IN	O	among	_	0	SENT_121	[p6l1658t767r1868b819],
11	patients	NNS	O	patient	prep_among	8	SENT_121	[p6l1900t752r2145b819],
12	with	IN	O	with	_	0	SENT_121	[p6l7t839r148b894],
13	HPR	NN	ORGANIZATION	hpr	nn	15	SENT_121	[p6l177t843r305b894],
14	(	CD	NUMBER	(	num	15	SENT_121	[p6l334t839r522b907],
15	Table	NNP	O	Table	prep_with	8	SENT_121	[p6l334t839r522b907],
16	2	CD	NUMBER	2	number	17	SENT_121	[p6l551t840r629b907],
17	)	CD	NUMBER	)	dep	15	SENT_121	[p6l551t840r629b907],
18	.	.	O	.	_	0	SENT_121	[p6l551t840r629b907],

1	Thus	RB	O	thus	advmod	18	SENT_122	[p6l656t839r817b902],
2	,	,	O	,	_	0	SENT_122	[p6l656t839r817b902],
3	more	JJR	O	more	quantmod	5	SENT_122	[p6l847t855r1005b894],
4	than	IN	O	than	quantmod	5	SENT_122	[p6l1033t839r1171b894],
5	half	NN	O	half	nsubj	18	SENT_122	[p6l1200t839r1320b894],
6	of	IN	O	of	_	0	SENT_122	[p6l1340t839r1404b894],
7	PIAI/PIAI	NN	O	piai/piai	nn	9	SENT_122	[p6l1425t839r1720b903],
8	homozygous	JJ	O	homozygous	amod	9	SENT_122	[p6l1756t839r2145b908],
9	patients	NNS	O	patient	prep_of	5	SENT_122	[p6l9t929r256b997],
10	and	CC	O	and	_	0	SENT_122	[p6l302t928r414b983],
11	only	RB	O	only	quantmod	12	SENT_122	[p6l460t928r595b997],
12	one	CD	NUMBER	one	num	13	SENT_122	[p6l639t944r748b983],
13	third	JJ	ORDINAL	third	nsubj	18	SENT_122	[p6l794t928r944b983],
14	of	IN	O	of	_	0	SENT_122	[p6l991t928r1055b983],
15	PlA2	NN	O	pla2	nn	17	SENT_122	[p6l1094t928r1228b982],
16	allele	NN	O	allele	nn	17	SENT_122	[p6l1277t928r1438b983],
17	carriers	NNS	O	carrier	prep_of	13	SENT_122	[p6l1485t929r1715b983],
18	presented	VBD	O	present	_	0	SENT_122	[p6l1762t928r2068b997],
19	a	DT	O	a	det	21	SENT_122	[p6l2115t944r2146b983],
20	persistent	JJ	O	persistent	amod	21	SENT_122	[p6l9t1019r314b1086],
21	HPR	NNP	O	HPR	dobj	18	SENT_122	[p6l339t1021r478b1073],
22	.	.	O	.	_	0	SENT_122	[p6l339t1021r478b1073],

1	Crude	NN	O	crude	nsubj	9	SENT_123	[p6l505t1018r684b1073],
2	as	RB	O	as	advmod	1	SENT_123	[p6l709t1033r769b1073],
3	well	RB	O	well	advmod	1	SENT_123	[p6l793t1018r923b1073],
4	as	IN	O	as	_	0	SENT_123	[p6l949t1034r1008b1073],
5	adjusted	VBN	O	adjust	amod	8	SENT_123	[p6l1034t1018r1295b1086],
6	logistic	JJ	O	logistic	amod	8	SENT_123	[p6l1322t1018r1538b1086],
7	regression	NN	O	regression	nn	8	SENT_123	[p6l1563t1019r1879b1086],
8	analysis	NN	O	analysis	prep_as	1	SENT_123	[p6l1904t1018r2145b1086],
9	showed	VBD	O	show	_	0	SENT_123	[p6l10t1106r246b1161],
10	that	IN	O	that	complm	17	SENT_123	[p6l281t1106r404b1161],
11	PIAI/PIAI	NNP	O	PIAI/PIAI	nn	12	SENT_123	[p6l439t1106r734b1170],
12	genotype	NN	O	genotype	nsubj	17	SENT_123	[p6l775t1115r1060b1175],
13	is	VBZ	O	be	cop	17	SENT_123	[p6l1096t1107r1139b1161],
14	an	DT	O	a	det	17	SENT_123	[p6l1175t1122r1247b1161],
15	independent	JJ	O	independent	amod	17	SENT_123	[p6l1283t1106r1673b1175],
16	risk	NN	O	risk	nn	17	SENT_123	[p6l1708t1107r1819b1161],
17	factor	NN	O	factor	ccomp	9	SENT_123	[p6l1853t1106r2028b1161],
18	for	IN	O	for	_	0	SENT_123	[p6l2063t1106r2147b1161],
19	aspirin	NN	O	aspirin	nn	20	SENT_123	[p6l9t1197r217b1264],
20	resistance	NN	O	resistance	prep_for	17	SENT_123	[p6l240t1197r544b1251],
21	leading	VBG	O	lead	partmod	20	SENT_123	[p6l568t1196r792b1264],
22	to	TO	O	to	_	0	SENT_123	[p6l812t1204r871b1251],
23	HPR	NNP	ORGANIZATION	HPR	nn	24	SENT_123	[p6l894t1199r1022b1250],
24	proﬁle	NN	O	proﬁle	prep_to	21	SENT_123	[p6l1043t1196r1240b1264],
25	(	CD	NUMBER	(	num	24	SENT_123	[p6l1268t1196r1455b1264],
26	Table	NNP	O	Table	nn	28	SENT_123	[p6l1268t1196r1455b1264],
27	3	CD	NUMBER	3	num	28	SENT_123	[p6l1477t1196r1557b1264],
28	)	NN	O	)	dep	24	SENT_123	[p6l1477t1196r1557b1264],
29	.	.	O	.	_	0	SENT_123	[p6l1477t1196r1557b1264],

1	Discussion	NN	O	discussion	_	0	SENT_124	[p6l8t1378r351b1432],

1	Platelet	NN	O	platelet	nn	2	SENT_125	[p6l111t1555r341b1610],
2	resistance	NN	O	resistance	nsubj	11	SENT_125	[p6l363t1556r667b1610],
3	to	TO	O	to	_	0	SENT_125	[p6l691t1563r750b1610],
4	aspirin	NN	O	aspirin	nn	6	SENT_125	[p6l774t1556r983b1623],
5	inhibitory	JJ	O	inhibitory	amod	6	SENT_125	[p6l1008t1555r1312b1623],
6	effect	NN	O	effect	prep_to	2	SENT_125	[p6l1334t1555r1502b1610],
7	is	VBZ	O	be	cop	11	SENT_125	[p6l1525t1556r1569b1610],
8	a	DT	O	a	det	11	SENT_125	[p6l1594t1571r1625b1610],
9	well	RB	O	well	advmod	10	SENT_125	[p6l1646t1555r1776b1610],
10	established	VBN	O	establish	amod	11	SENT_125	[p6l1801t1555r2145b1610],
11	feature	NN	O	feature	_	0	SENT_125	[p6l9t1643r224b1698],
12	leading	VBG	O	lead	partmod	11	SENT_125	[p6l266t1643r489b1712],
13	to	TO	O	to	_	0	SENT_125	[p6l529t1651r587b1698],
14	increased	VBN	O	increase	amod	16	SENT_125	[p6l629t1643r919b1698],
15	ischemic	JJ	O	ischemic	amod	16	SENT_125	[p6l961t1643r1229b1698],
16	outcomes	NNS	O	outcome	prep_to	12	SENT_125	[p6l1269t1651r1564b1698],
17	in	IN	O	in	_	0	SENT_125	[p6l1606t1644r1662b1698],
18	cardiovascular	JJ	O	cardiovascular	amod	20	SENT_125	[p6l1703t1643r2147b1698],
19	disease	NN	O	disease	nn	20	SENT_125	[p6l9t1732r229b1787],
20	patients	NNS	O	patient	prep_in	16	SENT_125	[p6l273t1733r533b1801],
21	.	.	O	.	_	0	SENT_125	[p6l273t1733r533b1801],

1	Among	IN	O	among	_	0	SENT_126	[p6l575t1735r796b1801],
2	genetic	JJ	O	genetic	amod	3	SENT_126	[p6l837t1733r1060b1801],
3	polymorphisms	NNS	O	polymorphism	prep_among	34	SENT_126	[p6l1102t1732r1582b1801],
4	suggested	VBD	O	suggest	rcmod	3	SENT_126	[p6l1627t1732r1930b1801],
5	to	TO	O	to	aux	7	SENT_126	[p6l1973t1740r2031b1787],
6	be	VB	O	be	auxpass	7	SENT_126	[p6l2075t1732r2145b1787],
7	implicated	VBN	O	implicate	xcomp	4	SENT_126	[p6l9t1822r343b1890],
8	in	IN	O	in	_	0	SENT_126	[p6l392t1822r449b1876],
9	the	DT	O	the	det	12	SENT_126	[p6l496t1822r595b1877],
10	inadequate	JJ	O	inadequate	amod	12	SENT_126	[p6l644t1822r995b1890],
11	platelet	NN	O	platelet	nn	12	SENT_126	[p6l1043t1822r1283b1890],
12	response	NN	O	response	prep_in	7	SENT_126	[p6l1330t1838r1609b1890],
13	to	TO	O	to	_	0	SENT_126	[p6l1657t1830r1717b1877],
14	aspirin	NN	O	aspirin	prep_to	7	SENT_126	[p6l1765t1823r1995b1890],
15	,	,	O	,	_	0	SENT_126	[p6l1765t1823r1995b1890],
16	PIA	NNP	ORGANIZATION	PIA	nn	17	SENT_126	[p6l2045t1822r2147b1876],
17	polymorphism	NN	O	polymorphism	nsubjpass	34	SENT_126	[p6l9t1911r461b1979],
18	of	IN	O	of	_	0	SENT_126	[p6l481t1911r544b1966],
19	GPlIla	NN	O	gplilum	nn	20	SENT_126	[p6l557t1914r735b1966],
20	subunit	NN	O	subunit	prep_of	17	SENT_126	[p6l755t1911r999b1974],
21	,	,	O	,	_	0	SENT_126	[p6l755t1911r999b1974],
22	a	DT	O	a	det	26	SENT_126	[p6l1020t1927r1051b1966],
23	major	JJ	O	major	amod	26	SENT_126	[p6l1071t1912r1252b1979],
24	platelet	NN	O	platelet	nn	26	SENT_126	[p6l1271t1911r1502b1979],
25	membrane	NN	O	membrane	nn	26	SENT_126	[p6l1521t1911r1853b1966],
26	receptor	NN	O	receptor	appos	20	SENT_126	[p6l1874t1919r2145b1979],
27	,	,	O	,	_	0	SENT_126	[p6l1874t1919r2145b1979],
28	has	VBZ	O	have	aux	34	SENT_126	[p6l9t1999r109b2054],
29	been	VBN	O	be	auxpass	34	SENT_126	[p6l136t1999r283b2054],
30	by	IN	O	by	advmod	34	SENT_126	[p6l310t1999r383b2067],
31	far	RB	O	far	advmod	30	SENT_126	[p6l409t1999r490b2054],
32	the	DT	O	the	dep	33	SENT_126	[p6l515t1999r612b2054],
33	most	RBS	O	most	advmod	34	SENT_126	[p6l640t2007r792b2054],
34	investigated	VBN	O	investigate	_	0	SENT_126	[p6l817t1999r1190b2068],
35	[	RB	O	[	advmod	34	SENT_126	[p6l1221t1999r1354b2068],
36	10	CD	NUMBER	10	num	37	SENT_126	[p6l1221t1999r1354b2068],
37	]	NN	O	]	dobj	34	SENT_126	[p6l1221t1999r1354b2068],
38	.	.	O	.	_	0	SENT_126	[p6l1221t1999r1354b2068],

1	In	IN	O	in	_	0	SENT_127	[p6l1382t2002r1439b2053],
2	the	DT	O	the	det	4	SENT_127	[p6l1465t1999r1563b2054],
3	present	JJ	DATE	present	amod	4	SENT_127	[p6l1591t2007r1822b2068],
4	study	NN	O	study	prep_in	8	SENT_127	[p6l1848t1999r2028b2068],
5	,	,	O	,	_	0	SENT_127	[p6l1848t1999r2028b2068],
6	we	PRP	O	we	nsubj	8	SENT_127	[p6l2055t2015r2145b2054],
7	have	VBP	O	have	aux	8	SENT_127	[p6l9t2088r152b2143],
8	shown	VBN	O	show	_	0	SENT_127	[p6l178t2088r380b2143],
9	that	IN	O	that	complm	25	SENT_127	[p6l404t2088r527b2143],
10	in	IN	O	in	_	0	SENT_127	[p6l550t2089r606b2142],
11	stable	JJ	O	stable	amod	13	SENT_127	[p6l631t2088r809b2143],
12	CAD	NN	O	cad	nn	13	SENT_127	[p6l834t2090r962b2143],
13	patients	NNS	O	patient	prep_in	25	SENT_127	[p6l987t2089r1232b2157],
14	a	DT	O	a	det	16	SENT_127	[p6l1256t2104r1287b2143],
15	persistent	JJ	O	persistent	amod	16	SENT_127	[p6l1312t2089r1617b2157],
16	HPR	NN	ORGANIZATION	hpr	nsubj	25	SENT_127	[p6l1640t2091r1768b2142],
17	assessed	VBN	O	assess	partmod	16	SENT_127	[p6l1790t2088r2049b2143],
18	by	IN	O	by	_	0	SENT_127	[p6l2074t2088r2147b2157],
19	PFA	NN	ORGANIZATION	pfa	nn	21	SENT_127	[p6l9t2180r265b2232],
20	—	CD	NUMBER	—	num	21	SENT_127	[p6l9t2180r265b2232],
21	lOO	NN	O	loo	agent	17	SENT_127	[p6l9t2180r265b2232],
22	is	VBZ	O	be	cop	25	SENT_127	[p6l303t2178r347b2232],
23	signiﬁcantly	RB	O	signiﬁcantly	advmod	25	SENT_127	[p6l386t2177r760b2246],
24	more	RBR	O	more	advmod	25	SENT_127	[p6l796t2193r954b2232],
25	frequent	JJ	O	frequent	ccomp	8	SENT_127	[p6l992t2177r1255b2246],
26	in	IN	O	in	_	0	SENT_127	[p6l1290t2178r1347b2232],
27	homozygous	JJ	O	homozygous	amod	30	SENT_127	[p6l1384t2178r1772b2246],
28	PIAI	NN	O	piaus	nn	30	SENT_127	[p6l1811t2178r1940b2232],
29	allele	NN	O	allele	nn	30	SENT_127	[p6l1985t2177r2145b2232],
30	carriers	NNS	O	carrier	prep_in	25	SENT_127	[p6l9t2267r253b2322],
31	.	.	O	.	_	0	SENT_127	[p6l9t2267r253b2322],

1	Furthermore	RB	O	furthermore	advmod	18	SENT_128	[p6l282t2266r685b2329],
2	,	,	O	,	_	0	SENT_128	[p6l282t2266r685b2329],
3	after	IN	O	after	_	0	SENT_128	[p6l715t2266r857b2321],
4	adjustment	NN	O	adjustment	prep_after	18	SENT_128	[p6l883t2266r1233b2335],
5	to	TO	O	to	_	0	SENT_128	[p6l1259t2274r1317b2321],
6	other	JJ	O	other	amod	8	SENT_128	[p6l1347t2266r1511b2321],
7	cardiovascular	JJ	O	cardiovascular	amod	8	SENT_128	[p6l1537t2266r1981b2321],
8	riskfactors	NNS	O	riskfactor	prep_to	4	SENT_128	[p6l2009t2266r2145b2321, p6l9t2356r235b2419],
9	,	,	O	,	_	0	SENT_128	[p6l2009t2266r2145b2321, p6l9t2356r235b2419],
10	PIAI	NN	O	piaus	nn	12	SENT_128	[p6l286t2356r418b2410],
11	allele	NN	O	allele	nn	12	SENT_128	[p6l473t2356r640b2411],
12	homozygosis	NN	O	homozygosis	nsubj	18	SENT_128	[p6l689t2356r1099b2424],
13	remained	VBD	O	remain	cop	18	SENT_128	[p6l1149t2356r1448b2411],
14	the	DT	O	the	det	18	SENT_128	[p6l1496t2356r1595b2411],
15	only	JJ	O	only	amod	18	SENT_128	[p6l1644t2356r1781b2424],
16	predictive	JJ	O	predictive	amod	18	SENT_128	[p6l1827t2356r2145b2424],
17	independent	JJ	O	independent	amod	18	SENT_128	[p6l9t2445r401b2513],
18	factor	NN	O	factor	_	0	SENT_128	[p6l425t2444r602b2500],
19	for	IN	O	for	_	0	SENT_128	[p6l626t2445r711b2500],
20	HPR	NNP	O	HPR	prep_for	18	SENT_128	[p6l737t2448r876b2500],
21	.	.	O	.	_	0	SENT_128	[p6l737t2448r876b2500],

1	Our	PRP$	O	we	poss	2	SENT_129	[p6l903t2448r1017b2500],
2	results	NNS	O	result	nsubj	11	SENT_129	[p6l1042t2445r1243b2500],
3	are	VBP	O	be	cop	11	SENT_129	[p6l1271t2461r1363b2500],
4	in	IN	O	in	advmod	11	SENT_129	[p6l1391t2446r1447b2499],
5	total	JJ	O	total	amod	6	SENT_129	[p6l1473t2445r1611b2500],
6	accordance	NN	O	accordance	pobj	4	SENT_129	[p6l1637t2445r1980b2500],
7	with	IN	O	with	_	0	SENT_129	[p6l2005t2445r2146b2500],
8	Macchi	NNP	PERSON	Macchi	prep_with	4	SENT_129	[p6l9t2533r226b2588],
9	et	FW	O	et	nn	11	SENT_129	[p6l261t2541r318b2588],
10	al.	FW	O	al.	nn	11	SENT_129	[p6l351t2533r415b2589],
11	[	FW	O	[	dep	26	SENT_129	[p6l454t2533r569b2602],
12	11	CD	NUMBER	11	number	13	SENT_129	[p6l454t2533r569b2602],
13	]	CD	NUMBER	]	num	14	SENT_129	[p6l454t2533r569b2602],
14	study	NN	O	study	dep	11	SENT_129	[p6l608t2533r776b2602],
15	demonstrating	VBG	O	demonstrate	partmod	14	SENT_129	[p6l809t2533r1261b2602],
16	that	IN	O	that	complm	20	SENT_129	[p6l1293t2533r1416b2588],
17	stable	JJ	O	stable	amod	19	SENT_129	[p6l1450t2533r1627b2588],
18	angina	NN	O	angina	nn	19	SENT_129	[p6l1662t2534r1867b2602],
19	patients	NNS	O	patient	dep	20	SENT_129	[p6l1900t2534r2145b2602],
20	homozygous	JJ	O	homozygous	dep	15	SENT_129	[p6l9t2623r397b2691],
21	for	IN	O	for	_	0	SENT_129	[p6l424t2622r509b2677],
22	PIAI	NNP	O	PIAI	nn	23	SENT_129	[p6l533t2623r662b2677],
23	allele	NN	O	allele	prep_for	20	SENT_129	[p6l695t2622r855b2677],
24	were	VBD	O	be	cop	26	SENT_129	[p6l879t2638r1032b2677],
25	less	RBR	O	less	advmod	26	SENT_129	[p6l1058t2623r1167b2677],
26	sensitive	JJ	O	sensitive	_	0	SENT_129	[p6l1194t2623r1460b2677],
27	to	TO	O	to	_	0	SENT_129	[p6l1486t2631r1544b2677],
28	inhibitory	JJ	O	inhibitory	amod	29	SENT_129	[p6l1570t2622r1875b2691],
29	effect	NN	O	effect	prep_to	26	SENT_129	[p6l1898t2622r2066b2677],
30	of	IN	O	of	_	0	SENT_129	[p6l2090t2622r2153b2677],
31	both	CC	O	both	preconj	32	SENT_129	[p6l8t2712r147b2766],
32	low	JJ	O	low	amod	37	SENT_129	[p6l192t2712r305b2766],
33	and	CC	O	and	_	0	SENT_129	[p6l348t2712r458b2766],
34	high	JJ	O	high	conj_and	32	SENT_129	[p6l504t2711r808b2780],
35	—	NN	O	—	nn	37	SENT_129	[p6l504t2711r808b2780],
36	dose	NN	O	dose	nn	37	SENT_129	[p6l504t2711r808b2780],
37	aspirin	NN	O	aspirin	prep_of	29	SENT_129	[p6l853t2712r1062b2780],
38	based	VBN	O	base	partmod	37	SENT_129	[p6l1106t2711r1280b2766],
39	on	IN	O	on	_	0	SENT_129	[p6l1325t2727r1400b2766],
40	PFA	NNP	O	PFA	prep_on	38	SENT_129	[p6l1445t2714r1701b2766],
41	—	CD	NUMBER	—	num	40	SENT_129	[p6l1445t2714r1701b2766],
42	100	CD	NUMBER	100	num	45	SENT_129	[p6l1445t2714r1701b2766],
43	closure	NN	O	closure	nn	45	SENT_129	[p6l1745t2711r1963b2766],
44	time	NN	O	time	nn	45	SENT_129	[p6l2008t2712r2145b2766],
45	determination	NN	O	determination	nsubj	26	SENT_129	[p6l9t2800r468b2854],
46	.	.	O	.	_	0	SENT_129	[p6l9t2800r468b2854],

1	Furthermore	RB	O	furthermore	advmod	13	SENT_130	[p6l516t2800r924b2862],
2	,	,	O	,	_	0	SENT_130	[p6l516t2800r924b2862],
3	different	JJ	O	different	nsubj	13	SENT_130	[p6l972t2800r1240b2854],
4	in	FW	O	in	nn	7	SENT_130	[p6l1285t2801r1338b2854],
5	vitro	FW	O	vitro	dep	7	SENT_130	[p6l1384t2801r1521b2854],
6	functional	JJ	O	functional	amod	7	SENT_130	[p6l1569t2800r1881b2854],
7	studies	NNS	O	study	advmod	8	SENT_130	[p6l1928t2800r2144b2854],
8	involving	VBG	O	involve	partmod	3	SENT_130	[p6l9t2888r296b2956],
9	healthy	JJ	O	healthy	amod	10	SENT_130	[p6l311t2888r541b2956],
10	subjects	NNS	O	subject	dobj	8	SENT_130	[p6l555t2888r800b2956],
11	have	VBP	O	have	aux	13	SENT_130	[p6l817t2888r960b2943],
12	well	RB	O	well	advmod	13	SENT_130	[p6l975t2888r1105b2943],
13	established	VBN	O	establish	_	0	SENT_130	[p6l1121t2888r1465b2943],
14	that	IN	O	that	complm	22	SENT_130	[p6l1481t2888r1604b2943],
15	platelets	NNS	O	platelet	nsubj	22	SENT_130	[p6l1619t2888r1877b2956],
16	carrying	VBG	O	carry	partmod	15	SENT_130	[p6l1894t2889r2147b2956],
17	PlA2	NN	O	pla2	nn	18	SENT_130	[p6l9t2976r144b3031],
18	allele	NN	O	allele	dobj	16	SENT_130	[p6l176t2976r336b3031],
19	were	VBD	O	be	cop	22	SENT_130	[p6l365t2992r518b3031],
20	much	RB	O	much	advmod	22	SENT_130	[p6l548t2976r719b3031],
21	more	RBR	O	more	advmod	22	SENT_130	[p6l750t2992r908b3031],
22	sensitive	JJ	O	sensitive	ccomp	13	SENT_130	[p6l939t2977r1206b3031],
23	to	TO	O	to	_	0	SENT_130	[p6l1235t2984r1293b3031],
24	aspirin	NN	O	aspirin	nn	25	SENT_130	[p6l1324t2977r1533b3045],
25	inhibition	NN	O	inhibition	prep_to	22	SENT_130	[p6l1563t2976r1862b3031],
26	[	CD	NUMBER	[	number	27	SENT_130	[p6l1895t2976r2144b3045],
27	12	CD	NUMBER	12	dep	25	SENT_130	[p6l1895t2976r2144b3045],
28	—	CD	NUMBER	—	num	30	SENT_130	[p6l1895t2976r2144b3045],
29	l4	NN	O	l4	nn	30	SENT_130	[p6l1895t2976r2144b3045],
30	]	NN	O	]	dep	27	SENT_130	[p6l1895t2976r2144b3045],
31	.	.	O	.	_	0	SENT_130	[p6l1895t2976r2144b3045],

1	However	RB	O	however	advmod	43	SENT_131	[p6l10t3068r301b3128],
2	,	,	O	,	_	0	SENT_131	[p6l10t3068r301b3128],
3	other	JJ	O	other	amod	4	SENT_131	[p6l319t3065r484b3120],
4	studies	NNS	O	study	nsubj	43	SENT_131	[p6l500t3065r714b3120],
5	evaluating	VBG	O	evaluate	partmod	4	SENT_131	[p6l733t3065r1054b3134],
6	the	DT	O	the	det	7	SENT_131	[p6l1069t3065r1167b3120],
7	relationship	NN	O	relationship	dobj	5	SENT_131	[p6l1185t3065r1552b3134],
8	between	IN	O	between	_	0	SENT_131	[p6l1569t3065r1834b3120],
9	GPllIa	NNP	O	GPllIa	nn	10	SENT_131	[p6l1853t3068r2030b3120],
10	PIA	NNP	O	PIA	prep_between	7	SENT_131	[p6l2047t3065r2148b3119],
11	polymorphism	NN	O	polymorphism	nsubj	18	SENT_131	[p6l9t3154r461b3223],
12	and	CC	O	and	_	0	SENT_131	[p6l493t3155r604b3209],
13	platelet	NN	O	platelet	nn	15	SENT_131	[p6l638t3155r870b3223],
14	functional	JJ	O	functional	amod	15	SENT_131	[p6l901t3154r1210b3209],
15	reactivity	NN	O	reactivity	nsubj	18	SENT_131	[p6l1243t3155r1532b3223],
16	had	VBD	O	have	aux	18	SENT_131	[p6l1564t3154r1674b3209],
17	clearly	RB	O	clearly	advmod	18	SENT_131	[p6l1708t3154r1911b3223],
18	shown	VBN	O	show	rcmod	10	SENT_131	[p6l1943t3154r2146b3209],
19	that	IN	O	that	complm	25	SENT_131	[p6l9t3243r131b3298],
20	human	JJ	O	human	amod	21	SENT_131	[p6l151t3244r365b3298],
21	platelets	NNS	O	platelet	nsubj	25	SENT_131	[p6l385t3243r644b3312],
22	with	IN	O	with	_	0	SENT_131	[p6l663t3244r804b3298],
23	PlA2	NN	O	pla2	nn	24	SENT_131	[p6l824t3244r959b3298],
24	allele	NN	O	allele	prep_with	21	SENT_131	[p6l981t3243r1141b3298],
25	exhibited	VBD	O	exhibit	ccomp	18	SENT_131	[p6l1162t3243r1449b3298],
26	an	DT	O	a	det	28	SENT_131	[p6l1470t3259r1542b3298],
27	increased	VBN	O	increase	amod	28	SENT_131	[p6l1562t3243r1852b3298],
28	response	NN	O	response	nsubj	32	SENT_131	[p6l1874t3259r2146b3312],
29	to	TO	O	to	_	0	SENT_131	[p6l9t3341r67b3388],
30	various	JJ	O	various	amod	31	SENT_131	[p6l85t3334r308b3388],
31	agonists	NNS	O	agonist	prep_to	28	SENT_131	[p6l328t3334r577b3401],
32	[	VBP	O	[	ccomp	25	SENT_131	[p6l600t3333r676b3401],
33	6	CD	NUMBER	6	num	34	SENT_131	[p6l600t3333r676b3401],
34	]	NN	O	]	dobj	32	SENT_131	[p6l600t3333r676b3401],
35	and	CC	O	and	_	0	SENT_131	[p6l699t3333r810b3388],
36	were	VBD	O	be	cop	37	SENT_131	[p6l828t3349r981b3388],
37	able	JJ	O	able	ccomp	25	SENT_131	[p6l1001t3333r1125b3388],
38	to	TO	O	to	aux	39	SENT_131	[p6l1144t3341r1202b3388],
39	produce	VB	O	produce	xcomp	37	SENT_131	[p6l1223t3333r1471b3401],
40	higher	JJR	O	higher	amod	42	SENT_131	[p6l1491t3333r1690b3401],
41	TxA2	NN	O	txa2	nn	42	SENT_131	[p6l1704t3335r1858b3387],
42	amounts	NNS	O	amount	dobj	39	SENT_131	[p6l1880t3341r2145b3388],
43	[	VBP	O	[	_	0	SENT_131	[p6l12t3422r145b3490],
44	15	CD	NUMBER	15	number	45	SENT_131	[p6l12t3422r145b3490],
45	]	CD	NUMBER	]	dobj	43	SENT_131	[p6l12t3422r145b3490],
46	.	.	O	.	_	0	SENT_131	[p6l12t3422r145b3490],

1	Thus	RB	O	thus	advmod	6	SENT_132	[p6l179t3422r340b3485],
2	,	,	O	,	_	0	SENT_132	[p6l179t3422r340b3485],
3	aspirin	NN	O	aspirin	nn	4	SENT_132	[p6l377t3423r585b3490],
4	intake	NN	O	intake	nsubj	6	SENT_132	[p6l622t3422r809b3477],
5	may	MD	O	may	aux	6	SENT_132	[p6l846t3438r976b3490],
6	induce	VB	O	induce	_	0	SENT_132	[p6l1011t3422r1214b3477],
7	a	DT	O	a	det	11	SENT_132	[p6l1250t3438r1281b3477],
8	more	RBR	O	more	advmod	9	SENT_132	[p6l1317t3438r1474b3477],
9	pronounced	JJ	O	pronounced	amod	11	SENT_132	[p6l1511t3422r1879b3490],
10	platelet	NN	O	platelet	nn	11	SENT_132	[p6l1915t3422r2147b3490],
11	inhibition	NN	O	inhibition	dobj	6	SENT_132	[p6l10t3510r309b3565],
12	due	JJ	O	due	_	0	SENT_132	[p6l333t3510r445b3565],
13	to	TO	O	to	_	0	SENT_132	[p6l469t3518r528b3565],
14	a	DT	O	a	det	16	SENT_132	[p6l553t3526r584b3565],
15	higher	JJR	O	higher	amod	16	SENT_132	[p6l609t3510r807b3579],
16	sensitivity	NN	O	sensitivity	prep_due_to	11	SENT_132	[p6l831t3511r1146b3579],
17	of	IN	O	of	_	0	SENT_132	[p6l1168t3510r1232b3565],
18	PlA2	NN	O	pla2	nn	20	SENT_132	[p6l1249t3510r1384b3565],
19	positive	JJ	O	positive	amod	20	SENT_132	[p6l1412t3511r1651b3579],
20	platelets	NNS	O	platelet	prep_of	16	SENT_132	[p6l1676t3510r1951b3579],
21	.	.	O	.	_	0	SENT_132	[p6l1676t3510r1951b3579],

1	However	RB	O	however	advmod	6	SENT_133	[p6l1977t3514r2145b3565, p6l9t3615r154b3662],
2	,	,	O	,	_	0	SENT_133	[p6l1977t3514r2145b3565, p6l9t3615r154b3662],
3	this	DT	O	this	nsubjpass	11	SENT_133	[p6l197t3599r307b3654],
4	is	VBZ	O	be	cop	6	SENT_133	[p6l351t3600r395b3654],
5	highly	RB	O	highly	advmod	6	SENT_133	[p6l439t3599r631b3668],
6	speculative	JJ	O	speculative	_	0	SENT_133	[p6l673t3599r1016b3668],
7	and	CC	O	and	_	0	SENT_133	[p6l1058t3599r1169b3654],
8	can	MD	O	can	aux	11	SENT_133	[p6l1212t3607r1421b3654],
9	not	RB	O	not	neg	11	SENT_133	[p6l1212t3607r1421b3654],
10	be	VB	O	be	auxpass	11	SENT_133	[p6l1461t3599r1531b3654],
11	inferred	VBN	O	infer	conj_and	6	SENT_133	[p6l1575t3599r1818b3654],
12	from	IN	O	from	_	0	SENT_133	[p6l1861t3599r2007b3654],
13	the	DT	O	the	det	15	SENT_133	[p6l2048t3599r2145b3654],
14	different	JJ	O	different	amod	15	SENT_133	[p6l9t3688r274b3742],
15	data	NNS	O	datum	prep_from	11	SENT_133	[p6l299t3688r430b3742],
16	available	JJ	O	available	amod	15	SENT_133	[p6l456t3688r725b3742],
17	in	IN	O	in	_	0	SENT_133	[p6l753t3689r809b3741],
18	the	DT	O	the	det	19	SENT_133	[p6l835t3688r931b3742],
19	literature	NN	O	literature	prep_in	16	SENT_133	[p6l959t3688r1258b3742],
20	.	.	O	.	_	0	SENT_133	[p6l959t3688r1258b3742],

1	Thus	RB	O	thus	advmod	5	SENT_134	[p6l1283t3688r1444b3750],
2	,	,	O	,	_	0	SENT_134	[p6l1283t3688r1444b3750],
3	our	PRP$	O	we	poss	4	SENT_134	[p6l1472t3703r1576b3742],
4	results	NNS	O	result	nsubj	5	SENT_134	[p6l1601t3688r1802b3742],
5	are	VBP	O	be	_	0	SENT_134	[p6l1830t3703r1923b3742],
6	in	IN	O	in	_	0	SENT_134	[p6l1950t3689r2006b3741],
7	disTable	JJ	O	distable	prep_in	5	SENT_134	[p6l2033t3688r2145b3742, p7l6t119r144b162],

1	3	CD	NUMBER	3	num	3	SENT_135	[p7l162t121r191b162],
2	Risk	NN	O	risk	nn	3	SENT_135	[p7l9t190r109b234],
3	Factors	NNS	O	factor	_	0	SENT_135	[p7l128t193r300b234],
4	predicting	VBG	O	predict	partmod	3	SENT_135	[p7l321t190r573b244],
5	residual	JJ	O	residual	amod	7	SENT_135	[p7l592t190r786b234],
6	platelet	NN	O	platelet	nn	7	SENT_135	[p7l807t190r992b244],
7	reactivity	NN	O	reactivity	dobj	4	SENT_135	[p7l1011t191r1243b244],
8	despite	IN	O	despite	_	0	SENT_135	[p7l1261t190r1438b244],
9	aspirin	NN	O	aspirin	nn	10	SENT_135	[p7l1458t191r1625b244],
10	therapy	NN	O	therapy	prep_despite	4	SENT_135	[p7l1645t190r1846b244],
11	.	.	O	.	_	0	SENT_135	[p7l1645t190r1846b244],

1	Variables	NNP	O	Variables	nn	3	SENT_136	[p7l57t328r284b372],
2	Crude	NNP	O	Crude	nn	3	SENT_136	[p7l730t328r874b372],
3	Adjusted	NNP	O	Adjusted	_	0	SENT_136	[p7l1453t328r1672b382],

1	OR	NN	O	or	_	0	SENT_137	[p7l730t469r801b510],
2	IC95	CD	PERCENT	ic95	num	3	SENT_137	[p7l914t469r1055b510],
3	%	NN	PERCENT	%	dep	1	SENT_137	[p7l914t469r1055b510],
4	P	NN	O	p	nn	10	SENT_137	[p7l1195t469r1223b510],
5	value	NN	O	value	nn	10	SENT_137	[p7l1242t467r1373b510],
6	OR	NN	O	or	nn	10	SENT_137	[p7l1456t469r1526b510],
7	lC95	CD	PERCENT	lc95	num	10	SENT_137	[p7l1639t469r1780b510],
8	%	NN	PERCENT	%	nn	10	SENT_137	[p7l1639t469r1780b510],
9	P	NN	O	p	nn	10	SENT_137	[p7l1920t469r1948b510],
10	value	NN	O	value	dep	1	SENT_137	[p7l1967t467r2099b510],

1	Age	NNP	O	Age	dep	7	SENT_138	[p7l57t608r149b660],
2	>	JJR	O	>	dep	1	SENT_138	[p7l171t617r207b648],
3	65	CD	DURATION	65	num	4	SENT_138	[p7l218t608r274b649],
4	years	NNS	NUMBER	year	dep	7	SENT_138	[p7l292t618r421b660],
5	1.1	CD	NUMBER	1.1	num	7	SENT_138	[p7l733t608r795b650],
6	0.59-2	CD	NUMBER	0.59-2	num	7	SENT_138	[p7l914t608r1106b650],
7	.1	NN	NUMBER	.1	dep	13	SENT_138	[p7l914t608r1106b650],
8	0.70	CD	NUMBER	0.70	number	9	SENT_138	[p7l1195t608r1297b650],
9	—	CD	NUMBER	—	dep	7	SENT_138	[p7l1456t631r1474b636],
10	—	NN	O	—	dep	9	SENT_138	[p7l1639t631r1657b636],
11	—	CD	NUMBER	—	num	10	SENT_138	[p7l1920t631r1938b637],
12	Female	JJ	O	female	amod	13	SENT_138	[p7l59t678r232b722],
13	1.2	CD	NUMBER	1.2	dep	32	SENT_138	[p7l733t680r800b722],
14	0.46-3	CD	NUMBER	0.46-3	num	15	SENT_138	[p7l914t680r1107b722],
15	.1	NN	NUMBER	.1	dep	13	SENT_138	[p7l914t680r1107b722],
16	0.69	CD	NUMBER	0.69	dep	15	SENT_138	[p7l1195t681r1297b722],
17	-	:	O	-	_	0	SENT_138	[p7l1456t704r1474b709],
18	-	:	O	-	_	0	SENT_138	[p7l1639t704r1657b709],
19	—	CD	NUMBER	—	num	20	SENT_138	[p7l1920t704r1938b709],
20	Hypertension	NN	O	hypertension	dep	28	SENT_138	[p7l59t750r393b804],
21	0.52	CD	NUMBER	0.52	num	22	SENT_138	[p7l730t752r831b793],
22	0.26-1	CD	NUMBER	0.26-1	dep	20	SENT_138	[p7l914t752r1113b793],
23	.0	CD	NUMBER	.0	number	24	SENT_138	[p7l914t752r1113b793],
24	0.065	CD	NUMBER	0.065	dep	20	SENT_138	[p7l1195t752r1326b793],
25	0.39	CD	NUMBER	0.39	num	26	SENT_138	[p7l1455t752r1557b793],
26	0.28-1	CD	NUMBER	0.28-1	dep	24	SENT_138	[p7l1639t752r1838b793],
27	.0	CD	NUMBER	.0	num	28	SENT_138	[p7l1639t752r1838b793],
28	0.066	CD	NUMBER	0.066	dep	15	SENT_138	[p7l1920t752r2053b793],
29	Diabetes	NNP	O	Diabetes	prep	28	SENT_138	[p7l59t822r269b865],
30	0.68	CD	NUMBER	0.68	num	31	SENT_138	[p7l730t824r831b866],
31	0.37-1	CD	NUMBER	0.37-1	dep	29	SENT_138	[p7l914t824r1111b866],
32	.2	NN	NUMBER	.2	dep	36	SENT_138	[p7l914t824r1111b866],
33	0.22	CD	NUMBER	0.22	num	32	SENT_138	[p7l1195t824r1296b866],
34	0.86	CD	NUMBER	0.86	num	36	SENT_138	[p7l1455t824r1558b866],
35	0.40-1	CD	NUMBER	0.40-1	num	36	SENT_138	[p7l1639t824r1836b866],
36	.3	NN	NUMBER	.3	dep	41	SENT_138	[p7l1639t824r1836b866],
37	0.35	CD	NUMBER	0.35	num	38	SENT_138	[p7l1920t824r2020b866],
38	Dyslipidemia	NNP	O	Dyslipidemia	dep	36	SENT_138	[p7l59t893r382b948],
39	0.62	CD	NUMBER	0.62	num	38	SENT_138	[p7l730t895r831b937],
40	0.32-1	CD	NUMBER	0.32-1	num	41	SENT_138	[p7l914t895r1111b937],
41	.2	NN	NUMBER	.2	dep	44	SENT_138	[p7l914t895r1111b937],
42	0.14	CD	NUMBER	0.14	num	43	SENT_138	[p7l1195t895r1298b937],
43	0.62	CD	NUMBER	0.62	dep	41	SENT_138	[p7l1455t895r1556b937],
44	0.33-1	CD	NUMBER	0.33-1	dep	45	SENT_138	[p7l1639t895r1837b937],
45	.2	NN	NUMBER	.2	dep	48	SENT_138	[p7l1639t895r1837b937],
46	0.198	CD	NUMBER	0.198	num	45	SENT_138	[p7l1920t895r2052b937],
47	Prior	JJ	O	prior	amod	48	SENT_138	[p7l59t966r178b1009],
48	MI	NNP	O	MI	dep	69	SENT_138	[p7l197t968r260b1009],
49	0.86	CD	NUMBER	0.86	num	50	SENT_138	[p7l730t968r832b1010],
50	0.46-1	CD	NUMBER	0.46-1	dep	48	SENT_138	[p7l914t968r1113b1010],
51	.6	CD	NUMBER	.6	number	52	SENT_138	[p7l914t968r1113b1010],
52	0.64	CD	NUMBER	0.64	amod	50	SENT_138	[p7l1195t968r1298b1010],
53	-	:	O	-	_	0	SENT_138	[p7l1456t991r1474b996],
54	-	:	O	-	_	0	SENT_138	[p7l1639t991r1657b996],
55	Prior	JJ	O	prior	dep	56	SENT_138	[p7l1920t991r1938b996, p7l59t1039r178b1081],
56	PCI	NN	O	pcus	dep	52	SENT_138	[p7l197t1040r272b1081],
57	1.06	CD	NUMBER	1.06	number	58	SENT_138	[p7l733t1040r832b1082],
58	0.53-2	CD	NUMBER	0.53-2	num	59	SENT_138	[p7l914t1040r1107b1082],
59	.1	NN	NUMBER	.1	dep	56	SENT_138	[p7l914t1040r1107b1082],
60	0.85	CD	NUMBER	0.85	amod	59	SENT_138	[p7l1195t1040r1295b1082],
61	-	:	O	-	_	0	SENT_138	[p7l1456t1064r1474b1069],
62	-	:	O	-	_	0	SENT_138	[p7l1639t1064r1657b1069],
63	CHF	NN	O	chf	dep	50	SENT_138	[p7l1920t1064r1938b1069, p7l59t1112r157b1154],
64	0.43	CD	NUMBER	0.43	num	63	SENT_138	[p7l730t1112r830b1154],
65	0.15-1	CD	NUMBER	0.15-1	num	66	SENT_138	[p7l914t1112r1111b1154],
66	.2	NN	NUMBER	.2	dep	63	SENT_138	[p7l914t1112r1111b1154],
67	0.12	CD	NUMBER	0.12	dep	66	SENT_138	[p7l1195t1112r1296b1154],
68	0.52	CD	NUMBER	0.52	num	69	SENT_138	[p7l1455t1112r1556b1154],
69	0.17-1	CD	NUMBER	0.17-1	dep	75	SENT_138	[p7l1639t1112r1837b1154],
70	.2	NN	NUMBER	.2	nn	73	SENT_138	[p7l1639t1112r1837b1154],
71	0.169	CD	NUMBER	0.169	num	73	SENT_138	[p7l1920t1112r2053b1154],
72	PLA1/A1	NN	O	pla1/a1	nn	73	SENT_138	[p7l59t1184r260b1233],
73	polymorphism	NN	O	polymorphism	dep	69	SENT_138	[p7l286t1182r648b1236],
74	2.07	CD	NUMBER	2.07	num	75	SENT_138	[p7l730t1184r831b1226],
75	1.1-3	CD	NUMBER	1.1-3	dep	81	SENT_138	[p7l948t1184r1112b1226],
76	.7	CD	NUMBER	.7	number	77	SENT_138	[p7l948t1184r1112b1226],
77	0.015	CD	NUMBER	0.015	dep	75	SENT_138	[p7l1195t1184r1326b1226],
78	2.07	CD	NUMBER	2.07	num	79	SENT_138	[p7l1455t1184r1557b1226],
79	1.14-3	CD	NUMBER	1.14-3	dep	77	SENT_138	[p7l1642t1184r1837b1226],
80	.7	CD	NUMBER	.7	num	81	SENT_138	[p7l1642t1184r1837b1226],
81	0.016	CD	NUMBER	0.016	_	0	SENT_138	[p7l1920t1184r2053b1226],

1	MI	NNP	O	MI	_	0	SENT_139	[p7l9t1323r86b1365],
2	:	:	O	:	_	0	SENT_139	[p7l9t1323r86b1365],
3	myocardial	JJ	O	myocardial	amod	4	SENT_139	[p7l114t1321r386b1375],
4	infarction	NN	O	infarction	dep	1	SENT_139	[p7l411t1321r662b1371],
5	;	:	O	;	_	0	SENT_139	[p7l411t1321r662b1371],
6	PCI	NNP	O	PCI	dep	1	SENT_139	[p7l690t1323r780b1365],
7	:	:	O	:	_	0	SENT_139	[p7l690t1323r780b1365],
8	percutaneous	JJ	O	percutaneous	amod	10	SENT_139	[p7l808t1327r1139b1375],
9	coronary	JJ	O	coronary	amod	10	SENT_139	[p7l1163t1333r1382b1375],
10	intervention	NN	O	intervention	dep	6	SENT_139	[p7l1405t1321r1724b1371],
11	;	:	O	;	_	0	SENT_139	[p7l1405t1321r1724b1371],
12	CHF	NNP	O	CHF	dep	10	SENT_139	[p7l1752t1323r1862b1365],
13	:	:	O	:	_	0	SENT_139	[p7l1752t1323r1862b1365],
14	congestive	JJ	O	congestive	amod	16	SENT_139	[p7l1890t1321r2149b1375],
15	heart	NN	O	heart	nn	16	SENT_139	[p7l9t1393r137b1437],
16	failure	NN	O	failure	dep	6	SENT_139	[p7l156t1393r323b1437],
17	.	.	O	.	_	0	SENT_139	[p7l156t1393r323b1437],

1	crepancy	NN	O	crepancy	_	0	SENT_140	[p7l10t1606r288b1659],
2	with	IN	O	with	_	0	SENT_140	[p7l312t1590r453b1645],
3	previous	JJ	O	previous	amod	5	SENT_140	[p7l481t1591r743b1659],
4	published	VBN	O	publish	amod	5	SENT_140	[p7l773t1590r1072b1659],
5	studies	NNS	O	study	nsubj	6	SENT_140	[p7l1102t1591r1316b1645],
6	showing	VBG	O	show	prepc_with	1	SENT_140	[p7l1346t1591r1607b1659],
7	that	IN	O	that	complm	13	SENT_140	[p7l1633t1591r1756b1645],
8	PlA1	NN	O	pla1	nn	10	SENT_140	[p7l1782t1590r1911b1645],
9	homozygous	JJ	O	homozygous	amod	10	SENT_140	[p7l1948t1591r2149b1645, p7l11t1695r220b1748],
10	platelets	NNS	O	platelet	nsubj	13	SENT_140	[p7l245t1679r504b1748],
11	were	VBD	O	be	cop	13	SENT_140	[p7l527t1695r681b1734],
12	more	RBR	O	more	advmod	13	SENT_140	[p7l706t1695r864b1734],
13	sensitive	JJ	O	sensitive	ccomp	6	SENT_140	[p7l888t1680r1155b1734],
14	to	TO	O	to	_	0	SENT_140	[p7l1179t1687r1238b1734],
15	aspirin	NN	O	aspirin	nn	17	SENT_140	[p7l1262t1680r1471b1748],
16	inhibitory	JJ	O	inhibitory	amod	17	SENT_140	[p7l1495t1679r1800b1748],
17	effect	NN	O	effect	prep_to	13	SENT_140	[p7l1822t1679r1990b1734],
18	than	IN	O	than	_	0	SENT_140	[p7l2012t1679r2150b1734],
19	platelets	NNS	O	platelet	prep_than	17	SENT_140	[p7l11t1769r270b1837],
20	carrying	VBG	O	carry	partmod	19	SENT_140	[p7l287t1770r540b1837],
21	PlA2	NN	O	pla2	nn	22	SENT_140	[p7l556t1769r691b1823],
22	allele	NN	O	allele	dobj	20	SENT_140	[p7l710t1769r870b1824],
23	[	CD	NUMBER	[	number	24	SENT_140	[p7l890t1769r1023b1837],
24	16	CD	NUMBER	16	num	25	SENT_140	[p7l890t1769r1023b1837],
25	]	NN	O	]	dep	22	SENT_140	[p7l890t1769r1023b1837],
26	.	.	O	.	_	0	SENT_140	[p7l890t1769r1023b1837],

1	On	IN	O	on	_	0	SENT_141	[p7l1041t1772r1126b1824],
2	the	DT	O	the	det	4	SENT_141	[p7l1142t1769r1239b1824],
3	other	JJ	O	other	amod	4	SENT_141	[p7l1257t1769r1421b1824],
4	hand	NN	O	hand	prep_on	10	SENT_141	[p7l1437t1769r1604b1832],
5	,	,	O	,	_	0	SENT_141	[p7l1437t1769r1604b1832],
6	two	CD	NUMBER	two	num	8	SENT_141	[p7l1621t1777r1737b1824],
7	other	JJ	O	other	amod	8	SENT_141	[p7l1755t1769r1920b1824],
8	studies	NNS	O	study	nsubj	10	SENT_141	[p7l1936t1769r2149b1824],
9	have	VBP	O	have	aux	10	SENT_141	[p7l11t1858r154b1913],
10	found	VBN	O	find	_	0	SENT_141	[p7l188t1858r365b1913],
11	no	DT	O	no	det	12	SENT_141	[p7l400t1874r474b1913],
12	relationship	NN	O	relationship	dobj	10	SENT_141	[p7l509t1858r876b1926],
13	between	IN	O	between	_	0	SENT_141	[p7l909t1858r1174b1913],
14	GPIIIa	NN	O	gpiium	nn	16	SENT_141	[p7l1209t1860r1387b1913],
15	PlA	NN	O	plum	nn	16	SENT_141	[p7l1420t1858r1521b1912],
16	polymorphism	NN	O	polymorphism	prep_between	12	SENT_141	[p7l1552t1858r2005b1926],
17	and	CC	O	and	_	0	SENT_141	[p7l2038t1858r2149b1913],
18	inadequate	JJ	O	inadequate	amod	19	SENT_141	[p7l11t1946r352b2015],
19	response	NN	O	response	prep_between	12	SENT_141	[p7l394t1962r666b2015],
20	to	TO	O	to	_	0	SENT_141	[p7l708t1954r766b2001],
21	aspirin	NN	O	aspirin	nn	22	SENT_141	[p7l808t1947r1018b2015],
22	treatment	NN	O	treatment	prep_to	10	SENT_141	[p7l1058t1954r1367b2001],
23	detected	VBN	O	detect	partmod	22	SENT_141	[p7l1407t1946r1669b2001],
24	with	IN	O	with	_	0	SENT_141	[p7l1710t1946r1852b2001],
25	PFA	NN	O	pfa	nn	26	SENT_141	[p7l1894t1949r2150b2001],
26	—	NN	O	—	prep_with	23	SENT_141	[p7l1894t1949r2150b2001],
27	100	CD	NUMBER	100	num	28	SENT_141	[p7l1894t1949r2150b2001],
28	method	NN	O	method	dep	26	SENT_141	[p7l11t2035r247b2090],
29	and	CC	O	and	cc	30	SENT_141	[p7l264t2035r375b2090],
30	more	JJR	O	more	num	37	SENT_141	[p7l394t2051r552b2090],
31	classical	JJ	O	classical	amod	37	SENT_141	[p7l569t2035r816b2090],
32	optical	JJ	O	optical	amod	37	SENT_141	[p7l834t2035r1038b2104],
33	platelet	NN	O	platelet	nn	37	SENT_141	[p7l1055t2035r1287b2104],
34	aggregation	NN	O	aggregation	nn	37	SENT_141	[p7l1302t2036r1665b2104],
35	[	CD	NUMBER	[	number	36	SENT_141	[p7l1685t2035r1872b2104],
36	8,17	CD	NUMBER	8,17	num	37	SENT_141	[p7l1685t2035r1872b2104],
37	]	NN	O	]	dep	28	SENT_141	[p7l1685t2035r1872b2104],
38	.	.	O	.	_	0	SENT_141	[p7l1685t2035r1872b2104],

1	This	DT	O	this	det	2	SENT_142	[p7l1887t2035r2013b2090],
2	lack	NN	O	lack	nsubjpass	14	SENT_142	[p7l2031t2035r2152b2090],
3	of	IN	O	of	_	0	SENT_142	[p7l10t2124r74b2179],
4	consistency	NN	O	consistency	prep_of	2	SENT_142	[p7l106t2125r463b2193],
5	between	IN	O	between	_	0	SENT_142	[p7l501t2124r767b2179],
6	all	DT	O	all	dep	8	SENT_142	[p7l806t2124r875b2179],
7	these	DT	O	these	det	8	SENT_142	[p7l916t2124r1078b2179],
8	studies	NNS	O	study	prep_between	4	SENT_142	[p7l1119t2124r1333b2179],
9	and	CC	O	and	_	0	SENT_142	[p7l1374t2124r1485b2179],
10	our	PRP$	O	we	poss	11	SENT_142	[p7l1526t2140r1629b2179],
11	results	NNS	O	result	prep_between	4	SENT_142	[p7l1668t2124r1870b2179],
12	may	MD	O	may	aux	14	SENT_142	[p7l1911t2140r2042b2193],
13	be	VB	O	be	auxpass	14	SENT_142	[p7l2079t2125r2149b2179],
14	explained	VBN	O	explain	_	0	SENT_142	[p7l10t2214r310b2282],
15	by	IN	O	by	_	0	SENT_142	[p7l327t2214r401b2282],
16	major	JJ	O	major	amod	17	SENT_142	[p7l417t2215r597b2282],
17	differences	NNS	O	difference	agent	14	SENT_142	[p7l612t2214r947b2269],
18	concerning	VBG	O	concern	prep	14	SENT_142	[p7l965t2215r1306b2282],
19	ﬁrst	IN	O	ﬁrst	pcomp	18	SENT_142	[p7l1323t2214r1443b2269],
20	the	DT	O	the	det	22	SENT_142	[p7l1459t2214r1556b2269],
21	studied	VBN	O	study	amod	22	SENT_142	[p7l1575t2214r1799b2269],
22	population	NN	O	population	pobj	19	SENT_142	[p7l1817t2214r2150b2282],
23	with	IN	O	with	_	0	SENT_142	[p7l9t2303r150b2358],
24	various	JJ	O	various	amod	26	SENT_142	[p7l176t2304r400b2358],
25	clinical	JJ	O	clinical	amod	26	SENT_142	[p7l429t2303r643b2358],
26	settings	NNS	O	setting	prep_with	22	SENT_142	[p7l673t2304r908b2371],
27	and	CC	O	and	_	0	SENT_142	[p7l937t2303r1064b2366],
28	,	,	O	,	_	0	SENT_142	[p7l937t2303r1064b2366],
29	second	JJ	ORDINAL	second	dep	26	SENT_142	[p7l1094t2303r1320b2366],
30	,	,	O	,	_	0	SENT_142	[p7l1094t2303r1320b2366],
31	the	DT	O	the	det	33	SENT_142	[p7l1349t2303r1446b2358],
32	experimental	JJ	O	experimental	amod	33	SENT_142	[p7l1474t2303r1884b2371],
33	method	NN	O	method	prep_with	22	SENT_142	[p7l1913t2303r2150b2358],
34	used	VBN	O	use	partmod	22	SENT_142	[p7l10t2391r154b2446],
35	to	TO	O	to	aux	36	SENT_142	[p7l201t2399r260b2446],
36	detect	VB	O	detect	xcomp	34	SENT_142	[p7l308t2391r501b2446],
37	aspirin	NN	O	aspirin	nn	38	SENT_142	[p7l547t2392r761b2460],
38	responsiveness	NN	O	responsiveness	dobj	36	SENT_142	[p7l808t2392r1299b2460],
39	.	.	O	.	_	0	SENT_142	[p7l808t2392r1299b2460],

1	The	DT	O	the	det	2	SENT_143	[p7l1345t2391r1458b2446],
2	later	JJ	O	later	nsubj	5	SENT_143	[p7l1506t2391r1649b2446],
3	is	VBZ	O	be	cop	5	SENT_143	[p7l1695t2392r1739b2446],
4	particularly	RB	O	particularly	advmod	5	SENT_143	[p7l1788t2391r2152b2460],
5	important	JJ	O	important	_	0	SENT_143	[p7l11t2481r321b2549],
6	since	IN	O	since	mark	11	SENT_143	[p7l348t2481r500b2535],
7	we	PRP	O	we	nsubj	11	SENT_143	[p7l526t2496r617b2535],
8	and	CC	O	and	_	0	SENT_143	[p7l645t2480r756b2535],
9	others	NNS	O	other	conj_and	7	SENT_143	[p7l785t2480r976b2535],
10	have	VBP	O	have	aux	11	SENT_143	[p7l1005t2480r1148b2535],
11	shown	VBN	O	show	advcl	5	SENT_143	[p7l1176t2480r1379b2535],
12	the	DT	O	the	det	13	SENT_143	[p7l1407t2480r1503b2535],
13	lack	NN	O	lack	dobj	11	SENT_143	[p7l1532t2480r1653b2535],
14	of	IN	O	of	_	0	SENT_143	[p7l1679t2480r1742b2535],
15	concordance	NN	O	concordance	prep_of	13	SENT_143	[p7l1762t2480r2149b2535],
16	between	IN	O	between	_	0	SENT_143	[p7l10t2570r275b2625],
17	these	DT	O	these	det	20	SENT_143	[p7l321t2570r483b2625],
18	various	JJ	O	various	amod	20	SENT_143	[p7l528t2571r753b2625],
19	biological	JJ	O	biological	amod	20	SENT_143	[p7l799t2570r1094b2638],
20	methods	NNS	O	method	prep_between	15	SENT_143	[p7l1140t2570r1407b2625],
21	proposed	VBN	O	propose	partmod	20	SENT_143	[p7l1455t2570r1740b2638],
22	to	TO	O	to	aux	23	SENT_143	[p7l1786t2578r1845b2625],
23	evaluate	VB	O	evaluate	xcomp	21	SENT_143	[p7l1891t2570r2149b2625],
24	platelet	NN	O	platelet	nn	26	SENT_143	[p7l11t2658r243b2727],
25	functional	JJ	O	functional	amod	26	SENT_143	[p7l270t2658r579b2713],
26	response	NN	O	response	dobj	23	SENT_143	[p7l608t2674r880b2727],
27	[	CD	NUMBER	[	number	28	SENT_143	[p7l913t2658r1139b2727],
28	18,19	CD	NUMBER	18,19	num	29	SENT_143	[p7l913t2658r1139b2727],
29	]	NN	O	]	dep	26	SENT_143	[p7l913t2658r1139b2727],
30	.	.	O	.	_	0	SENT_143	[p7l913t2658r1139b2727],

1	Furthermore	RB	O	furthermore	advmod	15	SENT_144	[p7l1170t2659r1574b2722],
2	,	,	O	,	_	0	SENT_144	[p7l1170t2659r1574b2722],
3	in	IN	O	in	_	0	SENT_144	[p7l1604t2659r1660b2713],
4	a	DT	O	a	det	6	SENT_144	[p7l1689t2674r1720b2713],
5	recent	JJ	O	recent	amod	6	SENT_144	[p7l1749t2667r1942b2713],
6	metaanalysis	NN	O	metaanalysis	prep_in	15	SENT_144	[p7l1970t2667r2149b2713, p7l10t2748r251b2816],
7	Goodman	NNP	PERSON	Goodman	dep	10	SENT_144	[p7l274t2748r572b2803],
8	et	FW	O	et	nn	10	SENT_144	[p7l594t2756r651b2803],
9	al.	FW	O	al.	nn	10	SENT_144	[p7l671t2748r736b2803],
10	[	FW	O	[	dep	6	SENT_144	[p7l762t2748r856b2816],
11	7	CD	NUMBER	7	num	12	SENT_144	[p7l762t2748r856b2816],
12	]	NN	O	]	dep	6	SENT_144	[p7l762t2748r856b2816],
13	,	,	O	,	_	0	SENT_144	[p7l762t2748r856b2816],
14	have	VBP	O	have	aux	15	SENT_144	[p7l880t2748r1023b2803],
15	showed	VBN	O	show	_	0	SENT_144	[p7l1046t2748r1283b2803],
16	that	IN	O	that	complm	19	SENT_144	[p7l1304t2748r1428b2803],
17	PlA2	NN	O	pla2	nn	18	SENT_144	[p7l1449t2748r1583b2802],
18	allele	NN	O	allele	nsubj	19	SENT_144	[p7l1607t2748r1767b2803],
19	seems	VBZ	O	seem	ccomp	15	SENT_144	[p7l1790t2764r1977b2803],
20	to	TO	O	to	aux	22	SENT_144	[p7l1999t2756r2057b2803],
21	be	VB	O	be	auxpass	22	SENT_144	[p7l2080t2748r2150b2803],
22	associated	VBN	O	associate	xcomp	19	SENT_144	[p7l10t2837r325b2892],
23	with	IN	O	with	_	0	SENT_144	[p7l358t2837r499b2892],
24	aspirin	NN	O	aspirin	nn	26	SENT_144	[p7l534t2838r742b2905],
25	platelet	NN	O	platelet	nn	26	SENT_144	[p7l777t2837r1010b2905],
26	nonresponsiveness	NN	O	nonresponsiveness	prep_with	22	SENT_144	[p7l1043t2838r1627b2905],
27	only	RB	O	only	advmod	26	SENT_144	[p7l1663t2837r1797b2905],
28	in	IN	O	in	_	0	SENT_144	[p7l1830t2838r1886b2891],
29	healthy	JJ	O	healthy	amod	30	SENT_144	[p7l1921t2837r2152b2905],
30	subjects	NNS	O	subject	prep_in	26	SENT_144	[p7l11t2925r256b2994],
31	and	CC	O	and	_	0	SENT_144	[p7l282t2925r393b2980],
32	when	WRB	O	when	advmod	36	SENT_144	[p7l417t2925r590b2980],
33	aspirin	NN	O	aspirin	nn	34	SENT_144	[p7l614t2926r823b2994],
34	response	NN	O	response	nsubjpass	36	SENT_144	[p7l848t2941r1121b2994],
35	is	VBZ	O	be	auxpass	36	SENT_144	[p7l1146t2926r1190b2980],
36	determined	VBN	O	determine	conj_and	19	SENT_144	[p7l1216t2925r1572b2980],
37	by	IN	O	by	_	0	SENT_144	[p7l1597t2925r1671b2994],
38	light	JJ	O	light	amod	40	SENT_144	[p7l1695t2925r1834b2994],
39	transmission	NN	O	transmission	nn	40	SENT_144	[p7l1857t2926r2150b2980, p7l11t3015r135b3069],
40	aggregometry	NN	O	aggregometry	agent	36	SENT_144	[p7l155t3022r599b3083],
41	.	.	O	.	_	0	SENT_144	[p7l155t3022r599b3083],

1	By	IN	O	by	_	0	SENT_145	[p7l621t3018r695b3083],
2	contrast	NN	O	contrast	prep_by	7	SENT_145	[p7l715t3022r978b3078],
3	,	,	O	,	_	0	SENT_145	[p7l715t3022r978b3078],
4	PlA2	NN	O	pla2	nn	5	SENT_145	[p7l1000t3014r1134b3069],
5	allele	NN	O	allele	nsubj	7	SENT_145	[p7l1158t3014r1318b3069],
6	may	MD	O	may	aux	7	SENT_145	[p7l1340t3030r1471b3083],
7	confer	VB	O	confer	_	0	SENT_145	[p7l1490t3014r1684b3069],
8	greater	JJR	O	greater	amod	10	SENT_145	[p7l1701t3022r1922b3083],
9	aspirin	NN	O	aspirin	nn	10	SENT_145	[p7l1941t3015r2150b3083],
10	sensitivity	NN	O	sensitivity	dobj	7	SENT_145	[p7l11t3104r326b3172],
11	in	IN	O	in	_	0	SENT_145	[p7l356t3105r413b3158],
12	CAD	NN	O	cad	nn	13	SENT_145	[p7l445t3106r573b3159],
13	patients	NNS	O	patient	prep_in	10	SENT_145	[p7l606t3105r851b3172],
14	and	CC	O	and	_	0	SENT_145	[p7l883t3104r994b3159],
15	when	WRB	O	when	advmod	19	SENT_145	[p7l1025t3104r1198b3159],
16	aspirin	NN	O	aspirin	nn	17	SENT_145	[p7l1230t3105r1439b3172],
17	response	NN	O	response	nsubjpass	19	SENT_145	[p7l1470t3120r1743b3172],
18	is	VBZ	O	be	auxpass	19	SENT_145	[p7l1776t3105r1819b3159],
19	evaluated	VBN	O	evaluate	conj_and	10	SENT_145	[p7l1852t3104r2149b3159],
20	with	IN	O	with	_	0	SENT_145	[p7l9t3192r150b3247],
21	PFA	NN	O	pfa	nn	22	SENT_145	[p7l174t3195r430b3247],
22	—	NN	O	—	prep_with	19	SENT_145	[p7l174t3195r430b3247],
23	100	CD	NUMBER	100	num	24	SENT_145	[p7l174t3195r430b3247],
24	method	NN	O	method	dep	22	SENT_145	[p7l456t3192r929b3261],
25	.	.	O	.	_	0	SENT_145	[p7l456t3192r929b3261],

1	Finally	RB	O	finally	advmod	9	SENT_146	[p7l456t3192r929b3261],
2	,	,	O	,	_	0	SENT_146	[p7l456t3192r929b3261],
3	Platelet	NN	O	platelet	nn	5	SENT_146	[p7l954t3192r1184b3247],
4	aspirin	NN	O	aspirin	nn	5	SENT_146	[p7l1207t3193r1415b3261],
5	nonresponsiveness	NN	O	nonresponsiveness	nsubj	9	SENT_146	[p7l1441t3193r2024b3261],
6	is	VBZ	O	be	cop	9	SENT_146	[p7l2050t3193r2094b3247],
7	a	DT	O	a	det	9	SENT_146	[p7l2119t3208r2150b3247],
8	multifactorial	JJ	O	multifactorial	amod	9	SENT_146	[p7l11t3282r425b3337],
9	phenomenon	NN	O	phenomenon	_	0	SENT_146	[p7l449t3282r859b3350],
10	and	CC	O	and	_	0	SENT_146	[p7l881t3282r992b3337],
11	it	PRP	O	it	nsubjpass	16	SENT_146	[p7l1017t3283r1058b3337],
12	can	MD	O	can	aux	16	SENT_146	[p7l1080t3290r1289b3337],
13	not	RB	O	not	neg	16	SENT_146	[p7l1080t3290r1289b3337],
14	be	VB	O	be	auxpass	16	SENT_146	[p7l1309t3282r1379b3337],
15	fully	RB	O	fully	advmod	16	SENT_146	[p7l1403t3282r1539b3350],
16	explained	VBN	O	explain	conj_and	9	SENT_146	[p7l1560t3282r1859b3350],
17	by	IN	O	by	_	0	SENT_146	[p7l1882t3282r1956b3350],
18	a	DT	O	a	det	21	SENT_146	[p7l1978t3298r2008b3337],
19	sole	JJ	O	sole	amod	21	SENT_146	[p7l2032t3282r2150b3337],
20	genetic	JJ	O	genetic	amod	21	SENT_146	[p7l9t3372r232b3439],
21	polymorphism	NN	O	polymorphism	agent	16	SENT_146	[p7l259t3371r710b3439],
22	of	IN	O	of	_	0	SENT_146	[p7l738t3371r801b3426],
23	a	DT	O	a	det	26	SENT_146	[p7l821t3387r852b3426],
24	single	JJ	O	single	amod	26	SENT_146	[p7l880t3371r1057b3439],
25	membrane	NN	O	membrane	nn	26	SENT_146	[p7l1085t3371r1417b3426],
26	receptor	NN	O	receptor	prep_of	21	SENT_146	[p7l1445t3379r1716b3439],
27	.	.	O	.	_	0	SENT_146	[p7l1445t3379r1716b3439],

1	Furthermore	RB	O	furthermore	advmod	10	SENT_147	[p7l1746t3371r2149b3434],
2	,	,	O	,	_	0	SENT_147	[p7l1746t3371r2149b3434],
3	the	DT	O	the	det	4	SENT_147	[p7l10t3459r107b3514],
4	prevalence	NN	O	prevalence	nsubj	10	SENT_147	[p7l138t3459r472b3528],
5	of	IN	O	of	_	0	SENT_147	[p7l502t3459r566b3514],
6	PlA1	NN	O	pla1	nn	9	SENT_147	[p7l589t3459r718b3514],
7	and	CC	O	and	_	0	SENT_147	[p7l757t3459r868b3514],
8	PlA2	NN	O	pla2	nn	9	SENT_147	[p7l899t3459r1034b3514],
9	alleles	NNS	O	allele	prep_of	4	SENT_147	[p7l1067t3459r1256b3514],
10	varies	VBZ	O	vary	_	0	SENT_147	[p7l1286t3460r1467b3514],
11	depending	VBG	O	depend	_	0	SENT_147	[p7l1498t3459r1825b3528],
12	on	IN	O	on	prepc_depending_on	10	SENT_147	[p7l1855t3475r1930b3514],
13	ethnic	JJ	O	ethnic	amod	14	SENT_147	[p7l1960t3459r2151b3514],
14	background	NN	O	background	pobj	10	SENT_147	[p7l10t3548r372b3617],
15	and	CC	O	and	_	0	SENT_147	[p7l398t3548r509b3603],
16	geographic	JJ	O	geographic	amod	17	SENT_147	[p7l535t3548r875b3617],
17	distribution	NN	O	distribution	pobj	10	SENT_147	[p7l899t3548r1274b3604],
18	.	.	O	.	_	0	SENT_147	[p7l899t3548r1274b3604],

1	Thus	RB	O	thus	_	0	SENT_148	[p7l1297t3548r1459b3612],
2	,	,	O	,	_	0	SENT_148	[p7l1297t3548r1459b3612],
3	in	IN	O	in	dep	1	SENT_148	[p7l1486t3549r1542b3603],
4	our	PRP$	O	we	poss	5	SENT_148	[p7l1568t3564r1671b3603],
5	population	NN	O	population	pobj	3	SENT_148	[p7l1695t3548r2028b3617],
6	the	DT	O	the	dep	5	SENT_148	[p7l2052t3548r2149b3603],

1	PlA2	NN	O	pla2	nn	3	SENT_149	[p8l11t17r146b71],
2	allele	NN	O	allele	nn	3	SENT_149	[p8l173t17r333b72],
3	prevalence	NN	O	prevalence	nsubj	5	SENT_149	[p8l360t17r694b85],
4	was	VBD	O	be	cop	5	SENT_149	[p8l719t32r838b72],
5	higher	JJR	O	higher	_	0	SENT_149	[p8l866t17r1064b85],
6	(	CD	PERCENT	(	num	9	SENT_149	[p8l1092t17r1259b85],
7	23	CD	PERCENT	23	number	8	SENT_149	[p8l1092t17r1259b85],
8	%	NN	PERCENT	%	amod	9	SENT_149	[p8l1092t17r1259b85],
9	)	NN	O	)	tmod	5	SENT_149	[p8l1092t17r1259b85],
10	than	IN	O	than	_	0	SENT_149	[p8l1290t17r1428b72],
11	that	DT	O	that	prep_than	9	SENT_149	[p8l1453t17r1576b72],
12	observed	VBN	O	observe	partmod	11	SENT_149	[p8l1600t17r1878b72],
13	in	IN	O	in	_	0	SENT_149	[p8l1905t18r1961b71],
14	other	JJ	O	other	amod	15	SENT_149	[p8l1987t17r2152b72],
15	types	NNS	O	type	prep_in	12	SENT_149	[p8l10t114r172b174],
16	of	IN	O	of	_	0	SENT_149	[p8l206t106r269b161],
17	population	NN	O	population	prep_of	15	SENT_149	[p8l295t106r627b174],
18	(	CD	NUMBER	(	num	17	SENT_149	[p8l664t106r995b174],
19	European	JJ	MISC	european	amod	26	SENT_149	[p8l664t106r995b174],
20	,	,	O	,	_	0	SENT_149	[p8l664t106r995b174],
21	American	JJ	LOCATION	american	amod	26	SENT_149	[p8l1027t107r1337b169],
22	,	,	O	,	_	0	SENT_149	[p8l1027t107r1337b169],
23	Chinese	JJ	MISC	chinese	amod	26	SENT_149	[p8l1370t106r1623b169],
24	,	,	O	,	_	0	SENT_149	[p8l1370t106r1623b169],
25	]	JJ	O	]	amod	26	SENT_149	[p8l1649t106r2036b174],
26	apanese	NN	O	apanese	dep	9	SENT_149	[p8l1649t106r2036b174],
27	...	:	O	...	_	0	SENT_149	[p8l1649t106r2036b174],
28	)	CD	NUMBER	)	dep	5	SENT_149	[p8l1649t106r2036b174],
29	.	.	O	.	_	0	SENT_149	[p8l1649t106r2036b174],

1	All	PDT	O	all	predet	3	SENT_150	[p8l2068t106r2149b160],
2	these	DT	O	these	det	3	SENT_150	[p8l10t195r172b250],
3	features	NNS	O	feature	nsubj	5	SENT_150	[p8l195t194r455b258],
4	,	,	O	,	_	0	SENT_150	[p8l195t194r455b258],
5	highlight	VBP	O	highlight	_	0	SENT_150	[p8l478t194r756b263],
6	the	DT	O	the	det	7	SENT_150	[p8l777t195r873b249],
7	difﬁculty	NN	O	difﬁculty	nsubj	9	SENT_150	[p8l896t194r1171b263],
8	to	TO	O	to	aux	9	SENT_150	[p8l1192t203r1250b249],
9	conclude	VB	O	conclude	xcomp	5	SENT_150	[p8l1273t195r1548b249],
10	whether	IN	O	whether	complm	14	SENT_150	[p8l1569t195r1831b249],
11	GPIIIa	NN	O	gpiium	nn	13	SENT_150	[p8l1852t197r2029b249],
12	PIA	NN	O	pium	nn	13	SENT_150	[p8l2052t194r2152b249],
13	polymorphism	NN	O	polymorphism	nsubj	14	SENT_150	[p8l10t284r462b352],
14	is	VBZ	O	be	ccomp	9	SENT_150	[p8l495t284r538b338],
15	associated	VBN	O	associate	dep	14	SENT_150	[p8l572t283r886b338],
16	or	CC	O	or	_	0	SENT_150	[p8l920t299r983b338],
17	not	RB	O	not	dep	14	SENT_150	[p8l1014t292r1115b338],
18	to	TO	O	to	_	0	SENT_150	[p8l1146t292r1204b338],
19	aspirin	NN	O	aspirin	nn	20	SENT_150	[p8l1237t284r1446b352],
20	resistance	NN	O	resistance	prep_to	17	SENT_150	[p8l1480t284r1783b338],
21	and	CC	O	and	_	0	SENT_150	[p8l1817t284r1928b338],
22	if	IN	O	if	mark	26	SENT_150	[p8l1962t283r2007b338],
23	it	PRP	O	it	nsubjpass	26	SENT_150	[p8l2032t284r2073b338],
24	is	VBZ	O	be	auxpass	26	SENT_150	[p8l2105t284r2149b338],
25	directly	RB	O	directly	advmod	26	SENT_150	[p8l10t373r244b441],
26	linked	VBN	O	link	ccomp	9	SENT_150	[p8l265t373r454b428],
27	to	TO	O	to	_	0	SENT_150	[p8l476t381r535b428],
28	clinical	JJ	O	clinical	amod	30	SENT_150	[p8l558t373r772b428],
29	outcomes	NNS	O	outcome	nn	30	SENT_150	[p8l795t381r1090b428],
30	prognosis	NN	O	prognosis	prep_to	26	SENT_150	[p8l1114t374r1425b441],
31	.	.	O	.	_	0	SENT_150	[p8l1114t374r1425b441],

1	In	IN	O	in	_	0	SENT_151	[p8l113t465r169b516],
2	conclusion	NN	O	conclusion	prep_in	6	SENT_151	[p8l203t462r544b525],
3	,	,	O	,	_	0	SENT_151	[p8l203t462r544b525],
4	our	PRP$	O	we	poss	5	SENT_151	[p8l578t478r682b517],
5	studyclearly	JJ	O	studyclearly	nsubj	6	SENT_151	[p8l713t462r1088b530],
6	demonstrated	VBD	O	demonstrate	_	0	SENT_151	[p8l1119t462r1548b517],
7	the	DT	O	the	det	8	SENT_151	[p8l1581t462r1678b517],
8	existence	NN	O	existence	dobj	6	SENT_151	[p8l1711t463r1997b517],
9	of	IN	O	of	_	0	SENT_151	[p8l2031t462r2094b517],
10	a	DT	O	a	det	12	SENT_151	[p8l2119t478r2150b517],
11	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_151	[p8l11t550r329b619],
12	association	NN	O	association	prep_of	8	SENT_151	[p8l360t551r699b605],
13	between	IN	O	between	_	0	SENT_151	[p8l731t550r996b605],
14	GPIIIa	NN	O	gpiium	nn	17	SENT_151	[p8l1030t553r1208b605],
15	P1A1	NN	O	p1a1	nn	17	SENT_151	[p8l1241t550r1369b605],
16	allele	NN	O	allele	nn	17	SENT_151	[p8l1411t550r1571b605],
17	homozygosis	NN	O	homozygosis	prep_between	12	SENT_151	[p8l1605t550r2004b619],
18	and	CC	O	and	_	0	SENT_151	[p8l2038t550r2149b605],
19	persistent	JJ	O	persistent	amod	20	SENT_151	[p8l10t640r323b708],
20	HPR	NN	ORGANIZATION	hpr	prep_between	12	SENT_151	[p8l371t642r501b693],
21	detected	VBN	O	detect	partmod	17	SENT_151	[p8l547t639r815b694],
22	by	IN	O	by	_	0	SENT_151	[p8l865t639r940b708],
23	PFA	NN	O	pfa	nn	25	SENT_151	[p8l988t641r1248b694],
24	—	CD	NUMBER	—	num	25	SENT_151	[p8l988t641r1248b694],
25	1OO	NN	O	1oo	agent	21	SENT_151	[p8l988t641r1248b694],
26	in	IN	O	in	_	0	SENT_151	[p8l1298t640r1355b693],
27	CAD	NNP	O	CAD	nn	29	SENT_151	[p8l1404t641r1534b694],
28	Tunisian	JJ	MISC	tunisian	amod	29	SENT_151	[p8l1581t640r1849b694],
29	patients	NNS	O	patient	prep_in	25	SENT_151	[p8l1898t640r2149b708],
30	receiving	VBG	O	receive	xcomp	21	SENT_151	[p8l11t729r291b797],
31	daily	RB	SET	daily	advmod	30	SENT_151	[p8l315t729r463b797],
32	oral	JJ	O	oral	amod	34	SENT_151	[p8l487t729r602b783],
33	aspirin	NN	O	aspirin	nn	34	SENT_151	[p8l627t729r836b797],
34	treatment	NN	O	treatment	dobj	30	SENT_151	[p8l860t737r1181b784],
35	.	.	O	.	_	0	SENT_151	[p8l860t737r1181b784],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_152	[p8l9t912r258b966],
2	of	IN	O	of	_	0	SENT_152	[p8l283t912r352b967],
3	interest	NN	O	interest	nn	4	SENT_152	[p8l372t912r623b966],
4	statement	NN	O	statement	prep_of	1	SENT_152	[p8l647t920r975b967],

1	The	DT	O	the	det	2	SENT_153	[p8l109t1086r221b1140],
2	authors	NNS	O	author	nsubj	3	SENT_153	[p8l246t1086r478b1140],
3	declare	VBP	O	declare	_	0	SENT_153	[p8l503t1086r723b1140],
4	no	DT	O	no	det	5	SENT_153	[p8l748t1101r822b1140],
5	conﬂict	NN	O	conﬂict	dobj	3	SENT_153	[p8l848t1086r1074b1140],
6	of	IN	O	of	_	0	SENT_153	[p8l1097t1086r1161b1140],
7	interest	NN	O	interest	prep_of	5	SENT_153	[p8l1178t1087r1427b1140],
8	.	.	O	.	_	0	SENT_153	[p8l1178t1087r1427b1140],

1	Acknowledgement	NN	O	acknowledgement	_	0	SENT_154	[p8l7t1270r618b1338],

1	This	DT	O	this	det	2	SENT_155	[p8l109t1448r235b1503],
2	study	NN	O	study	nsubjpass	4	SENT_155	[p8l282t1448r451b1517],
3	was	VBD	O	be	auxpass	4	SENT_155	[p8l493t1464r612b1503],
4	supported	VBN	O	support	_	0	SENT_155	[p8l659t1448r970b1517],
5	by	IN	O	by	_	0	SENT_155	[p8l1015t1448r1089b1517],
6	funding	VBG	O	fund	agent	4	SENT_155	[p8l1133t1448r1371b1517],
7	obtain	VB	O	obtain	ccomp	6	SENT_155	[p8l1415t1448r1608b1503],
8	from	IN	O	from	_	0	SENT_155	[p8l1654t1448r1800b1503],
9	Tunisian	NNP	MISC	Tunisian	poss	11	SENT_155	[p8l1842t1449r2149b1503],
10	's	POS	O	's	_	0	SENT_155	[p8l1842t1449r2149b1503],
11	ministry	NN	O	ministry	prep_from	7	SENT_155	[p8l11t1538r270b1605],
12	of	IN	O	of	_	0	SENT_155	[p8l292t1537r356b1592],
13	public	JJ	O	public	amod	14	SENT_155	[p8l373t1537r561b1605],
14	health	NN	O	health	prep_of	11	SENT_155	[p8l584t1537r791b1592],
15	.	.	O	.	_	0	SENT_155	[p8l584t1537r791b1592],

1	References	NNS	O	reference	_	0	SENT_156	[p8l9t1721r358b1775],

1	[	NN	O	[	_	0	SENT_157	[p8l39t1867r100b1922],
2	1	CD	NUMBER	1	number	3	SENT_157	[p8l39t1867r100b1922],
3	]	CD	NUMBER	]	dep	1	SENT_157	[p8l39t1867r100b1922],
4	Antithrombolic	JJ	O	antithrombolic	amod	6	SENT_157	[p8l132t1867r510b1911],
5	trialist	NN	O	trialist	nn	6	SENT_157	[p8l533t1867r692b1911],
6	collaboration	NN	O	collaboration	dep	3	SENT_157	[p8l714t1868r1048b1911],
7	.	.	O	.	_	0	SENT_157	[p8l714t1868r1048b1911],

1	Collaborative	JJ	O	collaborative	amod	2	SENT_158	[p8l1073t1867r1396b1911],
2	meta-analysis	NN	O	meta-analysis	nsubj	4	SENT_158	[p8l1421t1868r1762b1922],
3	of	IN	O	of	prep	2	SENT_158	[p8l1787t1867r1838b1911],
4	randomized	VBN	O	randomize	_	0	SENT_158	[p8l1855t1868r2149b1911],
5	trials	NNS	O	trial	dobj	4	SENT_158	[p8l134t1934r255b1977],
6	of	IN	O	of	_	0	SENT_158	[p8l279t1934r330b1977],
7	antiplatelet	JJ	O	antiplatelet	amod	8	SENT_158	[p8l347t1934r629b1988],
8	therapy	NN	O	therapy	prep_of	5	SENT_158	[p8l652t1934r842b1988],
9	for	IN	O	for	_	0	SENT_158	[p8l865t1934r933b1977],
10	prevention	NN	O	prevention	prep_for	4	SENT_158	[p8l956t1934r1224b1988],
11	of	IN	O	of	_	0	SENT_158	[p8l1248t1934r1299b1977],
12	death	NN	O	death	prep_of	10	SENT_158	[p8l1316t1934r1465b1984],
13	,	,	O	,	_	0	SENT_158	[p8l1316t1934r1465b1984],
14	myocardial	JJ	O	myocardial	amod	15	SENT_158	[p8l1490t1934r1763b1988],
15	infarction	NN	O	infarction	prep_of	10	SENT_158	[p8l1787t1934r2036b1984],
16	,	,	O	,	_	0	SENT_158	[p8l1787t1934r2036b1984],
17	and	CC	O	and	_	0	SENT_158	[p8l2061t1934r2149b1977],
18	stroke	NN	O	stroke	conj_and	12	SENT_158	[p8l135t2000r285b2044],
19	in	IN	O	in	_	0	SENT_158	[p8l305t2001r350b2043],
20	high	JJ	O	high	amod	22	SENT_158	[p8l371t2000r478b2055],
21	risk	NN	O	risk	nn	22	SENT_158	[p8l498t2000r587b2044],
22	patients	NNS	O	patient	prep_in	4	SENT_158	[p8l606t2001r815b2055],
23	.	.	O	.	_	0	SENT_158	[p8l606t2001r815b2055],

1	Br	NNP	O	Br	nsubj	2	SENT_159	[p8l836t2003r888b2043],
2	Med	VBD	O	med	_	0	SENT_159	[p8l907t2000r1047b2054],
3	]	CD	NUMBER	]	num	4	SENT_159	[p8l907t2000r1047b2054],
4	2002	CD	DATE	2002	dobj	2	SENT_159	[p8l1067t2003r1487b2050],
5	;	:	O	;	_	0	SENT_159	[p8l1067t2003r1487b2050],
6	324:71	CD	NUMBER	324:71	number	7	SENT_159	[p8l1067t2003r1487b2050],
7	—	CD	NUMBER	—	dep	4	SENT_159	[p8l1067t2003r1487b2050],
8	86	CD	NUMBER	86	dep	7	SENT_159	[p8l1067t2003r1487b2050],
9	.	.	O	.	_	0	SENT_159	[p8l1067t2003r1487b2050],

1	[	NN	O	[	nn	5	SENT_160	[p8l39t2065r100b2120],
2	2	CD	NUMBER	2	num	5	SENT_160	[p8l39t2065r100b2120],
3	]	CD	NUMBER	]	num	5	SENT_160	[p8l39t2065r100b2120],
4	Gasparyan	NNP	PERSON	Gasparyan	nn	5	SENT_160	[p8l134t2068r392b2120],
5	AY	NNP	PERSON	AY	_	0	SENT_160	[p8l408t2068r488b2115],
6	,	,	O	,	_	0	SENT_160	[p8l408t2068r488b2115],
7	Watson	NNP	PERSON	Watson	nn	8	SENT_160	[p8l505t2068r695b2109],
8	T	NN	O	t	appos	5	SENT_160	[p8l711t2068r751b2116],
9	,	,	O	,	_	0	SENT_160	[p8l711t2068r751b2116],
10	Lip	NNP	O	Lip	nn	11	SENT_160	[p8l771t2066r841b2120],
11	GY	NNP	O	GY	appos	8	SENT_160	[p8l860t2068r939b2109],
12	.	.	O	.	_	0	SENT_160	[p8l860t2068r939b2109],

1	The	DT	O	the	det	2	SENT_161	[p8l956t2066r1046b2109],
2	role	NN	O	role	_	0	SENT_161	[p8l1065t2066r1158b2109],
3	of	IN	O	of	_	0	SENT_161	[p8l1176t2065r1227b2109],
4	aspirin	NN	O	aspirin	prep_of	2	SENT_161	[p8l1239t2066r1406b2120],
5	in	IN	O	in	_	0	SENT_161	[p8l1425t2066r1470b2109],
6	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_161	[p8l1488t2066r1845b2109],
7	prevention	NN	O	prevention	prep_in	4	SENT_161	[p8l1862t2066r2146b2120],
8	:	:	O	:	_	0	SENT_161	[p8l1862t2066r2146b2120],

1	implications	NNS	O	implication	_	0	SENT_162	[p8l134t2132r436b2186],
2	of	IN	O	of	_	0	SENT_162	[p8l457t2132r507b2176],
3	aspirin	NN	O	aspirin	nn	4	SENT_162	[p8l521t2133r689b2186],
4	resistance	NN	O	resistance	prep_of	1	SENT_162	[p8l709t2133r964b2176],
5	.	.	O	.	_	0	SENT_162	[p8l709t2133r964b2176],
6	]	SYM	O	]	dep	1	SENT_162	[p8l979t2135r999b2186],

1	Am	VBP	O	be	dep	3	SENT_163	[p8l1016t2134r1101b2175],
2	Coll	NNP	O	Coll	nn	3	SENT_163	[p8l1121t2132r1211b2176],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_163	[p8l1232t2132r1404b2176],
4	2008	CD	DATE	2008	num	3	SENT_163	[p8l1425t2134r1876b2182],
5	;	:	O	;	_	0	SENT_163	[p8l1425t2134r1876b2182],
6	51:1829	CD	NUMBER	51:1829	dep	3	SENT_163	[p8l1425t2134r1876b2182],
7	—	CD	NUMBER	—	num	8	SENT_163	[p8l1425t2134r1876b2182],
8	43	CD	NUMBER	43	dep	6	SENT_163	[p8l1425t2134r1876b2182],
9	.	.	O	.	_	0	SENT_163	[p8l1425t2134r1876b2182],

1	[	NN	O	[	_	0	SENT_164	[p8l39t2198r100b2252],
2	3	CD	NUMBER	3	num	5	SENT_164	[p8l39t2198r100b2252],
3	]	NN	O	]	nn	5	SENT_164	[p8l39t2198r100b2252],
4	Feher	NN	PERSON	feher	nn	5	SENT_164	[p8l134t2198r271b2242],
5	G	NN	PERSON	g	dep	1	SENT_164	[p8l292t2200r338b2248],
6	,	,	O	,	_	0	SENT_164	[p8l292t2200r338b2248],
7	Feher	NNP	PERSON	Feher	nn	8	SENT_164	[p8l362t2198r498b2242],
8	A	NNP	O	A	appos	5	SENT_164	[p8l518t2200r564b2248],
9	,	,	O	,	_	0	SENT_164	[p8l518t2200r564b2248],
10	Pusch	NNP	PERSON	Pusch	nn	11	SENT_164	[p8l587t2198r729b2242],
11	G	NNP	PERSON	G	appos	5	SENT_164	[p8l752t2200r798b2248],
12	,	,	O	,	_	0	SENT_164	[p8l752t2200r798b2248],
13	Lupkovics	NNP	O	Lupkovics	nn	14	SENT_164	[p8l821t2198r1064b2252],
14	G	NNP	O	G	appos	5	SENT_164	[p8l1088t2200r1133b2248],
15	,	,	O	,	_	0	SENT_164	[p8l1088t2200r1133b2248],
16	Szapary	NNP	PERSON	Szapary	nn	17	SENT_164	[p8l1157t2200r1349b2252],
17	L	NNP	PERSON	L	appos	5	SENT_164	[p8l1371t2201r1405b2248],
18	,	,	O	,	_	0	SENT_164	[p8l1371t2201r1405b2248],
19	Papp	NNP	PERSON	Papp	nn	22	SENT_164	[p8l1429t2201r1548b2252],
20	E.	NNP	O	E.	nn	22	SENT_164	[p8l1572t2201r1610b2242],
21	The	NNP	O	The	nn	22	SENT_164	[p8l1631t2198r1721b2242],
22	genetics	NNS	O	genetics	appos	5	SENT_164	[p8l1743t2199r1943b2252],
23	of	IN	O	of	_	0	SENT_164	[p8l1967t2198r2019b2242],
24	antiplatelet	JJ	O	antiplatelet	prep_of	22	SENT_164	[p8l2035t2199r2149b2242, p8l134t2264r320b2318],

1	drug	NN	O	drug	_	0	SENT_165	[p8l338t2264r452b2318],
2	resistance	NN	O	resistance	dep	1	SENT_165	[p8l472t2265r728b2308],
3	.	.	O	.	_	0	SENT_165	[p8l472t2265r728b2308],

1	Clin	NNP	PERSON	Clin	nn	2	SENT_166	[p8l749t2264r842b2307],
2	Genet	NNP	PERSON	Genet	_	0	SENT_166	[p8l862t2266r1007b2307],
3	2009	CD	DATE	2009	num	2	SENT_166	[p8l1026t2266r1383b2314],
4	;	:	O	;	_	0	SENT_166	[p8l1026t2266r1383b2314],
5	75:1	CD	NUMBER	75:1	number	6	SENT_166	[p8l1026t2266r1383b2314],
6	—	CD	NUMBER	—	dep	2	SENT_166	[p8l1026t2266r1383b2314],
7	18	CD	NUMBER	18	dep	6	SENT_166	[p8l1026t2266r1383b2314],
8	.	.	O	.	_	0	SENT_166	[p8l1026t2266r1383b2314],

1	[	NN	O	[	dep	6	SENT_167	[p8l39t2329r100b2384],
2	4	CD	NUMBER	4	num	3	SENT_167	[p8l39t2329r100b2384],
3	]	NN	O	]	dep	1	SENT_167	[p8l39t2329r100b2384],
4	Shattil	NN	O	shattil	nn	5	SENT_167	[p8l134t2329r290b2373],
5	S	NN	O	s	dep	6	SENT_167	[p8l306t2332r359b2384],
6	]	CD	NUMBER	]	dep	18	SENT_167	[p8l306t2332r359b2384],
7	,	,	O	,	_	0	SENT_167	[p8l306t2332r359b2384],
8	Kashiwagi	NNP	PERSON	Kashiwagi	nn	9	SENT_167	[p8l375t2330r626b2384],
9	H	NNP	PERSON	H	appos	6	SENT_167	[p8l642t2332r690b2380],
10	,	,	O	,	_	0	SENT_167	[p8l642t2332r690b2380],
11	Pampori	NNP	PERSON	Pampori	nn	14	SENT_167	[p8l706t2330r911b2384],
12	N.	NNP	O	N.	nn	14	SENT_167	[p8l926t2332r974b2373],
13	integrin	NN	O	integrin	nn	14	SENT_167	[p8l991t2330r1184b2384],
14	signialing	NN	O	signialing	appos	6	SENT_167	[p8l1199t2330r1534b2384],
15	:	:	O	:	_	0	SENT_167	[p8l1199t2330r1534b2384],
16	the	DT	O	the	det	18	SENT_167	[p8l1199t2330r1534b2384],
17	platelet	NN	O	platelet	nn	18	SENT_167	[p8l1550t2330r1736b2384],
18	paradigm	NN	O	paradigm	_	0	SENT_167	[p8l1750t2330r1996b2384],
19	.	.	O	.	_	0	SENT_167	[p8l1750t2330r1996b2384],

1	Blood	NN	O	blood	_	0	SENT_168	[p8l2012t2329r2149b2373],

1	[	NN	O	[	_	0	SENT_169	[p8l39t2462r100b2517],
2	5	CD	NUMBER	5	num	1	SENT_169	[p8l39t2462r100b2517],
3	]	CD	NUMBER	]	num	6	SENT_169	[p8l39t2462r100b2517],
4	Newman	NNP	PERSON	Newman	nn	6	SENT_169	[p8l134t2465r356b2506],
5	P	NN	O	p	nn	6	SENT_169	[p8l374t2465r429b2516],
6	]	NN	O	]	dep	1	SENT_169	[p8l374t2465r429b2516],
7	,	,	O	,	_	0	SENT_169	[p8l374t2465r429b2516],
8	Derbes	NNP	ORGANIZATION	Derbes	nn	9	SENT_169	[p8l448t2462r616b2506],
9	RS	NN	ORGANIZATION	r	appos	6	SENT_169	[p8l636t2465r705b2512],
10	,	,	O	,	_	0	SENT_169	[p8l636t2465r705b2512],
11	Aster	NN	O	aster	nn	12	SENT_169	[p8l722t2464r853b2506],
12	RH	NN	O	rh	appos	6	SENT_169	[p8l870t2465r951b2506],
13	.	.	O	.	_	0	SENT_169	[p8l870t2465r951b2506],

1	The	DT	O	the	det	4	SENT_170	[p8l968t2462r1058b2506],
2	human	JJ	O	human	amod	4	SENT_170	[p8l1077t2462r1249b2506],
3	platelet	NN	O	platelet	nn	4	SENT_170	[p8l1267t2462r1453b2517],
4	alloantigen	NN	O	alloantigen	nsubjpass	11	SENT_170	[p8l1470t2462r1756b2517],
5	,	,	O	,	_	0	SENT_170	[p8l1470t2462r1756b2517],
6	PllA1	NN	O	plla1	appos	4	SENT_170	[p8l1776t2462r1895b2505],
7	and	CC	O	and	_	0	SENT_170	[p8l1919t2462r2009b2506],
8	PlA2	NN	O	pla2	conj_and	6	SENT_170	[p8l2028t2462r2149b2512],
9	,	,	O	,	_	0	SENT_170	[p8l2028t2462r2149b2512],
10	are	VBP	O	be	auxpass	11	SENT_170	[p8l134t2541r211b2572],
11	associated	VBN	O	associate	_	0	SENT_170	[p8l251t2528r513b2572],
12	with	IN	O	with	_	0	SENT_170	[p8l553t2528r670b2572],
13	a	DT	O	a	det	17	SENT_170	[p8l710t2541r735b2572],
14	Leucine33/proline33	NN	O	leucine33/proline33	nn	17	SENT_170	[p8l775t2528r1303b2583],
15	amino	NN	O	amino	nn	17	SENT_170	[p8l1345t2529r1504b2572],
16	acid	NN	O	acid	nn	17	SENT_170	[p8l1544t2528r1645b2572],
17	polymorphism	NN	O	polymorphism	prep_with	11	SENT_170	[p8l1686t2528r2063b2583],
18	in	IN	O	in	_	0	SENT_170	[p8l2104t2529r2149b2571],
19	membrane	NN	O	membrane	nn	21	SENT_170	[p8l134t2594r401b2638],
20	glycoprotein	NN	O	glycoprotein	nn	21	SENT_170	[p8l420t2594r732b2648],
21	Illa	NN	O	illum	prep_in	17	SENT_170	[p8l752t2597r836b2644],
22	,	,	O	,	_	0	SENT_170	[p8l752t2597r836b2644],
23	and	CC	O	and	_	0	SENT_170	[p8l858t2594r947b2638],
24	are	VBP	O	be	cop	25	SENT_170	[p8l967t2607r1042b2638],
25	distinguishable	JJ	O	distinguishable	conj_and	11	SENT_170	[p8l1063t2594r1437b2648],
26	by	IN	O	by	prep	25	SENT_170	[p8l1457t2594r1516b2648],
27	DNA	NN	O	dna	nn	28	SENT_170	[p8l1536t2596r1648b2637],
28	typing	NN	O	typing	dep	26	SENT_170	[p8l1666t2595r1869b2648],
29	.	.	O	.	_	0	SENT_170	[p8l1666t2595r1869b2648],
30	]	SYM	O	]	dep	25	SENT_170	[p8l1666t2595r1869b2648],

1	Clin	NNP	O	Clin	nn	2	SENT_171	[p8l1889t2594r1982b2638],
2	Invest	NNP	O	Invest	_	0	SENT_171	[p8l2003t2597r2151b2638],
3	1989	CD	DATE	1989	num	2	SENT_171	[p8l136t2662r585b2710],
4	;	:	O	;	_	0	SENT_171	[p8l136t2662r585b2710],
5	83:1778	CD	NUMBER	83:1778	number	6	SENT_171	[p8l136t2662r585b2710],
6	—	CD	NUMBER	—	dep	2	SENT_171	[p8l136t2662r585b2710],
7	81	CD	NUMBER	81	dep	6	SENT_171	[p8l136t2662r585b2710],
8	.	.	O	.	_	0	SENT_171	[p8l136t2662r585b2710],

1	[	NN	O	[	nn	4	SENT_172	[p8l39t2726r100b2780],
2	6	CD	NUMBER	6	num	4	SENT_172	[p8l39t2726r100b2780],
3	]	NN	O	]	nn	4	SENT_172	[p8l39t2726r100b2780],
4	Feng	NN	O	feng	_	0	SENT_172	[p8l134t2728r249b2780],
5	D	NN	O	d	dep	4	SENT_172	[p8l265t2728r311b2776],
6	,	,	O	,	_	0	SENT_172	[p8l265t2728r311b2776],
7	1indpaintnerI	NN	O	1indpaintnerus	nn	8	SENT_172	[p8l329t2726r694b2780],
8	(	NN	O	(	appos	5	SENT_172	[p8l329t2726r694b2780],
9	,	,	O	,	_	0	SENT_172	[p8l329t2726r694b2780],
10	Larson	NNP	PERSON	Larson	nn	11	SENT_172	[p8l711t2728r870b2769],
11	MG	NN	O	mg	appos	5	SENT_172	[p8l887t2728r984b2776],
12	,	,	O	,	_	0	SENT_172	[p8l887t2728r984b2776],
13	Rao	NNP	PERSON	Rao	nn	14	SENT_172	[p8l1001t2728r1088b2769],
14	VS	NNP	O	VS	appos	5	SENT_172	[p8l1102t2728r1177b2776],
15	,	,	O	,	_	0	SENT_172	[p8l1102t2728r1177b2776],
16	O'Donnell	NNP	PERSON	O'Donnell	nn	18	SENT_172	[p8l1194t2726r1436b2769],
17	C	NNP	O	C	nn	18	SENT_172	[p8l1453t2728r1510b2780],
18	]	NN	O	]	appos	5	SENT_172	[p8l1453t2728r1510b2780],
19	,	,	O	,	_	0	SENT_172	[p8l1453t2728r1510b2780],
20	Lipinska	FW	O	lipinska	appos	5	SENT_172	[p8l1527t2726r1729b2780],
21	I	PRP	O	I	dep	20	SENT_172	[p8l1745t2728r1770b2776],
22	,	,	O	,	_	0	SENT_172	[p8l1745t2728r1770b2776],
23	et	FW	O	et	nn	24	SENT_172	[p8l1786t2732r1832b2769],
24	al.	FW	O	al.	appos	5	SENT_172	[p8l1847t2726r1899b2770],
25	.	.	O	.	_	0	SENT_172	[p8l1847t2726r1899b2770],

1	Increased	VBN	O	increase	amod	3	SENT_173	[p8l1916t2726r2149b2769],
2	platelet	NN	O	platelet	nn	3	SENT_173	[p8l134t2791r320b2846],
3	aggregability	NN	O	aggregability	_	0	SENT_173	[p8l351t2791r671b2846],
4	associated	VBN	O	associate	partmod	3	SENT_173	[p8l702t2792r954b2835],
5	with	IN	O	with	_	0	SENT_173	[p8l986t2791r1099b2835],
6	platelet	NN	O	platelet	nn	9	SENT_173	[p8l1131t2792r1317b2846],
7	GPIIa	NN	O	gpium	nn	9	SENT_173	[p8l1348t2794r1475b2835],
8	PlA2	NN	O	pla2	nn	9	SENT_173	[p8l1507t2792r1615b2834],
9	polymorphism	NN	O	polymorphism	prep_with	4	SENT_173	[p8l1649t2792r2025b2846],
10	:	:	O	:	_	0	SENT_173	[p8l1649t2792r2025b2846],
11	The	DT	O	the	det	12	SENT_173	[p8l2060t2792r2149b2835],
12	Framingham	NNP	O	Framingham	dep	3	SENT_173	[p8l134t2858r447b2912],
13	Offspring	NNP	O	Offspring	nn	14	SENT_173	[p8l466t2857r694b2912],
14	Study	NNP	O	Study	dep	12	SENT_173	[p8l713t2858r863b2912],
15	.	.	O	.	_	0	SENT_173	[p8l713t2858r863b2912],

1	Arterioscler	NNP	O	Arterioscler	nn	4	SENT_174	[p8l882t2858r1172b2901],
2	Thromb	NNP	O	Thromb	nn	4	SENT_174	[p8l1189t2857r1385b2901],
3	Vasc	NNP	O	Vasc	nn	4	SENT_174	[p8l1403t2860r1515b2901],
4	Biol	NNP	O	Biol	_	0	SENT_174	[p8l1534t2858r1624b2901],
5	1999	CD	DATE	1999	num	4	SENT_174	[p8l1647t2860r2065b2907],
6	;	:	O	;	_	0	SENT_174	[p8l1647t2860r2065b2907],
7	19:1142	CD	NUMBER	19:1142	number	8	SENT_174	[p8l1647t2860r2065b2907],
8	-7	CD	NUMBER	-7	dep	4	SENT_174	[p8l1647t2860r2065b2907],
9	.	.	O	.	_	0	SENT_174	[p8l1647t2860r2065b2907],

1	[	NN	O	[	_	0	SENT_175	[p8l39t2924r100b2979],
2	7	CD	NUMBER	7	number	3	SENT_175	[p8l39t2924r100b2979],
3	]	CD	NUMBER	]	dep	1	SENT_175	[p8l39t2924r100b2979],
4	Goodman	NNP	ORGANIZATION	Goodman	dep	3	SENT_175	[p8l135t2924r374b2968],
5	T	NN	ORGANIZATION	t	dep	1	SENT_175	[p8l410t2927r451b2974],
6	,	,	O	,	_	0	SENT_175	[p8l410t2927r451b2974],
7	Ferro	NNP	ORGANIZATION	Ferro	nn	8	SENT_175	[p8l491t2927r617b2968],
8	A	NNP	ORGANIZATION	A	appos	5	SENT_175	[p8l654t2926r700b2974],
9	,	,	O	,	_	0	SENT_175	[p8l654t2926r700b2974],
10	Sharma	NNP	PERSON	Sharma	nn	12	SENT_175	[p8l740t2924r926b2968],
11	P.	NNP	PERSON	P.	nn	12	SENT_175	[p8l965t2927r1003b2968],
12	Pharmacogenetics	NNP	PERSON	Pharmacogenetics	appos	1	SENT_175	[p8l1043t2924r1493b2978],
13	of	IN	O	of	_	0	SENT_175	[p8l1532t2924r1583b2968],
14	aspirin	NN	O	aspirin	nn	15	SENT_175	[p8l1615t2925r1783b2979],
15	resistance	NN	O	resistance	prep_of	12	SENT_175	[p8l1822t2925r2083b2968],
16	:	:	O	:	_	0	SENT_175	[p8l1822t2925r2083b2968],
17	a	DT	O	a	det	20	SENT_175	[p8l2125t2937r2150b2968],
18	comprehensive	JJ	O	comprehensive	amod	20	SENT_175	[p8l135t2990r511b3044],
19	systematic	JJ	O	systematic	amod	20	SENT_175	[p8l532t2991r793b3044],
20	review	NN	O	review	dep	12	SENT_175	[p8l813t2991r991b3034],
21	.	.	O	.	_	0	SENT_175	[p8l813t2991r991b3034],

1	Br	NN	O	br	nn	4	SENT_176	[p8l1012t2993r1096b3044],
2	]	CD	NUMBER	]	num	4	SENT_176	[p8l1012t2993r1096b3044],
3	Clin	NNP	O	Clin	nn	4	SENT_176	[p8l1116t2990r1209b3033],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_176	[p8l1229t2990r1489b3033],
5	2008	CD	DATE	2008	dep	4	SENT_176	[p8l1508t2992r1929b3040],
6	;	:	O	;	_	0	SENT_176	[p8l1508t2992r1929b3040],
7	66:222	CD	NUMBER	66:222	number	8	SENT_176	[p8l1508t2992r1929b3040],
8	—	CD	NUMBER	—	dep	4	SENT_176	[p8l1508t2992r1929b3040],
9	32	CD	NUMBER	32	dep	8	SENT_176	[p8l1508t2992r1929b3040],
10	.	.	O	.	_	0	SENT_176	[p8l1508t2992r1929b3040],

1	[	NN	O	[	_	0	SENT_177	[p8l39t3056r103b3110],
2	8	CD	NUMBER	8	num	1	SENT_177	[p8l39t3056r103b3110],
3	]	CD	NUMBER	]	num	5	SENT_177	[p8l39t3056r103b3110],
4	Lev	NN	O	lev	nn	5	SENT_177	[p8l137t3059r221b3099],
5	EI	NN	O	eus	dep	1	SENT_177	[p8l261t3059r318b3106],
6	,	,	O	,	_	0	SENT_177	[p8l261t3059r318b3106],
7	Patel	NNP	ORGANIZATION	Patel	nn	8	SENT_177	[p8l359t3056r482b3099],
8	RT	NN	ORGANIZATION	rt	appos	5	SENT_177	[p8l522t3059r595b3106],
9	,	,	O	,	_	0	SENT_177	[p8l522t3059r595b3106],
10	Guthikonda	NNP	PERSON	Guthikonda	nn	11	SENT_177	[p8l637t3056r937b3099],
11	S	NNP	O	S	appos	5	SENT_177	[p8l976t3058r1014b3106],
12	,	,	O	,	_	0	SENT_177	[p8l976t3058r1014b3106],
13	Lopez	NNP	PERSON	Lopez	nn	14	SENT_177	[p8l1055t3059r1200b3110],
14	D	NNP	PERSON	D	appos	5	SENT_177	[p8l1241t3059r1288b3106],
15	,	,	O	,	_	0	SENT_177	[p8l1241t3059r1288b3106],
16	Bray	NNP	LOCATION	Bray	nn	17	SENT_177	[p8l1330t3059r1442b3110],
17	PF	NNP	LOCATION	PF	appos	5	SENT_177	[p8l1481t3059r1549b3106],
18	,	,	O	,	_	0	SENT_177	[p8l1481t3059r1549b3106],
19	Kleiman	NNP	PERSON	Kleiman	nn	20	SENT_177	[p8l1590t3056r1798b3099],
20	NS	NNP	O	NS	appos	5	SENT_177	[p8l1839t3058r1917b3100],
21	.	.	O	.	_	0	SENT_177	[p8l1839t3058r1917b3100],

1	Genetic	JJ	O	genetic	amod	2	SENT_178	[p8l1958t3057r2151b3099],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_178	[p8l137t3122r522b3176],
3	of	IN	O	of	_	0	SENT_178	[p8l556t3122r607b3165],
4	the	DT	O	the	det	7	SENT_178	[p8l633t3122r711b3165],
5	platelet	NN	O	platelet	nn	7	SENT_178	[p8l744t3122r930b3176],
6	receptors	NNS	O	receptor	nn	7	SENT_178	[p8l962t3128r1190b3176],
7	P2Y	NN	O	p2y	prep_of	2	SENT_178	[p8l1224t3124r1318b3165],
8	(	CD	NUMBER	(	number	9	SENT_178	[p8l1351t3122r1467b3176],
9	12	CD	NUMBER	12	num	10	SENT_178	[p8l1351t3122r1467b3176],
10	)	NN	O	)	dep	7	SENT_178	[p8l1351t3122r1467b3176],
11	,	,	O	,	_	0	SENT_178	[p8l1351t3122r1467b3176],
12	P2Y	NN	O	p2y	nn	13	SENT_178	[p8l1501t3124r1595b3165],
13	(	NN	O	(	conj_and	7	SENT_178	[p8l1628t3122r1697b3176],
14	1	CD	NUMBER	1	num	15	SENT_178	[p8l1628t3122r1697b3176],
15	)	NN	O	)	dep	13	SENT_178	[p8l1628t3122r1697b3176],
16	and	CC	O	and	_	0	SENT_178	[p8l1734t3122r1822b3165],
17	GP	NN	O	gp	nn	18	SENT_178	[p8l1857t3124r1922b3165],
18	Illa	NN	PERSON	illum	conj_and	7	SENT_178	[p8l1954t3124r2028b3165],
19	and	CC	O	and	_	0	SENT_178	[p8l2061t3122r2149b3165],
20	response	NN	O	response	conj_and	7	SENT_178	[p8l137t3200r355b3242],
21	to	TO	O	to	_	0	SENT_178	[p8l375t3194r422b3231],
22	aspirin	NN	O	aspirin	prep_to	18	SENT_178	[p8l442t3188r610b3242],
23	and	CC	O	and	_	0	SENT_178	[p8l630t3188r718b3231],
24	clopidogrel	NN	O	clopidogrel	conj_and	22	SENT_178	[p8l739t3188r1026b3242],
25	.	.	O	.	_	0	SENT_178	[p8l739t3188r1026b3242],

1	Thromb	NNP	O	Thromb	nn	2	SENT_179	[p8l1045t3188r1240b3231],
2	Res	NNP	O	Res	_	0	SENT_179	[p8l1261t3190r1342b3231],
3	2007	CD	DATE	2007	num	2	SENT_179	[p8l1362t3190r1814b3238],
4	;	:	O	;	_	0	SENT_179	[p8l1362t3190r1814b3238],
5	119:355	CD	NUMBER	119:355	number	6	SENT_179	[p8l1362t3190r1814b3238],
6	—	CD	NUMBER	—	dep	2	SENT_179	[p8l1362t3190r1814b3238],
7	60	CD	NUMBER	60	dep	6	SENT_179	[p8l1362t3190r1814b3238],
8	.	.	O	.	_	0	SENT_179	[p8l1362t3190r1814b3238],

1	[	NN	O	[	nn	4	SENT_180	[p8l39t3254r100b3309],
2	9	CD	NUMBER	9	num	4	SENT_180	[p8l39t3254r100b3309],
3	]	NN	O	]	nn	4	SENT_180	[p8l39t3254r100b3309],
4	Addad	NN	O	addad	_	0	SENT_180	[p8l132t3254r290b3298],
5	F	NN	O	f	dep	4	SENT_180	[p8l308t3257r343b3304],
6	,	,	O	,	_	0	SENT_180	[p8l308t3257r343b3304],
7	Chakroun	NN	O	chakroun	nn	8	SENT_180	[p8l360t3254r598b3298],
8	T	NN	O	t	appos	5	SENT_180	[p8l613t3257r653b3304],
9	,	,	O	,	_	0	SENT_180	[p8l613t3257r653b3304],
10	Abderazek	NN	O	abderazek	nn	11	SENT_180	[p8l668t3254r931b3298],
11	F	NN	O	f	appos	5	SENT_180	[p8l946t3257r982b3304],
12	,	,	O	,	_	0	SENT_180	[p8l946t3257r982b3304],
13	Ben	NNP	PERSON	Ben	appos	5	SENT_180	[p8l999t3254r1270b3298],
14	.	.	O	.	_	0	SENT_180	[p8l999t3254r1270b3298],

1	—	NN	O	—	_	0	SENT_181	[p8l999t3254r1270b3298],
2	.	.	O	.	_	0	SENT_181	[p8l999t3254r1270b3298],

1	Farhat	NNP	O	Farhat	nn	2	SENT_182	[p8l999t3254r1270b3298],
2	M	NNP	O	M	_	0	SENT_182	[p8l1286t3257r1344b3304],
3	,	,	O	,	_	0	SENT_182	[p8l1286t3257r1344b3304],
4	Hamdi	NNP	PERSON	Hamdi	nn	5	SENT_182	[p8l1362t3254r1524b3298],
5	S	NNP	PERSON	S	appos	2	SENT_182	[p8l1541t3257r1577b3304],
6	,	,	O	,	_	0	SENT_182	[p8l1541t3257r1577b3304],
7	Dridi	NNP	PERSON	Dridi	nn	8	SENT_182	[p8l1595t3254r1716b3298],
8	Z	NNP	O	Z	appos	2	SENT_182	[p8l1732t3257r1772b3304],
9	,	,	O	,	_	0	SENT_182	[p8l1732t3257r1772b3304],
10	et	FW	O	et	nn	11	SENT_182	[p8l1789t3261r1835b3298],
11	al.	FW	O	al.	appos	2	SENT_182	[p8l1850t3254r1902b3298],
12	.	.	O	.	_	0	SENT_182	[p8l1850t3254r1902b3298],

1	Response	NN	O	response	_	0	SENT_183	[p8l1920t3257r2149b3309],
2	variability	NN	O	variability	dep	1	SENT_183	[p8l132t3320r383b3374],
3	to	TO	O	to	_	0	SENT_183	[p8l402t3326r449b3363],
4	aspirin	NN	O	aspirin	prep_to	2	SENT_183	[p8l471t3320r638b3374],
5	and	CC	O	and	_	0	SENT_183	[p8l660t3320r749b3363],
6	one-year	JJ	DURATION	one-year	amod	7	SENT_183	[p8l771t3332r990b3374],
7	prediction	NN	O	prediction	conj_and	2	SENT_183	[p8l1011t3319r1263b3374],
8	of	IN	O	of	_	0	SENT_183	[p8l1284t3319r1335b3363],
9	vascular	JJ	O	vascular	amod	10	SENT_183	[p8l1348t3320r1553b3363],
10	events	NNS	O	event	prep_of	7	SENT_183	[p8l1573t3326r1731b3363],
11	in	IN	O	in	_	0	SENT_183	[p8l1753t3320r1799b3362],
12	patients	NNS	O	patient	prep_in	10	SENT_183	[p8l1820t3320r2017b3374],
13	with	IN	O	with	prep	12	SENT_183	[p8l2037t3320r2150b3363],
14	stable	JJ	O	stable	amod	16	SENT_183	[p8l135t3386r277b3430],
15	coronary	JJ	O	coronary	amod	16	SENT_183	[p8l297t3399r516b3440],
16	artery	NN	O	artery	dep	13	SENT_183	[p8l535t3393r682b3440],
17	disease	NN	O	disease	dep	16	SENT_183	[p8l701t3386r923b3440],
18	.	.	O	.	_	0	SENT_183	[p8l701t3386r923b3440],
19	]	SYM	O	]	dep	7	SENT_183	[p8l701t3386r923b3440],

1	Thromb	NNP	O	Thromb	nn	2	SENT_184	[p8l941t3386r1136b3430],
2	Thrombolysis	NNP	O	Thrombolysis	_	0	SENT_184	[p8l1154t3386r1488b3440],
3	2009	CD	DATE	2009	num	2	SENT_184	[p8l1509t3388r1723b3436],
4	;	:	O	;	_	0	SENT_184	[p8l1509t3388r1723b3436],
5	19	CD	NUMBER	19	dep	2	SENT_184	[p8l1509t3388r1723b3436],
6	.	.	O	.	_	0	SENT_184	[p8l1509t3388r1723b3436],

1	[	NN	O	[	nn	5	SENT_185	[p8l12t3452r104b3506],
2	10	CD	NUMBER	10	num	5	SENT_185	[p8l12t3452r104b3506],
3	]	CD	NUMBER	]	num	5	SENT_185	[p8l12t3452r104b3506],
4	Cook	NNP	ORGANIZATION	Cook	nn	5	SENT_185	[p8l138t3452r259b3495],
5	GE	NNP	ORGANIZATION	GE	_	0	SENT_185	[p8l289t3454r366b3502],
6	,	,	O	,	_	0	SENT_185	[p8l289t3454r366b3502],
7	Bray	NNP	ORGANIZATION	Bray	nn	8	SENT_185	[p8l397t3455r507b3506],
8	PF	NNP	ORGANIZATION	PF	appos	5	SENT_185	[p8l537t3455r603b3502],
9	,	,	O	,	_	0	SENT_185	[p8l537t3455r603b3502],
10	Hamlington	NNP	ORGANIZATION	Hamlington	nn	11	SENT_185	[p8l635t3452r926b3506],
11	JD	NNP	ORGANIZATION	JD	appos	5	SENT_185	[p8l951t3455r1021b3506],
12	,	,	O	,	_	0	SENT_185	[p8l951t3455r1021b3506],
13	Pham	NNP	O	Pham	nn	14	SENT_185	[p8l1053t3452r1191b3495],
14	DM	NN	O	dm	appos	5	SENT_185	[p8l1221t3455r1318b3502],
15	,	,	O	,	_	0	SENT_185	[p8l1221t3455r1318b3502],
16	Goldschmidt	NNP	PERSON	Goldschmidt	nn	18	SENT_185	[p8l1350t3452r1912b3495],
17	—	CD	NUMBER	—	num	18	SENT_185	[p8l1350t3452r1912b3495],
18	clermont	NN	O	clermont	appos	5	SENT_185	[p8l1350t3452r1912b3495],
19	P	NN	O	p	dep	18	SENT_185	[p8l1943t3455r1997b3506],
20	]	CD	NUMBER	]	num	19	SENT_185	[p8l1943t3455r1997b3506],
21	.	.	O	.	_	0	SENT_185	[p8l1943t3455r1997b3506],

1	PLA2	NN	O	pla2	_	0	SENT_186	[p8l2029t3454r2148b3495],

1	polymorphism	NN	O	polymorphism	_	0	SENT_187	[p8l138t3518r500b3572],
2	and	CC	O	and	_	0	SENT_187	[p8l520t3518r609b3561],
3	efﬁcacity	NN	O	efﬁcacity	conj_and	1	SENT_187	[p8l630t3518r851b3572],
4	of	IN	O	of	_	0	SENT_187	[p8l870t3518r920b3561],
5	aspirin	NN	O	aspirin	prep_of	1	SENT_187	[p8l934t3519r1113b3572],
6	.	.	O	.	_	0	SENT_187	[p8l934t3519r1113b3572],

1	Lancet	NNP	O	Lancet	_	0	SENT_188	[p8l1134t3521r1292b3561],
2	1998	CD	DATE	1998	num	1	SENT_188	[p8l1313t3520r1700b3568],
3	;	:	O	;	_	0	SENT_188	[p8l1313t3520r1700b3568],
4	351:1253	CD	NUMBER	351:1253	dep	1	SENT_188	[p8l1313t3520r1700b3568],
5	.	.	O	.	_	0	SENT_188	[p8l1313t3520r1700b3568],

1	[	NN	O	[	nn	5	SENT_189	[p8l12t3583r104b3638],
2	11	CD	NUMBER	11	num	5	SENT_189	[p8l12t3583r104b3638],
3	]	CD	NUMBER	]	num	5	SENT_189	[p8l12t3583r104b3638],
4	Macchi	NNP	PERSON	Macchi	nn	5	SENT_189	[p8l138t3584r312b3627],
5	L	NNP	PERSON	L	_	0	SENT_189	[p8l332t3586r366b3633],
6	,	,	O	,	_	0	SENT_189	[p8l332t3586r366b3633],
7	Christiaens	NNP	ORGANIZATION	Christiaens	nn	8	SENT_189	[p8l386t3584r658b3627],
8	L	NNP	ORGANIZATION	L	appos	5	SENT_189	[p8l678t3586r712b3634],
9	,	,	O	,	_	0	SENT_189	[p8l678t3586r712b3634],
10	Brabant	NNP	LOCATION	Brabant	nn	11	SENT_189	[p8l732t3584r924b3627],
11	S	NNP	O	S	appos	5	SENT_189	[p8l942t3586r978b3633],
12	,	,	O	,	_	0	SENT_189	[p8l942t3586r978b3633],
13	et	FW	O	et	nn	14	SENT_189	[p8l998t3590r1044b3627],
14	al.	FW	O	al.	appos	5	SENT_189	[p8l1062t3584r1114b3627],
15	.	.	O	.	_	0	SENT_189	[p8l1062t3584r1114b3627],

1	Resistance	NN	O	resistance	_	0	SENT_190	[p8l1134t3584r1390b3627],
2	In	FW	O	in	nn	3	SENT_190	[p8l1410t3586r1455b3627],
3	vitro	FW	O	vitro	dobj	5	SENT_190	[p8l1473t3584r1588b3627],
4	to	TO	O	to	infmod	3	SENT_190	[p8l1607t3590r1654b3627],
5	low-dose	JJ	O	low-dose	dep	1	SENT_190	[p8l1674t3584r1900b3627],
6	Aspirin	NN	O	aspirin	nsubjpass	8	SENT_190	[p8l1917t3584r2095b3638],
7	is	VBZ	O	be	auxpass	8	SENT_190	[p8l2114t3584r2149b3627],
8	associated	VBN	O	associate	ccomp	5	SENT_190	[p8l138t3650r389b3693],
9	with	IN	O	with	_	0	SENT_190	[p8l407t3650r520b3693],
10	platelet	NN	O	platelet	nn	11	SENT_190	[p8l539t3650r724b3704],
11	PLA1	NN	O	pla1	prep_with	8	SENT_190	[p8l742t3652r856b3693],
12	(	CD	NUMBER	(	num	14	SENT_190	[p8l884t3650r971b3704],
13	GP	NN	O	gp	nn	14	SENT_190	[p8l884t3650r971b3704],
14	Illa	NN	O	illum	dep	11	SENT_190	[p8l989t3650r1082b3704],
15	)	CD	NUMBER	)	num	16	SENT_190	[p8l989t3650r1082b3704],
16	polymorphism	NN	O	polymorphism	dep	14	SENT_190	[p8l1104t3650r1466b3704],
17	but	CC	O	but	_	0	SENT_190	[p8l1485t3650r1566b3693],
18	not	RB	O	not	_	0	SENT_190	[p8l1583t3656r1664b3693],
19	with	IN	O	with	_	0	SENT_190	[p8l1679t3650r1792b3693],
20	C	NN	O	c	dep	8	SENT_190	[p8l1811t3652r1841b3693],
21	807T	CD	NUMBER	807t	number	22	SENT_190	[p8l1858t3652r1980b3693],
22	(	CD	NUMBER	(	num	23	SENT_190	[p8l1999t3650r2151b3704],
23	GPIa	NN	O	gpium	dep	20	SENT_190	[p8l1999t3650r2151b3704],
24	/	:	O	/	punct	20	SENT_190	[p8l1999t3650r2151b3704],
25	Ila	NN	O	ilum	dep	20	SENT_190	[p8l138t3717r215b3770],
26	)	NN	O	)	dep	25	SENT_190	[p8l138t3717r215b3770],
27	and	CC	O	and	_	0	SENT_190	[p8l238t3716r327b3760],
28	C-ST	NN	O	c-st	nn	29	SENT_190	[p8l348t3719r459b3760],
29	Kozak	NN	PERSON	kozak	dep	20	SENT_190	[p8l477t3716r625b3760],
30	(	CD	NUMBER	(	num	33	SENT_190	[p8l647t3716r842b3770],
31	GPIDOL	NN	O	gpidol	nn	33	SENT_190	[p8l647t3716r842b3770],
32	)	CD	NUMBER	)	num	33	SENT_190	[p8l647t3716r842b3770],
33	polymorphisms	NNS	O	polymorphism	dep	29	SENT_190	[p8l866t3716r1297b3771],
34	.	.	O	.	_	0	SENT_190	[p8l866t3716r1297b3771],
35	]	SYM	O	]	dep	1	SENT_190	[p8l866t3716r1297b3771],

1	Am	VBP	O	be	cop	3	SENT_191	[p8l1315t3718r1400b3759],
2	Coll	NN	PERSON	coll	nn	3	SENT_191	[p8l1420t3716r1510b3760],
3	cardiol	NN	O	cardiol	_	0	SENT_191	[p8l1531t3716r1696b3760],
4	2003	CD	DATE	2003	dep	3	SENT_191	[p8l1717t3719r2044b3766],
5	;	:	O	;	_	0	SENT_191	[p8l1717t3719r2044b3766],
6	42:5	CD	NUMBER	42:5	number	7	SENT_191	[p8l1717t3719r2044b3766],
7	—	CD	NUMBER	—	dep	3	SENT_191	[p8l1717t3719r2044b3766],
8	9	CD	NUMBER	9	dep	7	SENT_191	[p8l1717t3719r2044b3766],
9	.	.	O	.	_	0	SENT_191	[p8l1717t3719r2044b3766],

1	e268	NN	O	e268	nn	3	SENT_192	[p9l6t51r63b72],
2	F.	NNP	PERSON	F.	nn	3	SENT_192	[p9l697t51r713b72],
3	Abderrazek	NNP	PERSON	Abderrazek	_	0	SENT_192	[p9l723t50r855b72],
4	et	FW	O	et	nn	5	SENT_192	[p9l865t53r887b72],
5	al.	FW	O	al.	dep	3	SENT_192	[p9l896t50r920b72],
6	/	:	O	/	punct	3	SENT_192	[p9l931t51r940b75],
7	Thrombosis	NNP	O	Thrombosis	nn	8	SENT_192	[p9l949t50r1081b72],
8	Research	NNP	O	Research	dep	3	SENT_192	[p9l1091t50r1193b72],
9	125	CD	NUMBER	125	number	10	SENT_192	[p9l1206t51r1246b72],
10	(	CD	NUMBER	(	nn	15	SENT_192	[p9l1258t50r1336b77],
11	2010	CD	DATE	2010	num	12	SENT_192	[p9l1258t50r1336b77],
12	)	CD	NUMBER	)	dep	10	SENT_192	[p9l1258t50r1336b77],
13	e265	NN	O	e265	dep	10	SENT_192	[p9l1348t51r1475b72],
14	—	CD	NUMBER	—	num	13	SENT_192	[p9l1348t51r1475b72],
15	e268	NN	O	e268	dep	8	SENT_192	[p9l1348t51r1475b72],

1	[	NN	O	[	_	0	SENT_193	[p9l6t126r51b153],
2	12	CD	NUMBER	12	num	1	SENT_193	[p9l6t126r51b153],
3	]	CD	NUMBER	]	num	5	SENT_193	[p9l6t126r51b153],
4	Michelson	NNP	PERSON	Michelson	nn	5	SENT_193	[p9l67t126r190b148],
5	AD	NN	O	ad	dep	1	SENT_193	[p9l204t127r245b151],
6	,	,	O	,	_	0	SENT_193	[p9l204t127r245b151],
7	Furman	NNP	O	Furman	nn	8	SENT_193	[p9l259t128r351b148],
8	Ml	NNP	O	Ml	appos	5	SENT_193	[p9l366t128r402b151],
9	,	,	O	,	_	0	SENT_193	[p9l366t128r402b151],
10	Goldschmidt	NNP	PERSON	Goldschmidt	nn	12	SENT_193	[p9l417t126r691b148],
11	—	CD	NUMBER	—	num	12	SENT_193	[p9l417t126r691b148],
12	clermont	NN	O	clermont	appos	5	SENT_193	[p9l417t126r691b148],
13	P	NN	O	p	dep	12	SENT_193	[p9l705t128r731b153],
14	]	CD	NUMBER	]	num	13	SENT_193	[p9l705t128r731b153],
15	,	,	O	,	_	0	SENT_193	[p9l705t128r731b153],
16	Mascelli	NNP	PERSON	Mascelli	nn	17	SENT_193	[p9l746t126r843b148],
17	MA	NNP	PERSON	MA	appos	13	SENT_193	[p9l858t127r904b151],
18	,	,	O	,	_	0	SENT_193	[p9l858t127r904b151],
19	Hendrix	NNP	PERSON	Hendrix	nn	20	SENT_193	[p9l918t126r1015b148],
20	C	NNP	O	C	appos	13	SENT_193	[p9l1029t127r1049b151],
21	,	,	O	,	_	0	SENT_193	[p9l1029t127r1049b151],
22	[	CD	NUMBER	[	number	23	SENT_193	[p9l1122t126r1168b153],
23	17	CD	NUMBER	17	appos	13	SENT_193	[p9l1122t126r1168b153],
24	]	CD	NUMBER	]	num	26	SENT_193	[p9l1122t126r1168b153],
25	Pamukcu	NN	PERSON	pamukcu	nn	26	SENT_193	[p9l1184t126r1294b148],
26	B	NN	PERSON	b	dep	23	SENT_193	[p9l1302t128r1322b151],
27	,	,	O	,	_	0	SENT_193	[p9l1302t128r1322b151],
28	Oﬂaz	NN	LOCATION	oﬂaz	nn	29	SENT_193	[p9l1330t126r1390b148],
29	H	NN	LOCATION	h	appos	13	SENT_193	[p9l1398t128r1422b151],
30	,	,	O	,	_	0	SENT_193	[p9l1398t128r1422b151],
31	Nisanci	NNP	O	Nisanci	nn	34	SENT_193	[p9l1430t127r1516b148],
32	Y.	NNP	O	Y.	nn	34	SENT_193	[p9l1524t128r1545b148],
33	The	NNP	O	The	nn	34	SENT_193	[p9l1552t126r1596b148],
34	role	NN	O	role	appos	5	SENT_193	[p9l1605t126r1650b148],
35	of	IN	O	of	_	0	SENT_193	[p9l1658t126r1683b148],
36	platelet	NN	O	platelet	nn	39	SENT_193	[p9l1688t126r1779b153],
37	glycoprotein	NN	O	glycoprotein	nn	39	SENT_193	[p9l1785t126r1937b153],
38	Illa	NN	PERSON	illum	nn	39	SENT_193	[p9l1945t128r1981b148],
39	polymorphism	NN	O	polymorphism	prep_of	34	SENT_193	[p9l6t159r183b186],

1	Coleman	NNP	PERSON	Coleman	nn	2	SENT_194	[p9l68t191r172b213],
2	L	NNP	O	L	_	0	SENT_194	[p9l179t192r196b216],
3	,	,	O	,	_	0	SENT_194	[p9l179t192r196b216],
4	et	FW	O	et	nn	5	SENT_194	[p9l203t194r226b213],
5	al.	FW	O	al.	appos	2	SENT_194	[p9l232t191r257b213],
6	.	.	O	.	_	0	SENT_194	[p9l232t191r257b213],

1	Platelet	NN	O	platelet	nn	3	SENT_195	[p9l265t191r354b213],
2	GPllla	NN	O	gplllum	nn	3	SENT_195	[p9l361t192r430b213],
3	P1	NN	O	p1	nsubj	8	SENT_195	[p9l437t191r458b212],
4	(	CD	NUMBER	(	dep	3	SENT_195	[p9l466t191r502b218],
5	A	DT	O	a	det	6	SENT_195	[p9l466t191r502b218],
6	)	NN	O	)	dep	3	SENT_195	[p9l466t191r502b218],
7	polymorphisms	NNS	O	polymorphism	dep	6	SENT_195	[p9l511t191r699b218],
8	display	VBP	O	display	_	0	SENT_195	[p9l706t191r792b218],
9	different	JJ	O	different	amod	10	SENT_195	[p9l798t191r902b213],
10	sensitivities	NNS	O	sensitivity	dobj	8	SENT_195	[p9l908t191r1049b213],
11	in	IN	O	in	_	0	SENT_195	[p9l1185t191r1207b212],
12	the	DT	O	the	det	14	SENT_195	[p9l1215t191r1253b213],
13	high	JJ	O	high	amod	14	SENT_195	[p9l1261t191r1314b218],
14	prevalence	NN	O	prevalence	prep_in	10	SENT_195	[p9l1322t191r1453b218],
15	of	IN	O	of	prep	14	SENT_195	[p9l1461t191r1486b213],
16	in	FW	O	in	nn	17	SENT_195	[p9l1492t191r1513b212],
17	vitro	FW	O	vitro	dep	19	SENT_195	[p9l1521t191r1578b213],
18	aspirin	NN	O	aspirin	nn	19	SENT_195	[p9l1586t191r1668b218],
19	resistance	NN	O	resistance	dep	15	SENT_195	[p9l1676t191r1796b213],
20	in	IN	O	in	_	0	SENT_195	[p9l1804t191r1826b212],
21	patients	NNS	O	patient	prep_in	8	SENT_195	[p9l1835t191r1931b218],
22	with	IN	O	with	_	0	SENT_195	[p9l1939t191r1994b213],
23	intracoronary	JJ	O	intracoronary	amod	25	SENT_195	[p9l6t224r171b251],
24	to	TO	O	to	prep	23	SENT_195	[p9l67t259r90b278],
25	agonists	NNS	O	agonist	prep_with	21	SENT_195	[p9l99t256r203b283],
26	.	.	O	.	_	0	SENT_195	[p9l99t256r203b283],

1	Circulation	NN	O	circulation	_	0	SENT_196	[p9l212t256r343b278],
2	2000	CD	DATE	2000	num	1	SENT_196	[p9l352t257r572b281],
3	;	:	O	;	_	0	SENT_196	[p9l352t257r572b281],
4	101:1013	CD	NUMBER	101:1013	number	5	SENT_196	[p9l352t257r572b281],
5	—	CD	NUMBER	—	dep	1	SENT_196	[p9l352t257r572b281],
6	8	CD	NUMBER	8	dep	5	SENT_196	[p9l352t257r572b281],
7	.	.	O	.	_	0	SENT_196	[p9l352t257r572b281],

1	stent	NN	O	stent	_	0	SENT_197	[p9l1184t259r1244b278],
2	restenosis	NN	O	restenosis	dep	1	SENT_197	[p9l1253t257r1379b278],
3	.	.	O	.	_	0	SENT_197	[p9l1253t257r1379b278],

1	Am	VBP	O	be	dep	2	SENT_198	[p9l1388t257r1429b278],
2	Heart	NNP	O	Heart	_	0	SENT_198	[p9l1439t258r1520b283],
3	]	CD	NUMBER	]	number	4	SENT_198	[p9l1439t258r1520b283],
4	2005	CD	DATE	2005	amod	2	SENT_198	[p9l1530t257r1750b281],
5	;	:	O	;	_	0	SENT_198	[p9l1530t257r1750b281],
6	149:675	CD	NUMBER	149:675	dep	4	SENT_198	[p9l1530t257r1750b281],
7	—	CD	NUMBER	—	num	8	SENT_198	[p9l1530t257r1750b281],
8	80	CD	NUMBER	80	dep	6	SENT_198	[p9l1530t257r1750b281],
9	.	.	O	.	_	0	SENT_198	[p9l1530t257r1750b281],

1	[	RB	O	[	advmod	2	SENT_199	[p9l1760t256r1805b283],
2	13	CD	NUMBER	13	_	0	SENT_199	[p9l1760t256r1805b283],
3	]	CD	NUMBER	]	dep	2	SENT_199	[p9l1760t256r1805b283],
4	Gonzalez-Conejero	NNP	O	Gonzalez-Conejero	dep	3	SENT_199	[p9l1821t257r2049b283],
5	R	NN	O	r	dep	4	SENT_199	[p9l2058t258r2078b281],
6	,	,	O	,	_	0	SENT_199	[p9l2058t258r2078b281],

1	Rivera	NNP	PERSON	Rivera	nn	2	SENT_200	[p9l6t289r101b316],
2	]	NNP	O	]	_	0	SENT_200	[p9l6t289r101b316],
3	,	,	O	,	_	0	SENT_200	[p9l6t289r101b316],
4	Corral	NNP	O	Corral	nn	5	SENT_200	[p9l110t289r203b316],
5	]	NNP	O	]	appos	2	SENT_200	[p9l110t289r203b316],
6	,	,	O	,	_	0	SENT_200	[p9l110t289r203b316],
7	Acuna	NNP	PERSON	Acuna	nn	8	SENT_200	[p9l211t290r285b310],
8	C	NNP	O	C	appos	2	SENT_200	[p9l294t290r314b314],
9	,	,	O	,	_	0	SENT_200	[p9l294t290r314b314],
10	Guerrero	NNP	LOCATION	Guerrero	nn	11	SENT_200	[p9l323t290r430b310],
11	JA	NNP	LOCATION	JA	appos	2	SENT_200	[p9l436t290r469b316],
12	,	,	O	,	_	0	SENT_200	[p9l436t290r469b316],
13	Vicente	NNP	PERSON	Vicente	nn	15	SENT_200	[p9l477t289r567b310],
14	V.	NNP	O	V.	nn	15	SENT_200	[p9l575t290r597b311],
15	Biological	NNP	O	Biological	appos	11	SENT_200	[p9l606t289r721b316],
16	[	CD	NUMBER	[	number	17	SENT_200	[p9l795t289r840b316],
17	18	CD	NUMBER	18	dep	2	SENT_200	[p9l795t289r840b316],
18	]	NN	O	]	nn	20	SENT_200	[p9l795t289r840b316],
19	Chakroun	NN	O	chakroun	nn	20	SENT_200	[p9l856t289r972b311],
20	T	NN	O	t	dep	17	SENT_200	[p9l987t290r1006b314],
21	,	,	O	,	_	0	SENT_200	[p9l987t290r1006b314],
22	Addad	NNP	ORGANIZATION	Addad	nn	23	SENT_200	[p9l1021t289r1098b311],
23	F	NN	ORGANIZATION	f	appos	2	SENT_200	[p9l1114t290r1131b314],
24	,	,	O	,	_	0	SENT_200	[p9l1114t290r1131b314],
25	Abderazek	NN	O	abderazek	nn	26	SENT_200	[p9l1146t289r1274b311],
26	F	NN	O	f	appos	2	SENT_200	[p9l1289t290r1306b314],
27	,	,	O	,	_	0	SENT_200	[p9l1289t290r1306b314],
28	Ben	NNP	PERSON	Ben	appos	2	SENT_200	[p9l1322t289r1454b311],
29	.	.	O	.	_	0	SENT_200	[p9l1322t289r1454b311],

1	—	NN	O	—	_	0	SENT_201	[p9l1322t289r1454b311],
2	.	.	O	.	_	0	SENT_201	[p9l1322t289r1454b311],

1	Farhat	NNP	O	Farhat	nn	2	SENT_202	[p9l1322t289r1454b311],
2	M	NNP	O	M	_	0	SENT_202	[p9l1469t290r1498b314],
3	,	,	O	,	_	0	SENT_202	[p9l1469t290r1498b314],
4	Hamdi	NNP	PERSON	Hamdi	nn	5	SENT_202	[p9l1513t289r1592b311],
5	S	NNP	PERSON	S	appos	2	SENT_202	[p9l1608t290r1626b314],
6	,	,	O	,	_	0	SENT_202	[p9l1608t290r1626b314],
7	Gamra	NNP	O	Gamra	nn	8	SENT_202	[p9l1642t290r1721b311],
8	H	NNP	O	H	appos	2	SENT_202	[p9l1736t290r1760b314],
9	,	,	O	,	_	0	SENT_202	[p9l1736t290r1760b314],
10	et	FW	O	et	nn	11	SENT_202	[p9l1776t292r1798b311],
11	al.	FW	O	al.	appos	2	SENT_202	[p9l1813t289r1838b311],
12	.	.	O	.	_	0	SENT_202	[p9l1813t289r1838b311],

1	assessment	NN	O	assessment	_	0	SENT_203	[p9l67t324r204b343],
2	of	IN	O	of	_	0	SENT_203	[p9l213t321r238b343],
3	aspirin	NN	O	aspirin	nn	4	SENT_203	[p9l244t321r326b348],
4	efﬁcacy	NN	O	efﬁcacy	prep_of	1	SENT_203	[p9l335t321r425b348],
5	on	IN	O	on	_	0	SENT_203	[p9l434t327r463b343],
6	healthy	JJ	O	healthy	amod	7	SENT_203	[p9l473t321r563b348],
7	individuals	NNS	O	individual	prep_on	4	SENT_203	[p9l572t321r711b343],
8	:	:	O	:	_	0	SENT_203	[p9l572t321r711b343],
9	heterogeneous	JJ	O	heterogeneous	amod	10	SENT_203	[p9l722t321r900b348],
10	response	NN	O	response	dep	1	SENT_203	[p9l909t327r1016b348],
11	or	CC	O	or	_	0	SENT_203	[p9l1025t327r1050b343],
12	Screening	NN	O	screening	conj_or	10	SENT_203	[p9l1184t321r1302b348],
13	for	IN	O	for	_	0	SENT_203	[p9l1308t321r1341b343],
14	aspirin	NN	O	aspirin	nn	15	SENT_203	[p9l1347t321r1428b348],
15	resistance	NN	O	resistance	prep_for	10	SENT_203	[p9l1435t321r1554b343],
16	in	IN	O	in	_	0	SENT_203	[p9l1561t321r1583b342],
17	stable	JJ	O	stable	amod	20	SENT_203	[p9l1590t321r1659b343],
18	coronary	JJ	O	coronary	amod	20	SENT_203	[p9l1666t327r1773b348],
19	artery	NN	O	artery	nn	20	SENT_203	[p9l1779t324r1851b348],
20	patients	NNS	O	patient	prep_in	15	SENT_203	[p9l1856t321r1953b348],
21	by	IN	O	by	_	0	SENT_203	[p9l1959t321r1988b348],
22	three	CD	NUMBER	three	prep_by	20	SENT_203	[p9l1993t321r2056b343],
23	different	JJ	O	different	amod	25	SENT_203	[p9l6t353r109b374],
24	aspirin	NN	O	aspirin	nn	25	SENT_203	[p9l67t385r149b412],
25	failure	NN	O	failure	dep	10	SENT_203	[p9l159t385r248b407],
26	?	.	O	?	_	0	SENT_203	[p9l159t385r248b407],

1	Stroke	NNP	O	Stroke	_	0	SENT_204	[p9l259t385r335b407],
2	2005	CD	DATE	2005	num	1	SENT_204	[p9l345t386r550b410],
3	;	:	O	;	_	0	SENT_204	[p9l345t386r550b410],
4	36:276	CD	NUMBER	36:276	number	5	SENT_204	[p9l345t386r550b410],
5	-130	CD	NUMBER	-130	dep	1	SENT_204	[p9l345t386r550b410],
6	.	.	O	.	_	0	SENT_204	[p9l345t386r550b410],

1	tests	NNS	O	test	_	0	SENT_205	[p9l1184t388r1245b407],
2	.	.	O	.	_	0	SENT_205	[p9l1184t388r1245b407],

1	Thromb	NNP	O	Thromb	nn	2	SENT_206	[p9l1253t385r1348b407],
2	Res	NNP	O	Res	_	0	SENT_206	[p9l1357t386r1397b407],
3	2007	CD	DATE	2007	num	2	SENT_206	[p9l1406t386r1611b410],
4	;	:	O	;	_	0	SENT_206	[p9l1406t386r1611b410],
5	121:413	CD	NUMBER	121:413	number	6	SENT_206	[p9l1406t386r1611b410],
6	—	CD	NUMBER	—	dep	2	SENT_206	[p9l1406t386r1611b410],
7	8	CD	NUMBER	8	dep	6	SENT_206	[p9l1406t386r1611b410],
8	.	.	O	.	_	0	SENT_206	[p9l1406t386r1611b410],

1	[	RB	O	[	advmod	2	SENT_207	[p9l6t417r51b445],
2	14	CD	NUMBER	14	_	0	SENT_207	[p9l6t417r51b445],
3	]	CD	NUMBER	]	num	5	SENT_207	[p9l6t417r51b445],
4	Naran	NN	O	naran	nn	5	SENT_207	[p9l68t419r139b439],
5	NH	NNP	O	NH	dep	2	SENT_207	[p9l151t419r194b443],
6	,	,	O	,	_	0	SENT_207	[p9l151t419r194b443],
7	Chetty	NNP	ORGANIZATION	Chetty	nn	8	SENT_207	[p9l206t417r284b445],
8	N	NNP	ORGANIZATION	N	appos	5	SENT_207	[p9l295t419r318b443],
9	,	,	O	,	_	0	SENT_207	[p9l295t419r318b443],
10	Crowther	NNP	PERSON	Crowther	nn	12	SENT_207	[p9l330t417r443b439],
11	N	NNP	O	N	nn	12	SENT_207	[p9l454t419r486b445],
12	]	NN	O	]	appos	5	SENT_207	[p9l454t419r486b445],
13	.	.	O	.	_	0	SENT_207	[p9l454t419r486b445],

1	The	DT	O	the	det	2	SENT_208	[p9l496t418r540b439],
2	prevalence	NN	O	prevalence	_	0	SENT_208	[p9l552t418r682b445],
3	of	IN	O	of	dep	2	SENT_208	[p9l694t417r719b439],
4	the	DT	O	the	det	7	SENT_208	[p9l727t417r765b439],
5	glycoprotein	NN	O	glycoprotein	nn	7	SENT_208	[p9l776t417r927b445],
6	Illa	NN	O	illum	nn	7	SENT_208	[p9l939t419r975b439],
7	PlA1	NN	O	pla1	pobj	3	SENT_208	[p9l986t418r1050b443],
8	/	:	O	/	punct	2	SENT_208	[p9l986t418r1050b443],
9	[	CD	NUMBER	[	num	10	SENT_208	[p9l1123t417r1168b445],
10	19	CD	NUMBER	19	dep	2	SENT_208	[p9l1123t417r1168b445],
11	]	NN	O	]	nn	13	SENT_208	[p9l1123t417r1168b445],
12	Lordkipanidzé	NN	O	lordkipanidzé	nn	13	SENT_208	[p9l1184t417r1351b445],
13	M	NN	O	m	dep	10	SENT_208	[p9l1362t419r1390b443],
14	,	,	O	,	_	0	SENT_208	[p9l1362t419r1390b443],
15	Pharand	NN	O	pharand	nn	16	SENT_208	[p9l1402t418r1499b439],
16	C	NN	O	c	appos	13	SENT_208	[p9l1510t419r1529b443],
17	,	,	O	,	_	0	SENT_208	[p9l1510t419r1529b443],
18	Schampaert	NNP	O	Schampaert	nn	19	SENT_208	[p9l1540t418r1681b445],
19	E	NNP	O	E	appos	13	SENT_208	[p9l1690t419r1709b443],
20	,	,	O	,	_	0	SENT_208	[p9l1690t419r1709b443],
21	Turgeon	NNP	PERSON	Turgeon	nn	22	SENT_208	[p9l1719t419r1817b445],
22	]	NNP	O	]	appos	13	SENT_208	[p9l1825t419r1840b445],
23	,	,	O	,	_	0	SENT_208	[p9l1825t419r1840b445],
24	Palisaitis	NNP	ORGANIZATION	Palisaitis	nn	25	SENT_208	[p9l1851t418r1952b439],
25	DA	NNP	ORGANIZATION	DA	appos	13	SENT_208	[p9l1963t419r2003b443],
26	,	,	O	,	_	0	SENT_208	[p9l1963t419r2003b443],
27	Diodati	NNP	O	Diodati	nn	28	SENT_208	[p9l2014t417r2098b439],
28	JG	NNP	O	JG	appos	13	SENT_208	[p9l2106t419r2139b445],
29	.	.	O	.	_	0	SENT_208	[p9l2106t419r2139b445],

1	A	DT	O	a	_	0	SENT_209	[p9l6t452r24b473],

1	PlA2	NN	O	pla2	nn	2	SENT_210	[p9l68t484r120b506],
2	polymorphism	NN	O	polymorphism	_	0	SENT_210	[p9l130t484r307b511],
3	in	IN	O	in	_	0	SENT_210	[p9l316t485r337b506],
4	three	CD	NUMBER	three	num	8	SENT_210	[p9l346t484r409b506],
5	south	JJ	O	south	amod	8	SENT_210	[p9l417t484r484b506],
6	African	NNP	MISC	African	nn	8	SENT_210	[p9l491t484r577b506],
7	ethnic	JJ	O	ethnic	amod	8	SENT_210	[p9l586t484r661b506],
8	groups	NNS	O	group	prep_in	2	SENT_210	[p9l668t490r750b511],
9	and	CC	O	and	_	0	SENT_210	[p9l759t484r803b506],
10	its	PRP$	O	its	poss	11	SENT_210	[p9l812t485r838b506],
11	effect	NN	O	effect	conj_and	8	SENT_210	[p9l847t484r913b506],
12	on	IN	O	on	_	0	SENT_210	[p9l921t490r951b506],
13	platelet	NN	O	platelet	nn	14	SENT_210	[p9l959t484r1050b511],
14	comparison	NN	O	comparison	prep_on	11	SENT_210	[p9l1184t485r1322b511],
15	of	IN	O	of	_	0	SENT_210	[p9l1328t484r1353b506],
16	six	CD	NUMBER	six	num	19	SENT_210	[p9l1356t485r1388b506],
17	major	JJ	O	major	amod	19	SENT_210	[p9l1394t485r1463b511],
18	plateletfunction	NN	O	plateletfunction	nn	19	SENT_210	[p9l1469t484r1659b511],
19	tests	NNS	O	test	prep_of	14	SENT_210	[p9l1666t487r1719b506],
20	to	TO	O	to	aux	21	SENT_210	[p9l1725t488r1748b506],
21	determine	VB	O	determine	infmod	2	SENT_210	[p9l1754t484r1876b506],
22	the	DT	O	the	det	23	SENT_210	[p9l1882t484r1920b506],
23	prevalence	NN	O	prevalence	dobj	21	SENT_210	[p9l1925t484r2053b511],
24	of	IN	O	of	_	0	SENT_210	[p9l6t517r31b539],
25	aspirin	NN	O	aspirin	nn	26	SENT_210	[p9l34t517r114b544],
26	function	NN	O	function	prep_of	23	SENT_210	[p9l68t549r173b571],
27	.	.	O	.	_	0	SENT_210	[p9l68t549r173b571],

1	Thromb	NNP	O	Thromb	nn	2	SENT_211	[p9l182t549r277b571],
2	Res	NNP	O	Res	_	0	SENT_211	[p9l287t550r327b571],
3	2008	CD	DATE	2008	num	2	SENT_211	[p9l337t550r557b574],
4	;	:	O	;	_	0	SENT_211	[p9l337t550r557b574],
5	123:316	CD	NUMBER	123:316	number	6	SENT_211	[p9l337t550r557b574],
6	—	CD	NUMBER	—	dep	2	SENT_211	[p9l337t550r557b574],
7	23	CD	NUMBER	23	dep	6	SENT_211	[p9l337t550r557b574],
8	.	.	O	.	_	0	SENT_211	[p9l337t550r557b574],

1	resistance	NN	O	resistance	_	0	SENT_212	[p9l1185t550r1301b571],
2	in	IN	O	in	_	0	SENT_212	[p9l1315t549r1337b570],
3	patients	NNS	O	patient	prep_in	1	SENT_212	[p9l1350t549r1443b576],
4	with	IN	O	with	_	0	SENT_212	[p9l1456t549r1510b571],
5	stable	JJ	O	stable	amod	8	SENT_212	[p9l1524t549r1593b571],
6	coronary	JJ	O	coronary	amod	8	SENT_212	[p9l1606t555r1711b576],
7	artery	NN	O	artery	nn	8	SENT_212	[p9l1723t552r1794b576],
8	disease	NN	O	disease	prep_with	1	SENT_212	[p9l1806t549r1896b571],
9	.	.	O	.	_	0	SENT_212	[p9l1806t549r1896b571],

1	Eur	NNP	O	Eur	nn	3	SENT_213	[p9l1910t550r1950b571],
2	Heart	NNP	O	Heart	nn	3	SENT_213	[p9l1963t550r2028b571],
3	J	NNP	O	J	_	0	SENT_213	[p9l2038t550r2047b576],

1	2007	CD	DATE	2007	num	3	SENT_214	[p9l6t582r110b606],
2	;	:	O	;	_	0	SENT_214	[p9l6t582r110b606],
3	28	CD	NUMBER	28	_	0	SENT_214	[p9l6t582r110b606],
4	:	:	O	:	_	0	SENT_214	[p9l6t582r110b606],
5	[	CD	NUMBER	[	num	9	SENT_214	[p9l120t581r165b608],
6	15	CD	NUMBER	15	num	9	SENT_214	[p9l120t581r165b608],
7	]	CD	NUMBER	]	num	9	SENT_214	[p9l120t581r165b608],
8	Cooke	NNP	PERSON	Cooke	nn	9	SENT_214	[p9l181t581r253b603],
9	GE	NNP	O	GE	dep	3	SENT_214	[p9l263t582r300b606],
10	,	,	O	,	_	0	SENT_214	[p9l263t582r300b606],
11	Liu	NNP	PERSON	Liu	appos	9	SENT_214	[p9l311t581r463b603],
12	.	.	O	.	_	0	SENT_214	[p9l311t581r463b603],

1	—	NN	O	—	_	0	SENT_215	[p9l311t581r463b603],
2	.	.	O	.	_	0	SENT_215	[p9l311t581r463b603],

1	Strattom	FW	O	strattom	_	0	SENT_216	[p9l311t581r463b603],
2	Y	NN	O	y	dep	1	SENT_216	[p9l471t582r493b606],
3	,	,	O	,	_	0	SENT_216	[p9l471t582r493b606],
4	Ferketich	NNP	ORGANIZATION	Ferketich	nn	5	SENT_216	[p9l503t581r613b603],
5	AK	NNP	ORGANIZATION	AK	appos	2	SENT_216	[p9l622t582r661b606],
6	,	,	O	,	_	0	SENT_216	[p9l622t582r661b606],
7	Moeschberger	NNP	O	Moeschberger	nn	8	SENT_216	[p9l671t581r843b608],
8	ML	NNP	O	ML	appos	2	SENT_216	[p9l852t582r893b606],
9	,	,	O	,	_	0	SENT_216	[p9l852t582r893b606],
10	Frid	NNP	PERSON	Frid	nn	12	SENT_216	[p9l903t581r949b603],
11	D	NNP	O	D	nn	12	SENT_216	[p9l959t582r990b608],
12	]	NNP	O	]	appos	2	SENT_216	[p9l959t582r990b608],
13	,	,	O	,	_	0	SENT_216	[p9l959t582r990b608],
14	Magorien	NNP	O	Magorien	nn	15	SENT_216	[p9l1000t581r1113b608],
15	RD	NNP	O	RD	appos	2	SENT_216	[p9l1123t582r1162b606],
16	,	,	O	,	_	0	SENT_216	[p9l1123t582r1162b606],
17	1702-8	CD	NUMBER	1702-8	appos	2	SENT_216	[p9l1299t582r1391b603],
18	.	.	O	.	_	0	SENT_216	[p9l1299t582r1391b603],

1	et	FW	O	et	_	0	SENT_217	[p9l67t617r90b636],
2	al.	FW	O	al.	dep	1	SENT_217	[p9l102t614r127b636],
3	.	.	O	.	_	0	SENT_217	[p9l102t614r127b636],

1	Effect	NN	O	effect	_	0	SENT_218	[p9l140t614r207b636],
2	of	IN	O	of	_	0	SENT_218	[p9l219t614r244b636],
3	platelet	NN	O	platelet	prep_of	1	SENT_218	[p9l253t614r344b641],
4	antigen	NN	O	antigen	dep	1	SENT_218	[p9l356t614r445b641],
5	polymorphism	NN	O	polymorphism	dep	4	SENT_218	[p9l458t614r634b641],
6	on	IN	O	on	_	0	SENT_218	[p9l647t620r676b636],
7	platelet	NN	O	platelet	nn	8	SENT_218	[p9l689t614r780b641],
8	inhibition	NN	O	inhibition	prep_on	5	SENT_218	[p9l792t614r908b636],
9	by	IN	O	by	prep	5	SENT_218	[p9l921t614r950b641],
10	aspirin	NN	O	aspirin	dep	9	SENT_218	[p9l961t614r1049b641],
11	,	,	O	,	_	0	SENT_218	[p9l961t614r1049b641],
12	Clopidogrel	NNP	O	Clopidogrel	conj_or	10	SENT_218	[p9l67t647r211b674],
13	,	,	O	,	_	0	SENT_218	[p9l67t647r211b674],
14	or	CC	O	or	_	0	SENT_218	[p9l221t653r246b669],
15	their	PRP$	O	they	poss	16	SENT_218	[p9l255t647r312b669],
16	combination	NN	O	combination	conj_or	10	SENT_218	[p9l321t647r494b674],
17	.	.	O	.	_	0	SENT_218	[p9l321t647r494b674],
18	]	SYM	O	]	dep	5	SENT_218	[p9l321t647r494b674],

1	Am	VBP	O	be	dep	3	SENT_219	[p9l503t648r544b668],
2	Coll	NNP	O	Coll	nn	3	SENT_219	[p9l554t647r598b669],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_219	[p9l608t647r692b669],
4	2006	CD	DATE	2006	num	3	SENT_219	[p9l702t648r892b672],
5	;	:	O	;	_	0	SENT_219	[p9l702t648r892b672],
6	47:541	CD	NUMBER	47:541	dep	3	SENT_219	[p9l702t648r892b672],
7	—	CD	NUMBER	—	num	8	SENT_219	[p9l702t648r892b672],
8	6	CD	NUMBER	6	dep	6	SENT_219	[p9l702t648r892b672],
9	.	.	O	.	_	0	SENT_219	[p9l702t648r892b672],

1	[	RB	O	[	dep	5	SENT_220	[p9l6t679r51b706],
2	16	CD	NUMBER	16	num	5	SENT_220	[p9l6t679r51b706],
3	]	CD	NUMBER	]	num	5	SENT_220	[p9l6t679r51b706],
4	Papp	NNP	O	Papp	nn	5	SENT_220	[p9l68t680r124b706],
5	E	NNP	O	E	_	0	SENT_220	[p9l134t680r153b704],
6	,	,	O	,	_	0	SENT_220	[p9l134t680r153b704],
7	Havasi	NNP	O	Havasi	nn	8	SENT_220	[p9l162t679r239b701],
8	V	NNP	O	V	appos	5	SENT_220	[p9l247t680r270b704],
9	,	,	O	,	_	0	SENT_220	[p9l247t680r270b704],
10	Bene	NNP	PERSON	Bene	nn	11	SENT_220	[p9l279t680r336b701],
11	J	NNP	PERSON	J	appos	5	SENT_220	[p9l341t680r357b706],
12	,	,	O	,	_	0	SENT_220	[p9l341t680r357b706],
13	Komlosi	NNP	PERSON	Komlosi	nn	14	SENT_220	[p9l366t679r460b701],
14	K	NNP	PERSON	K	appos	11	SENT_220	[p9l470t680r491b704],
15	,	,	O	,	_	0	SENT_220	[p9l470t680r491b704],
16	Czopf	NNP	ORGANIZATION	Czopf	nn	19	SENT_220	[p9l500t679r568b706],
17	L	NNP	ORGANIZATION	L	nn	19	SENT_220	[p9l574t680r591b704],
18	Magyar	NNP	ORGANIZATION	Magyar	nn	19	SENT_220	[p9l601t680r689b706],
19	E	NNP	ORGANIZATION	E	appos	11	SENT_220	[p9l697t680r716b704],
20	,	,	O	,	_	0	SENT_220	[p9l697t680r716b704],
21	et	FW	O	et	nn	22	SENT_220	[p9l725t682r748b701],
22	al.	FW	O	al.	appos	11	SENT_220	[p9l756t679r781b701],
23	.	.	O	.	_	0	SENT_220	[p9l756t679r781b701],

1	Glycoprotein	NN	O	glycoprotein	nn	3	SENT_221	[p9l790t679r941b706],
2	Illa	NN	O	illum	nn	3	SENT_221	[p9l951t680r986b701],
3	gene	NN	O	gene	_	0	SENT_221	[p9l994t685r1050b706],
4	(	CD	NUMBER	(	num	7	SENT_221	[p9l69t711r126b738],
5	PIA	NNP	ORGANIZATION	PIA	nn	7	SENT_221	[p9l69t711r126b738],
6	)	CD	NUMBER	)	num	7	SENT_221	[p9l69t711r126b738],
7	polymorphism	NN	O	polymorphism	dep	3	SENT_221	[p9l136t711r309b738],
8	and	CC	O	and	_	0	SENT_221	[p9l317t711r359b733],
9	aspirin	NN	O	aspirin	nn	10	SENT_221	[p9l368t711r447b738],
10	resistance	NN	O	resistance	dep	3	SENT_221	[p9l456t711r578b733],
11	:	:	O	:	_	0	SENT_221	[p9l456t711r578b733],
12	is	VBZ	O	be	cop	13	SENT_221	[p9l589t711r606b733],
13	there	EX	O	there	dep	3	SENT_221	[p9l614t711r675b733],
14	any	DT	O	any	det	15	SENT_221	[p9l683t717r726b738],
15	correlation	NN	O	correlation	nsubj	13	SENT_221	[p9l733t711r873b733],
16	?	.	O	?	_	0	SENT_221	[p9l733t711r873b733],

1	Ann	NNP	PERSON	Ann	nn	2	SENT_222	[p9l881t712r929b732],
2	Pharmacother	NNP	PERSON	Pharmacother	_	0	SENT_222	[p9l937t711r1049b733, p9l68t744r131b765],
3	2005	CD	DATE	2005	num	2	SENT_222	[p9l138t745r241b768],
4	;	:	O	;	_	0	SENT_222	[p9l138t745r241b768],
5	39	CD	NUMBER	39	num	7	SENT_222	[p9l138t745r241b768],
6	:	:	O	:	_	0	SENT_222	[p9l138t745r241b768],
7	1013-8	CD	NUMBER	1013-8	dep	2	SENT_222	[p9l246t745r338b765],
8	.	.	O	.	_	0	SENT_222	[p9l246t745r338b765],

